,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,BioPlanet_2019,Immune system,150 of 998,1.0644485230209222e-48,1.0995753242806128e-45,0,0,5.175347013580098,571.6772546050474,IFITM3;UBE2D3;RNF19B;UBE2L6;IFI35;IFI30;UBE2Z;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;LGALS3;MT2A;TBK1;PPP2R1B;DHX58;TRIM25;MAP3K8;FBXO6;HLA-DOB;TRIM21;B2M;GBP6;PDIA3;GBP5;GBP7;TAP2;HLA-B;TAP1;HLA-C;HLA-A;HLA-F;RBX1;HLA-E;IFI27;PSME1;PSME2;TXNIP;RBCK1;IL6ST;KPNB1;CFB;CD274;UBA6;DAPP1;UBR2;TXN;HSP90B1;RASGRP3;SOCS2;RAP1B;SOCS3;SOCS1;UBB;UBC;RIPK1;TNFRSF14;LYN;STAT5A;EGR1;JUN;UBE2B;HSPA5;EIF2AK2;ISG15;NFKB1;NFKB2;ISG20;NFKBIA;CYLD;REL;HLA-DRA;XAF1;NFKBIE;MAP3K14;LGMN;CD40;CDKN1A;YWHAB;TNFAIP3;ADAR;CTSS;OASL;IFIH1;CTSO;CTSL;PPP2R5E;CASP4;ITGAV;RAC1;JAK2;JAK1;DTX3L;RIPK2;DDX58;IFNGR2;YWHAZ;TAPBP;PSMA5;PSMA6;RNF144B;PSMA3;PSMA4;PSMA1;OAS1;PSMA2;TRAF3;OAS2;IRF1;OAS3;IRF2;PELI1;TAX1BP1;IRF7;IRF8;IRF9;BIRC3;SP100;C1S;C1R;UNC93B1;NLRC5;IFI6;TANK;USP18;PSMB10;RELA;PSMB4;PAK1;PSMB2;PSMB3;GBP2;GBP1;GBP4;GBP3;CD74;ERAP2;STAT1;STAT2;MX2;STAT3;ERAP1;MX1;PSMB8;PML;PSMB9;TNIP2;PIK3AP1;PTPN2
1,BioPlanet_2019,"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",75 of 280,8.513631381807052e-42,4.183576691292633e-39,0,0,9.8967838184783,935.908218481188,IFITM3;YWHAB;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;OASL;HERC5;MT2A;TRIM25;MAP3K8;JAK2;B2M;JAK1;GBP6;GBP5;GBP7;RIPK2;DDX58;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;YWHAZ;HLA-E;RBX1;IFI27;OAS1;OAS2;IRF1;OAS3;IRF2;PELI1;IRF7;IRF8;IL6ST;KPNB1;IRF9;SP100;IFI6;USP18;RELA;SOCS2;SOCS3;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;GBP3;LYN;STAT5A;EGR1;STAT1;STAT2;MX2;STAT3;MX1;EIF2AK2;ISG15;PSMB8;NFKB1;PML;NFKB2;ISG20;TNIP2;HLA-DRA;XAF1;PTPN2
2,BioPlanet_2019,Interferon signaling,60 of 168,1.2149787099591383e-41,4.183576691292633e-39,0,0,14.789538842463632,1393.341122573818,IFITM3;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;OASL;HERC5;MT2A;TRIM25;JAK2;B2M;JAK1;GBP6;GBP5;GBP7;DDX58;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;IFI27;OAS1;OAS2;IRF1;OAS3;IRF2;IRF7;IRF8;KPNB1;IRF9;SP100;IFI6;USP18;SOCS3;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;GBP3;EGR1;STAT1;MX2;STAT2;MX1;EIF2AK2;ISG15;PML;PSMB8;ISG20;HLA-DRA;XAF1;PTPN2
3,BioPlanet_2019,Interferon alpha/beta signaling,36 of 64,3.1203662155396173e-34,8.058345751631061e-32,0,0,33.25876010781671,2565.9114395873457,IFITM3;IFI6;ADAR;IFI35;IFIT1;USP18;IFIT3;IFIT2;OASL;SOCS3;SOCS1;GBP2;JAK1;EGR1;STAT1;MX2;STAT2;MX1;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PSMB8;HLA-E;ISG20;IFI27;OAS1;OAS2;IRF1;OAS3;IRF2;IRF7;IRF8;XAF1;IRF9
4,BioPlanet_2019,T cell receptor regulation of apoptosis,97 of 603,1.2877410834202853e-33,2.660473078346309e-31,0,0,5.268501912439856,398.9963916141113,IFITM3;CD83;TRAF3IP2;PDCD5;F11R;BZW1;ETS2;TBK1;NAMPT;MAP3K8;PIM2;JUNB;IER2;IER3;IL15RA;HLA-B;TAP1;MR1;PPA1;NCL;PSME1;S100A6;PSME2;LAP3;ATF3;ABCB1;MAX;HSP90B1;TP53BP2;PMAIP1;MCL1;STAT5A;EGR1;HSPA8;JUN;GADD45B;HSPA5;TNFRSF10B;NFKB1;NFKBIA;CXCL10;CXCL11;BCL3;REL;NFKBIE;MAP3K14;CDKN1A;CXCL9;TNFAIP8;BTG1;CXCL8;TRADD;ILK;TNFAIP3;BBC3;CASP3;CASP4;CD38;RAC1;ACTR3;EIF5A;DUSP5;SERPINB1;HSP90AA1;IL15;PGAM1;SPHK1;TNFRSF1A;PSMA5;PSMA6;TRAF3;IRF1;IRF7;PTMA;BIRC3;CEBPD;BCL2A1;RELA;RELB;CCL5;STOM;GBP1;APOL3;GBP3;CCL20;CDKN2A;IL10RB;STAT1;ERAP1;MX1;CFLAR;SOD2;PSMB8;PNRC1;PSMB9;NUCB1;FAS
5,BioPlanet_2019,Interferon-gamma signaling pathway,38 of 97,1.6327710467936415e-28,2.811087485563053e-26,0,0,16.678744846541456,1067.1411874229243,CEBPB;SP100;IFI30;ICAM1;OASL;RAP1B;SOCS3;MT2A;SOCS1;JAK2;GBP2;B2M;GBP1;GBP4;JAK1;GBP3;GBP6;GBP5;GBP7;STAT1;IFNGR2;STAT3;HLA-B;HLA-C;HLA-A;HLA-F;PML;HLA-E;OAS1;OAS2;IRF1;OAS3;IRF2;IRF7;HLA-DRA;IRF8;IRF9;PTPN2
6,BioPlanet_2019,"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",43 of 135,9.131012976244683e-28,1.34747662920868e-25,0,0,12.164892043774032,757.3947666343598,DDR1;CD40;TNFAIP8;CD83;CXCL8;CSF1;CRABP2;BCL2A1;IFIT5;TNFAIP2;TNFAIP3;CXCL1;TAPBPL;CXCL3;CXCL2;CX3CL1;ICAM1;RND1;RELB;UBD;CCL5;NRIP1;TNFSF10;PMAIP1;CCL2;RIPK2;CD70;IFNGR2;SPHK1;TNFRSF10B;INHBA;CFLAR;SOD2;NFKB2;NFKBIA;CXCL10;CXCL11;TRAF4;IRF1;NFKBIE;OPTN;PTPN2;BIRC3
7,BioPlanet_2019,Thymic stromal lymphopoietin (TSLP) pathway,33 of 90,7.803665261656534e-24,1.0076482769113997e-21,0,0,14.893323913811374,792.43576816414,CD274;CD40;CXCL9;CD83;CXCL8;CD82;CSF1;PDCD5;CXCL1;CXCL3;CXCL2;PSMB10;ICAM1;PSMB4;PSMB2;LAMP3;CCL2;IL15RA;IL15;CCL20;PSMB8;PSMB9;PSMA5;CXCL10;PSMA4;PSMA1;PSMA2;IRF1;IRF2;BCL3;PSME1;PSME2;IDO1
8,BioPlanet_2019,Interleukin-2 signaling pathway,95 of 847,6.560625115526189e-21,7.530139715931725e-19,0,0,3.416268184791751,158.76491823510548,IFITM3;BTG1;CXCL8;CSF1;YWHAB;IFIT1;LITAF;ACTB;CTSS;ETS2;BBC3;ICAM1;MT2A;CTSO;ZFP36;CASP3;NAMPT;TNFSF10;BCAP29;PIM2;JAK2;TRIM21;JAK1;IER3;DENND2D;PDIA3;DUSP5;HSP90AA1;WARS;BTN3A1;ACTN1;ARAP2;TAP1;TRAFD1;BTN3A3;BPGM;BTN3A2;ATP1B1;CEACAM1;KARS;TMX1;IRF1;NINJ1;TAGLN2;TOP1;IL6ST;VAMP5;IRF9;LY6E;BIRC3;MT1E;B4GALT5;MACF1;SP100;USP15;ABCB1;CREM;TXN;SAMHD1;RELA;SOCS2;SOCS3;PAK1;SOCS1;CCL5;UBC;RAB29;CTNNA1;PMAIP1;TNFRSF14;GBP1;ZNF267;S100A11;LYN;STAT5A;JUN;APOBEC3G;STAT1;CD70;PTCH1;LIMK2;STAT3;MX1;IFI44;CFLAR;NMI;NFKB1;FOSL2;EHD1;KLF6;BCL6;REL;FAS;CD68;LIMS1
9,BioPlanet_2019,Interleukin-5 regulation of apoptosis,37 of 144,1.8570499493141662e-20,1.918332597641533e-18,0,0,8.920188681624982,405.26836942382056,CXCL8;SDC4;MAX;EBI3;MT1X;CXCL1;HIF1A;CXCL2;RELA;ICAM1;RELB;PSMB4;TBK1;SOCS1;CASP4;CCL2;QSOX1;IER2;IER3;EGR1;DUSP5;LIMK2;INHBA;SOD2;NFKB1;IL17RB;FOSL2;NFKB2;CEACAM1;TRAF3;IRF2;REL;ZYX;NFKBIE;IDO1;NFE2L2;BIRC3
10,BioPlanet_2019,Adaptive immune system,77 of 606,3.0288393002329584e-20,2.8443554519460417e-18,0,0,3.881468277831561,174.44685642354744,CDKN1A;CD40;YWHAB;UBE2D3;RNF19B;UBE2L6;IFI30;UBE2Z;CTSS;ICAM1;CTSO;PPP2R1B;CTSL;PPP2R5E;MAP3K8;ITGAV;FBXO6;RAC1;HLA-DOB;B2M;TRIM21;PDIA3;DTX3L;RIPK2;TAP2;HLA-B;TAP1;HLA-C;HLA-A;HLA-F;YWHAZ;RBX1;HLA-E;TAPBP;PSMA5;PSMA6;RNF144B;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;RBCK1;CD274;UBA6;DAPP1;UBR2;RELA;PSMB10;RASGRP3;RAP1B;SOCS3;PSMB4;PAK1;SOCS1;PSMB2;UBB;PSMB3;UBC;TNFRSF14;LYN;CD74;ERAP2;HSPA5;UBE2B;ERAP1;PSMB8;NFKB1;PSMB9;NFKBIA;REL;HLA-DRA;PIK3AP1;NFKBIE;MAP3K14;LGMN
11,BioPlanet_2019,Apoptosis,47 of 242,3.8058237218341365e-20,3.2761799205455522e-18,0,0,6.273590795889017,280.5246752342723,YWHAB;TRADD;RELA;PSMB10;BBC3;PSMB4;CASP7;PSMB2;FNTA;UBB;PSMB3;CASP3;UBC;CASP4;TNFSF10;PMAIP1;RIPK1;MCL1;JUN;CDKN2A;TNFRSF10B;CFLAR;PSMB8;NFKB1;PSMB9;TNFRSF1A;PSMA5;TJP1;NFKBIA;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;TRAF3;IRF1;IRF2;PSME1;NMT1;IRF7;PSME2;FAS;NFKBIE;MAP3K14;KPNB1;TJP2;BIRC3
12,BioPlanet_2019,Antigen processing: cross presentation,28 of 79,5.9112307533202e-20,4.697154898599821e-18,0,0,14.03367320261438,621.3387451326331,CTSS;PSMB10;PSMB4;PSMB2;UBB;PSMB3;UBC;ITGAV;B2M;PDIA3;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;PSMB8;HLA-E;TAPBP;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2
13,BioPlanet_2019,Type II interferon signaling (interferon-gamma),23 of 50,1.0775884523885092e-19,7.951063366552358e-18,0,0,21.657346087809664,945.8714040257028,CXCL9;STAT1;IFNGR2;STAT2;HLA-B;IFI6;TAP1;EIF2AK2;ISG15;ICAM1;IFIT2;PSMB9;SOCS3;CXCL10;SOCS1;OAS1;IRF1;IRF2;IRF8;JAK2;GBP1;IRF9;JAK1
14,BioPlanet_2019,"Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins",46 of 255,2.1049156246578136e-18,1.3933112359449883e-16,0,0,5.716775171908908,232.6856482042604,UBA6;UBE2D3;RNF19B;UBE2L6;UBR2;UBE2Z;CTSS;PSMB10;SOCS3;PSMB4;SOCS1;PSMB2;UBB;PSMB3;UBC;FBXO6;ITGAV;B2M;TRIM21;PDIA3;HSPA5;UBE2B;DTX3L;ERAP2;ERAP1;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;PSMB8;HLA-E;PSMB9;RBX1;TAPBP;PSMA5;PSMA6;RNF144B;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;RBCK1
15,BioPlanet_2019,Interleukin-1 regulation of extracellular matrix,32 of 120,2.1580812947841062e-18,1.3933112359449883e-16,0,0,9.32683402388496,379.3905388340708,CXCL8;RRAD;C1R;TNFAIP2;AKR1B1;TNFAIP3;CXCL1;CXCL3;CXCL2;RELA;ICAM1;MT2A;ZFP36;SLC25A28;CCL5;NAMPT;CCL2;PIM2;KDM6B;IL15RA;JUN;CCL20;HLA-B;INHBA;AMPD3;SOD2;NFKB1;RHOB;NFKBIA;NFKBIE;ACPP;BIRC3
16,BioPlanet_2019,Proteasome degradation,24 of 63,3.791332823113203e-18,2.303792238985846e-16,0,0,15.656396653744132,628.0377840339626,UBE2B;UBE2D3;HLA-B;HLA-C;HLA-A;HLA-F;UCHL3;PSMB10;PSMB8;HLA-E;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
17,BioPlanet_2019,RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways,25 of 76,4.595182088478359e-17,2.637123942998969e-15,0,0,12.4801447803557,469.4897951986747,UBE2D3;NLRC5;TNFAIP3;UBE2L6;TANK;RELA;HERC5;IFIH1;TBK1;UBB;DHX58;UBC;TRIM25;RIPK1;DDX58;ISG15;NFKB1;NFKB2;NFKBIA;CYLD;TRAF3;IRF1;IRF2;IRF7;TAX1BP1
18,BioPlanet_2019,BDNF signaling pathway,44 of 261,1.6420198644841646e-16,8.927402736906012e-15,0,0,5.250065922475169,190.81592647185136,BTG2;CDKN1A;ABCB1;BTG1;TRAF3IP2;CRABP2;MAST4;INPP1;ADM;RND3;AMOT;PSMB4;ZFP36;PPP2R1B;DPYSL3;TIMP1;PHLDA2;JUNB;CLIC1;IER2;S100A11;TMOD1;KLF10;EGR1;DUSP5;HSPA8;JUN;GCH1;HSPA5;IGFBP3;FNDC3A;SLC39A14;RHOB;DNAJA1;KLF6;MARCKS;ZEB1;CDC42EP4;ZYX;TXNIP;MYH9;B4GALT6;ATF3;LIMS1
19,BioPlanet_2019,Antigen processing and presentation,25 of 81,2.563138883557657e-16,1.3238612333575295e-14,0,0,11.3628818061089,407.9289209932479,IFI30;CTSS;CTSL;B2M;HLA-DOB;PDIA3;CD74;HSPA8;HSP90AA1;HSPA5;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;PSMB8;HLA-E;TAPBP;PSMB9;RFX5;PSME1;PSME2;HLA-DRA;LGMN
20,BioPlanet_2019,Oncostatin M,47 of 311,1.217651295330268e-15,5.989684705124604e-14,0,0,4.617097790490403,158.5596915735602,CDKN1A;CXCL8;CRABP2;C1S;CEBPD;RRAD;C1R;CXCL1;CXCL3;HIF1A;CXCL2;STX11;ETS2;ICAM1;SOCS3;MT2A;SOCS1;CHL1;CCL5;NAMPT;CASP4;CCL2;ITGAV;TIMP1;B2M;JUNB;IER3;TGM2;LYN;KLF10;JUN;SERPINB1;HSPA5;CCL20;STAT1;STAT3;TPM1;AMPD3;SOD2;FOSL2;BTC;OAS1;IRF1;LCN2;IL6ST;ATF3;MT1E
21,BioPlanet_2019,Activation of NF-kappaB in B cells,21 of 68,6.26835413201246e-14,2.9432771901676687e-12,0,0,11.317771719272605,344.06792783680095,PSMB10;RELA;NFKB1;PSMB8;PSMB9;PSMA5;NFKBIA;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;REL;PSME2;NFKBIE
22,BioPlanet_2019,TNF-alpha signaling pathway,25 of 101,7.516184834209015e-14,3.3757473624947442e-12,0,0,8.36391276997274,252.7501892895944,TRADD;TNFAIP3;TXN;TANK;RELA;CASP7;TBK1;CASP3;MAP3K8;RIPK1;RAC1;GLUL;JUN;HSP90AA1;STAT1;CFLAR;NFKB1;NFKB2;TNFRSF1A;NFKBIA;CYLD;REL;NFKBIE;MAP3K14;BIRC3
23,BioPlanet_2019,Negative regulators of RIG-I/MDA5 signaling,15 of 33,3.338384324949269e-13,1.436896253196914e-11,0,0,20.9742245522062,602.5500241963039,DDX58;UBE2D3;NLRC5;TNFAIP3;UBE2L6;ISG15;HERC5;IFIH1;CYLD;TBK1;UBB;TRAF3;UBC;TAX1BP1;TRIM25
24,BioPlanet_2019,mRNA stability regulation by proteins that bind AU-rich elements,22 of 86,1.1479010182624745e-12,4.7431270074605437e-11,0,0,8.711061507936508,239.49396356159625,HSPA8;YWHAB;YWHAZ;PSMB10;PSMB8;ZFP36L1;PSMB9;PSMA5;PSMA6;ZFP36;PSMA3;PSMB4;PSMA4;PSMA1;XRN1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
25,BioPlanet_2019,Downstream signaling events Of B cell receptor (BCR),23 of 98,2.501723658530521e-12,9.939540535623185e-11,0,0,7.777147902869757,207.7590491707718,CDKN1A;NFKB1;PSMB10;RELA;PSMB8;RASGRP3;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;REL;PSME2;NFKBIE
26,BioPlanet_2019,Destabilization of mRNA by AUF1 (hnRNP D0),19 of 66,4.028904268583622e-12,1.541428929424771e-10,0,0,10.212906119474113,267.9613966939486,HSPA8;APOBEC3G;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
27,BioPlanet_2019,Innate immune system,42 of 319,4.606736865107237e-12,1.6995568505913484e-10,0,0,3.902890048657981,101.879095645956,C1S;C1R;UNC93B1;UBE2D3;NLRC5;TNFAIP3;UBE2L6;TXN;TANK;CTSS;RELA;HSP90B1;HERC5;IFIH1;LGALS3;TBK1;PPP2R1B;UBB;CTSL;DHX58;UBC;CASP4;TRIM25;RIPK1;JUN;RIPK2;DDX58;ISG15;NFKB1;NFKB2;NFKBIA;CYLD;TRAF3;IRF1;IRF2;PELI1;TAX1BP1;IRF7;TXNIP;CFB;LGMN;BIRC3
28,BioPlanet_2019,Degradation of beta-catenin by the destruction complex,19 of 73,2.867998363941084e-11,1.0216007965348756e-09,0,0,8.885765871273117,215.7003819323045,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;PSMA1;PSMB2;UBB;PPP2R5E;PSMA2;PSMB3;UBC;PSME1;PSME2
29,BioPlanet_2019,FSH regulation of apoptosis,36 of 263,5.1752236402428926e-11,1.7820020067903023e-09,0,0,4.059869147559281,96.15618790336772,IFITM3;CTNND1;CREM;ILK;MT1X;IFI35;ACTB;CX3CL1;CASP4;PMAIP1;STX4;ACP2;TIMP1;GBP1;IER3;KLF10;IL15;STAT1;ITGA3;ACTN1;ANXA4;IGFBP3;TPM1;RAB27A;ISG15;CFLAR;RANGAP1;RHOB;ZEB1;VGF;BCL3;ID4;S100A6;ACPP;ANGPTL1;PLA1A
30,BioPlanet_2019,Apoptosis regulation,19 of 78,1.0069822374147524e-10,3.2687490874918132e-09,0,0,8.130613429802818,187.15772020294656,CDKN1A;POMP;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;CASP3;UBC;PSME1;PSME2
31,BioPlanet_2019,Toll receptor cascades,27 of 159,1.0125844220691001e-10,3.2687490874918132e-09,0,0,5.199431061614817,119.65630099934056,UNC93B1;UBE2D3;TNFAIP3;UBE2L6;UBE2Z;CTSS;RELA;HSP90B1;TBK1;PPP2R1B;UBB;CTSL;UBC;MAP3K8;RIPK1;JUN;UBE2B;RIPK2;EIF2AK2;NFKB1;NFKB2;NFKBIA;TRAF3;IRF7;PELI1;MAP3K14;LGMN
32,BioPlanet_2019,RIG-I-like receptor signaling pathway,18 of 71,1.5323915637139369e-10,4.796849955504537e-09,0,0,8.566087388282027,193.5851913573365,CXCL8;DDX58;TRADD;ISG15;TMEM173;TANK;RELA;NFKB1;IFIH1;NFKBIA;CXCL10;CYLD;TBK1;TRAF3;DHX58;IRF7;TRIM25;RIPK1
33,BioPlanet_2019,Apoptosis modulation and signaling,19 of 80,1.6160233897173144e-10,4.833426429404931e-09,0,0,7.863215188233007,177.28312567553928,JUN;BCL2A1;CDKN2A;TRADD;TNFRSF10B;CFLAR;NFKB1;BBC3;TNFRSF1A;NFKBIA;CASP7;TRAF3;CASP3;TNFSF10;PMAIP1;FAS;MAP3K14;BIRC3;MCL1
34,BioPlanet_2019,Signaling by the B cell receptor (BCR),26 of 151,1.6376565830510415e-10,4.833426429404931e-09,0,0,5.282148936170213,119.02046789421112,CDKN1A;DAPP1;PSMB10;RELA;RASGRP3;PSMB4;UBB;PSMB2;PSMB3;UBC;LYN;NFKB1;PSMB8;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;REL;PSME2;NFKBIE;PIK3AP1
35,BioPlanet_2019,Cyclin A-Cdk2-associated events at S phase entry,18 of 72,1.9698392882267227e-10,5.652344402050568e-09,0,0,8.407017543859649,187.87917871002276,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
36,BioPlanet_2019,Interleukin-4 regulation of apoptosis,35 of 267,3.205224920183611e-10,8.948641466350461e-09,0,0,3.855815194690676,84.29224072731236,CDKN1A;CEBPB;NNMT;CXCL8;IFI6;CREM;RNF19B;UBE2L6;LITAF;CXCL2;RASGRP3;CTSL;CASP3;TNFSF10;TP53BP2;CCL2;GBP2;TMOD1;HSPA8;JUN;RSAD2;GADD45B;RIPK2;CCL20;STAT1;DENND4A;ACTN1;MX1;ARID5B;INHBA;BCL6;NINJ1;MXD1;MAP3K14;FKBP5
37,BioPlanet_2019,TGF-beta regulation of extracellular matrix,55 of 565,4.0629630842289614e-10,1.1044844384232944e-08,0,0,2.791093754237518,60.35443940695471,CSF1;TNFAIP2;AKR1B1;TNFAIP3;CXCL1;IFIT1;SAT1;IFIT3;ETS2;LGALS3;CTSL;TNFSF10;JUNB;ACTR3;KLF10;ATG3;ARID5A;TAP1;LMO7;BTN3A2;ATP1B1;TNFRSF1A;PKM;ELF3;PPA1;RBP1;NINJ1;MYH9;ATF3;CFB;IRF9;IDO1;CRABP2;C1S;CEBPD;SDC4;STX17;C1R;INPP1;CREM;SDCBP;RRAS;CREG1;STOM;GBP2;SKIL;S100A11;CDKN2A;DENND4A;LIMK2;INHBA;RAB13;LCN2;ID4;PFKP
38,BioPlanet_2019,HIV factor interactions with host,23 of 128,7.78505100809651e-10,2.0620404336829985e-08,0,0,5.546401766004415,116.3282648432874,APOBEC3G;HLA-A;RANGAP1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;RAC1;B2M;KPNB1
39,BioPlanet_2019,Toll-like receptor signaling pathway regulation,24 of 142,1.222053103739041e-09,3.155952140406073e-08,0,0,5.15326170031021,105.75901663803128,JUN;CD40;CXCL9;CXCL8;STAT1;TRAFD1;TNFAIP3;NFKB1;RELA;NFKB2;NFKBIA;CXCL10;CYLD;CXCL11;TBK1;SOCS1;TRAF3;CCL5;IRF7;PELI1;MAP3K8;RIPK1;RBCK1;RAC1
40,BioPlanet_2019,Ubiquitin-mediated degradation of phosphorylated Cdc25A,16 of 64,2.008826570868751e-09,5.0612630431888295e-08,0,0,8.387576552930884,167.96721826855088,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
41,BioPlanet_2019,Interleukin-12-mediated signaling events,16 of 65,2.569585600248202e-09,6.319956964419984e-08,0,0,8.215973003374579,162.50801216667077,STAT5A;GADD45B;RIPK2;STAT1;STAT3;HLA-A;RELA;NFKB1;RELB;NFKB2;SOCS1;TBX21;HLA-DRA;STAT6;JAK2;B2M
42,BioPlanet_2019,Induction of apoptosis through DR3 and DR4/5 death receptors,12 of 34,2.749962821616753e-09,6.60630603425606e-08,0,0,13.671967718965108,269.49743138353506,NFKBIA;CASP7;TRADD;CASP3;TNFSF10;TNFRSF10B;RIPK1;CFLAR;MAP3K14;RELA;NFKB1;BIRC3
43,BioPlanet_2019,Prolactin activation of MAPK signaling,17 of 75,3.216044836133367e-09,7.55039617210402e-08,0,0,7.381122841995559,144.33869525849147,STAT5A;JUN;STAT1;STAT3;YWHAZ;RELA;NFKB1;SOCS2;NFKBIA;SOCS3;PAK1;SOCS1;CASP3;IRF1;RAC1;JAK2;JAK1
44,BioPlanet_2019,TWEAK signaling pathway,13 of 42,3.795315878425089e-09,8.712358449806926e-08,0,0,11.246743295019158,218.0687088087421,JUN;RELA;NFKB1;RELB;NFKB2;NFKBIA;CASP7;TRAF3;CASP3;CCL5;CCL2;RIPK1;RAC1
45,BioPlanet_2019,Endosomal/vacuolar pathway,7 of 9,4.413328270899468e-09,9.910800225737285e-08,0,0,87.2503242542153,1678.577292219562,HLA-B;HLA-C;HLA-A;HLA-F;B2M;CTSS;HLA-E
46,BioPlanet_2019,Prolactin regulation of apoptosis,21 of 118,5.074755551208034e-09,1.1153664860421063e-07,0,0,5.4695692437592776,104.46323450989406,EGR1;HSP90AA1;CEBPB;HSPA5;FNDC3A;RBX1;MYL12B;SOCS2;SOCS3;KLF6;TBK1;PSMA4;BCL6;FTH1;IRF1;BCL3;PHLDA2;TRIB1;GBP1;IER3;GBP3
47,BioPlanet_2019,Interleukin-23-mediated signaling events,12 of 37,8.342689791410963e-09,1.7954163655265677e-07,0,0,12.029451697127936,223.77041880776247,STAT5A;NFKBIA;SOCS3;CXCL9;ITGA3;STAT1;STAT3;CCL2;CXCL1;JAK2;RELA;NFKB1
48,BioPlanet_2019,NOD signaling pathway,17 of 85,2.4043772074195927e-08,5.068819704621305e-07,0,0,6.292378449408673,110.38964810432292,HSP90AA1;CXCL8;RIPK2;TNFAIP3;CXCL1;CXCL2;RELA;NFKB1;HSP90B1;NFKBIA;CYLD;CASP7;CCL5;CASP4;CCL2;RAC1;BIRC3
49,BioPlanet_2019,Autodegradation of Cdh1 by Cdh1-APC/C,14 of 58,3.34194694070478e-08,6.904462379496076e-07,0,0,7.987029985721085,137.48975004785996,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;PSMA2;PSMB3;PSME1;PSME2
50,BioPlanet_2019,Erythropoietin-mediated neuroprotection through NF-kB,7 of 11,3.7776149349141275e-08,7.651522015228025e-07,0,0,43.62062256809339,745.5457050090065,NFKBIA;CDKN1A;JAK2;SOD2;HIF1A;NFKB1;RELA
51,BioPlanet_2019,Epithelial cell signaling in Helicobacter pylori infection,15 of 68,4.008502619252876e-08,7.91713266988167e-07,0,0,7.110339029155024,121.10516425015972,ATP6V1A;LYN;JUN;CXCL8;CXCL1;F11R;RELA;NFKB1;NFKBIA;TJP1;PAK1;CASP3;CCL5;RAC1;MAP3K14
52,BioPlanet_2019,DNA replication pre-Initiation,17 of 88,4.138675355020428e-08,7.91713266988167e-07,0,0,6.025559401084562,102.436347432502,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
53,BioPlanet_2019,HIF-1 degradation in normoxia,17 of 88,4.138675355020428e-08,7.91713266988167e-07,0,0,6.025559401084562,102.436347432502,HSP90AA1;TXN;HIF1A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;PSMA2;PSMB3;PSME1;PSME2
54,BioPlanet_2019,Mitotic G1-G1/S phases,21 of 135,5.910615356259672e-08,1.1101210296393165e-06,0,0,4.649794896753112,77.3908644806869,CDKN1A;MAX;CDKN2A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;E2F5
55,BioPlanet_2019,Antiviral mechanism by interferon-stimulated genes,15 of 70,6.063401165254108e-08,1.1130569112046563e-06,0,0,6.851066364827833,113.85382878026606,DDX58;STAT1;MX2;MX1;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;HERC5;UBB;UBC;TRIM25;KPNB1;JAK1
56,BioPlanet_2019,Epstein-Barr virus LMP1 signaling,9 of 22,6.141746751080872e-08,1.1130569112046563e-06,0,0,17.293287986395917,287.1649310811418,HSP90AA1;CXCL8;CCL20;TRADD;CCL5;MAP3K14;NFKB1;RELA;NFKB2
57,BioPlanet_2019,Licensing factor removal from origins,14 of 61,6.656229250854828e-08,1.185497382091903e-06,0,0,7.476049905313579,123.5426786164907,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;PSMA2;PSMB3;PSME1;PSME2
58,BioPlanet_2019,Interleukin-6 signaling pathway,15 of 71,7.41415319879345e-08,1.2981051278565485e-06,0,0,6.728374836173002,110.46168075261085,CEBPB;JUN;CEBPD;STAT1;STAT3;HSP90B1;SOCS3;IRF1;RAC1;TIMP1;JAK2;IL6ST;JUNB;JAK1;MCL1
59,BioPlanet_2019,APC/C-mediated degradation of cell cycle proteins,16 of 82,8.923160898884055e-08,1.5362708680912045e-06,0,0,6.094329117951165,98.92333611517248,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
60,BioPlanet_2019,Tumor necrosis factor (TNF) pathway,10 of 30,1.1090942153285525e-07,1.878187417105565e-06,0,0,12.501302083333334,200.2027521685881,NFKBIA;JUN;TRADD;CASP3;TNFAIP3;CFLAR;NFKB1;NFKB2;TNFRSF1A;BIRC3
61,BioPlanet_2019,Proteasome complex,9 of 24,1.505054893640782e-07,2.50761565343698e-06,0,0,14.98595578673602,235.41836990279455,PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;PSMA2;PSMB3
62,BioPlanet_2019,TNFR2 signaling pathway,8 of 18,1.5650234823455234e-07,2.550816212040365e-06,0,0,19.96051948051948,312.7852290157542,NFKBIA;TRAF3;TNFAIP3;RIPK1;TANK;MAP3K14;NFKB1;RELA
63,BioPlanet_2019,CD40/CD40L signaling,10 of 31,1.58037016041223e-07,2.550816212040365e-06,0,0,11.905381944444445,186.44347857563835,STAT5A;NFKBIA;CD40;JUN;TRAF3;TNFAIP3;MAP3K14;RELA;NFKB1;BIRC3
64,BioPlanet_2019,Death receptor signaling,7 of 13,1.834371143246912e-07,2.915239063037016e-06,0,0,29.07738867271941,451.0308301412636,TRADD;TNFSF10;TNFRSF10B;FAS;RIPK1;CFLAR;TNFRSF1A
65,BioPlanet_2019,Signaling by interleukins,18 of 109,2.0547632472854547e-07,3.216015809766476e-06,0,0,4.97914979757085,76.66862502679182,LYN;STAT5A;YWHAB;RIPK2;STAT1;STAT3;YWHAZ;NFKB1;RELA;RBX1;NFKB2;SOCS3;TNIP2;PELI1;MAP3K8;IL6ST;JAK2;JAK1
66,BioPlanet_2019,Leptin influence on immune response,18 of 110,2.368873860980185e-07,3.65230850506348e-06,0,0,4.924771167048055,75.13073778892756,IL15;CXCL1;NFKB1;CTSS;CX3CL1;CXCL16;IFIT2;SOCS3;CEACAM1;OAS2;CCL5;IRF2;TNFSF10;CD38;IRF8;CCL2;TIMP1;ANGPTL1
67,BioPlanet_2019,"cAMP receptor, G-protein-independent pathways inferred from amoeba model",6 of 9,2.582508588931235e-07,3.9231343711264205e-06,0,0,49.79015544041451,755.2835178595585,STAT5A;KLF6;STAT1;STAT2;STAT3;STAT6
68,BioPlanet_2019,HIV-1 Nef as negative effector of Fas and TNF,13 of 58,2.639506062605336e-07,3.9516083516975536e-06,0,0,7.241859114015977,109.69608880204603,TRADD;CFLAR;RELA;NFKB1;ACTG1;TNFRSF1A;NFKBIA;CASP7;CASP3;FAS;RIPK1;MAP3K14;BIRC3
69,BioPlanet_2019,HIV infection,25 of 200,2.7528257619905014e-07,4.0623843030516976e-06,0,0,3.613545816733068,54.58429967868119,GTF2B;PSMB10;PSMB4;PSMB2;UBB;PSMB3;UBC;RAC1;B2M;APOBEC3G;HLA-A;RANGAP1;PSMB8;PSMB9;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;NMT1;PSME2;KPNB1
70,BioPlanet_2019,S phase,18 of 112,3.1320412576350005e-07,4.556899463573177e-06,0,0,4.819484882418813,72.17858496145234,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
71,BioPlanet_2019,Interleukin-27-mediated signaling events,9 of 26,3.3531895449667654e-07,4.81089555548704e-06,0,0,13.221525281113744,197.10892709150693,STAT5A;STAT1;TBX21;STAT2;EBI3;STAT3;JAK2;IL6ST;JAK1
72,BioPlanet_2019,Chemokine signaling pathway,24 of 189,3.5446455856440254e-07,4.949139501981459e-06,0,0,3.676296117675428,54.60276700078922,LYN;CXCL9;CXCL8;CCL20;STAT1;STAT2;STAT3;CXCL1;CXCL3;CXCL2;NFKB1;CX3CL1;RELA;CXCL16;RAP1B;NFKBIA;CXCL10;CXCL11;PAK1;GNG5;CCL5;CCL2;RAC1;JAK2
73,BioPlanet_2019,Interferon gamma signaling regulation,7 of 14,3.545366148563679e-07,4.949139501981459e-06,0,0,24.92217898832685,370.1555222473745,SOCS3;SOCS1;STAT1;IFNGR2;JAK2;PTPN2;JAK1
74,BioPlanet_2019,Interleukin-1 signaling pathway,19 of 125,3.632705691186803e-07,5.003446638661291e-06,0,0,4.514430606309196,66.94050933074108,JUN;CXCL8;UBE2B;RIPK2;UBE2D3;TNFAIP3;UBE2L6;UBE2Z;NFKB1;RELA;RBX1;NFKBIA;ZFP36;TNIP2;REL;PELI1;CCL2;MAP3K8;MAP3K14
75,BioPlanet_2019,Interleukin-7 interactions in immune response,10 of 34,4.202526195873196e-07,5.7121178425487e-06,0,0,10.41558159722222,152.9258376415005,CXCL10;JUN;CXCL11;CXCL8;TRAF3;UBC;CXCL1;CXCL3;CXCL2;LITAF
76,BioPlanet_2019,p53 signaling pathway,20 of 139,4.47310386834381e-07,6.000930254544358e-06,0,0,4.235604532050287,61.92459376869679,DUSP5;DDX5;JUN;BTG2;CDKN1A;CD82;BCL2A1;IGFBP3;TAP1;TNFRSF10B;CX3CL1;PML;BBC3;RNF144B;BCL6;TP53BP2;PMAIP1;FAS;ATF3;MCL1
77,BioPlanet_2019,TNF/stress-related signaling,9 of 27,4.856662369520693e-07,6.43196439450625e-06,0,0,12.48634590377113,181.5233027943472,NFKBIA;JUN;TRADD;RIPK1;TANK;MAP3K14;RELA;NFKB1;TNFRSF1A
78,BioPlanet_2019,Viral myocarditis,14 of 71,4.96232078597816e-07,6.488705534070176e-06,0,0,6.1612473592357855,89.43803519833331,CD40;HLA-B;HLA-C;HLA-A;HLA-F;ACTB;ACTG1;ICAM1;HLA-E;CASP3;MYH9;HLA-DRA;RAC1;HLA-DOB
79,BioPlanet_2019,Binding of chemokines to chemokine receptors,12 of 54,8.407682311785606e-07,1.0856419785093163e-05,0,0,7.154046997389034,100.0776043286129,CXCL10;CXCL9;CXCL11;CXCL8;CCL20;CCL5;CCL2;CXCL1;CXCL3;CXCL2;CX3CL1;CXCL16
80,BioPlanet_2019,TSH regulation of gene expression,16 of 97,9.841127917315848e-07,1.2550475479737374e-05,0,0,4.961861248825378,68.63010950102611,PPP1R15A;EGR1;JUN;CXCL8;CSF1;GADD45B;TNFAIP3;ADM;TTF2;STX11;ICAM1;VMP1;TP53BP2;CCL2;HES1;NFKBIE
81,BioPlanet_2019,CD40L signaling pathway,7 of 16,1.1036980702271214e-06,1.390390373834898e-05,0,0,19.381899409136764,265.8584932281463,NFKBIA;CD40;TRAF3;TNFAIP3;MAP3K14;NFKB1;RELA
82,BioPlanet_2019,Semaphorin interactions,13 of 66,1.28355233478776e-06,1.5974813998021158e-05,0,0,6.146183253175484,83.37837870797512,HSP90AA1;LIMK2;ITGA1;RND1;RHOB;MYL12B;PAK1;RRAS;CFL1;DPYSL3;MYH9;PLXNC1;RAC1
83,BioPlanet_2019,NF-kappaB signaling pathway,8 of 24,2.1367236506198323e-06,2.627661346536056e-05,0,0,12.471428571428572,162.82992599104642,NFKBIA;TRADD;TNFAIP3;RIPK1;MAP3K14;NFKB1;RELA;TNFRSF1A
84,BioPlanet_2019,Caspase cascade in apoptosis,12 of 59,2.2954996239748505e-06,2.789707190077671e-05,0,0,6.391311593800345,82.98836910530193,CASP7;TRADD;CASP3;CFL2;CASP4;TNFSF10;TNFRSF10B;FAS;RIPK1;TOP1;TNFRSF1A;BIRC3
85,BioPlanet_2019,CXCR4 signaling pathway,17 of 116,2.4936596172789062e-06,2.995291144940825e-05,0,0,4.315042673781176,55.67164151770863,LYN;STAT5A;ITGA3;STAT1;STAT2;ITGA1;STAT3;NFKB1;RELA;RHOB;RAP1B;PAK1;CFL1;HLA-DRA;ITGAV;RAC1;JAK2
86,BioPlanet_2019,PDGFB signaling pathway,18 of 129,2.621448445500277e-06,3.112593384139985e-05,0,0,4.07773826458037,52.40620955466155,LYN;STAT5A;ACTR3;JUN;YWHAB;STAT1;SPHK1;STAT3;EIF2AK2;ARPC5;YWHAZ;RAP1B;PAK1;ARPC2;ITGAV;RAC1;JAK2;PTPN2
87,BioPlanet_2019,Cell cycle checkpoints,17 of 117,2.813618278399189e-06,3.302804183620866e-05,0,0,4.271668856767412,54.59636736133911,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
88,BioPlanet_2019,Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP),10 of 42,3.55643076989445e-06,4.127857286855018e-05,0,0,7.808430989583333,97.9704557930839,STAT5A;CSF1;STAT1;ITGA1;STAT3;EIF2AK2;STAT6;KPNB1;PTPN2;JAK1
89,BioPlanet_2019,Interleukin-22 soluble receptor signaling pathway,6 of 13,4.6132966730362586e-06,5.295039403607172e-05,0,0,21.33419689119171,262.1240574810533,STAT5A;SOCS3;STAT1;STAT3;JAK2;JAK1
90,BioPlanet_2019,Cytokine-cytokine receptor interaction,27 of 265,5.267151029646758e-06,5.979084630357255e-05,0,0,2.8677058040260044,34.85415640099306,CD40;CXCL9;CXCL8;CSF1;CXCL1;CXCL3;CXCL2;CX3CL1;CXCL16;CCL5;TNFSF10;CCL2;TNFRSF14;IL15RA;IL15;CCL20;CD70;IL10RB;IFNGR2;TNFRSF10B;INHBA;IL17RB;TNFRSF1A;CXCL10;CXCL11;FAS;IL6ST
91,BioPlanet_2019,Gastrin pathway,10 of 44,5.589257281693138e-06,6.275763882596752e-05,0,0,7.348345588235294,88.87577191222726,CHGA;JUN;CXCL8;CDKN2A;S100A6;HES1;ITGAV;NFKB1;IER3;BIRC3
92,BioPlanet_2019,Senescence and autophagy,15 of 99,6.346190619106372e-06,7.049048289824605e-05,0,0,4.479030144167759,53.60349120673835,ATG3;UVRAG;JUN;CDKN1A;CEBPB;CXCL8;KMT2A;CDKN2A;CXCL1;INHBA;IRF1;CREG1;IRF7;IL6ST;SLC39A1
93,BioPlanet_2019,EGFR1 pathway,19 of 152,7.290187250423604e-06,8.01145045711445e-05,0,0,3.5928853754940717,42.50017401441533,CDKN1A;BTG1;CSF1;SDC4;ITGA3;IGFBP3;PDCD5;ARID5B;MT1X;ZFP36L1;EHD1;BCL6;NINJ1;MT1F;LCN2;ZYX;TXNIP;PHLDA2;IER3
94,BioPlanet_2019,TRAF3-dependent IRF activation pathway,6 of 14,7.807403818090268e-06,8.4895243621971e-05,0,0,18.666450777202076,219.5256382966194,IFIH1;TBK1;DDX58;TRAF3;IRF7;TRIM25
95,BioPlanet_2019,Cytosolic DNA-sensing pathway,11 of 56,8.638955635947355e-06,9.295876220764184e-05,0,0,6.111748515138346,71.25827466007146,NFKBIA;CXCL10;TBK1;DDX58;CCL5;IRF7;ADAR;RIPK1;TMEM173;RELA;NFKB1
96,BioPlanet_2019,Phagosome,19 of 154,8.82887070591024e-06,9.402292205366266e-05,0,0,3.539286585663397,41.188389045654674,ATP6V1A;STX12;C1R;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;ACTB;CTSS;ACTG1;HLA-E;TUBA1C;CTSL;HLA-DRA;ITGAV;RAC1;HLA-DOB
97,BioPlanet_2019,Allograft rejection,9 of 37,9.088223576591128e-06,9.57972954552922e-05,0,0,8.022756827048115,93.13242209433652,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-DOB;HLA-E
98,BioPlanet_2019,Activation of pro-caspase 8,5 of 9,9.725382942366212e-06,0.00010147798565115452,0,0,31.07697283311772,358.65223591868545,TRADD;TNFSF10;FAS;TNFRSF10B;RIPK1
99,BioPlanet_2019,Pathways in cancer,30 of 325,1.1662205078334044e-05,0.00012009299846792824,0,0,2.5732348409317503,29.229779276884774,CDKN1A;RALA;CXCL8;MAX;HIF1A;RELA;HSP90B1;CASP3;CTNNA1;ITGAV;RAC1;JAK1;STAT5A;JUN;HSP90AA1;LAMB3;CDKN2A;STAT1;ITGA3;PTCH1;STAT3;NFKB1;PML;RBX1;NFKB2;NFKBIA;TRAF4;TRAF3;FAS;BIRC3
100,BioPlanet_2019,Interleukin-4 signaling pathway,15 of 104,1.1741909821162396e-05,0.00012009299846792824,0,0,4.226294785515484,47.97836104285776,STAT5A;CEBPB;STAT1;STAT3;PARP14;NFKB1;RELA;NFKBIA;SOCS3;SOCS1;BCL6;HLA-DRA;STAT6;JAK2;JAK1
101,BioPlanet_2019,TRAF6 mediated NF-kB activation,7 of 22,1.3408571429087709e-05,0.0001357946498651726,0,0,11.625507998270644,130.43374015637397,IFIH1;NFKBIA;DDX58;TRIM25;NFKB1;RELA;NFKB2
102,BioPlanet_2019,Interferon-beta enhancer pathway,8 of 30,1.382013791554826e-05,0.00013727117756501302,0,0,9.067296340023614,101.4574584164994,JUN;GTF2B;IRF1;IRF2;IRF7;ACTB;RELA;NFKB1
103,BioPlanet_2019,TRAF6-mediated IRF7 activation,8 of 30,1.382013791554826e-05,0.00013727117756501302,0,0,9.067296340023614,101.4574584164994,IFIH1;TBK1;DDX58;IRF1;IRF2;IRF7;TRIM25;TANK
104,BioPlanet_2019,AP-1 transcription factor network,12 of 70,1.4741389191918529e-05,0.00014502719081192227,0,0,5.176195192221122,57.58440248223318,EGR1;MT2A;JUN;CXCL8;CDKN2A;CCL2;TIMP1;HLA-A;JUNB;HIF1A;ATF3;FOSL2
105,BioPlanet_2019,Regular glucocorticoid receptor pathway,13 of 82,1.5790010099439557e-05,0.00015387811728982136,0,0,4.717040825992233,52.1522311635444,STAT5A;EGR1;CDKN1A;HSP90AA1;JUN;CXCL8;STAT1;RELA;NFKB1;ICAM1;IRF1;TBX21;FKBP5
106,BioPlanet_2019,Adipogenesis,17 of 133,1.6234148669243234e-05,0.0001567278091152174,0,0,3.679391907200145,40.577782130990144,STAT5A;CDKN1A;CEBPB;GADD45B;CEBPD;STAT1;STAT2;STAT3;HIF1A;SOCS3;KLF6;SOCS1;NAMPT;NRIP1;FAS;STAT6;IL6ST
107,BioPlanet_2019,Alpha-V beta-3 integrin/OPN pathway,8 of 31,1.799546105852164e-05,0.00017212325253197086,0,0,8.672614342179559,94.75170263960304,NFKBIA;JUN;ILK;ITGAV;RAC1;MAP3K14;RELA;NFKB1
108,BioPlanet_2019,Acetylation and deacetylation of RelA in the nucleus,6 of 16,1.947243486612603e-05,0.00018121644339376744,0,0,14.93160621761658,161.95582644441842,NFKBIA;TRADD;RIPK1;NFKB1;RELA;TNFRSF1A
109,BioPlanet_2019,Interleukin-10 anti-inflammatory signaling pathway,6 of 16,1.947243486612603e-05,0.00018121644339376744,0,0,14.93160621761658,161.95582644441842,STAT5A;IL10RB;STAT1;STAT3;BLVRA;JAK1
110,BioPlanet_2019,p75 neurotrophin receptor signaling via NF-kB,6 of 16,1.947243486612603e-05,0.00018121644339376744,0,0,14.93160621761658,161.95582644441842,NFKBIA;UBB;RIPK2;UBC;NFKB1;RELA
111,BioPlanet_2019,Leptin signaling pathway,11 of 61,2.0322636811455266e-05,0.00018744003416279725,0,0,5.499139504563233,59.41146688706996,SOCS2;SOCS3;STAT1;CFL2;STAT3;REL;RAC1;JAK2;RELA;NFKB1;JAK1
112,BioPlanet_2019,Disease,49 of 674,2.099669155102865e-05,0.0001919432068337398,0,0,2.00000658436214,21.542362276806823,CDKN1A;CXCL8;YWHAB;GTF2B;ACTB;RAC1;B2M;SLC30A7;HSP90AA1;IGFBP3;HLA-A;RANGAP1;PDIA6;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;DNAJB11;PSME1;PSME2;ATF3;KPNB1;ATP6V1A;STX12;STX11;PSMB10;HSP90B1;PSMB4;PSMB2;UBB;PSMB3;UBC;CCL2;STX4;EPS15;STAT5A;APOBEC3G;HSPA5;STAT1;STAT3;EIF2AK2;RAB27A;PSMB8;PSMB9;NMT1;HDGF
113,BioPlanet_2019,Shigellosis,11 of 62,2.384755610761273e-05,0.00021609232858915743,0,0,5.391032032108802,57.38122208682504,NFKBIA;CXCL8;ARPC2;RIPK2;RAC1;ARPC5;PFN1;ACTB;RELA;NFKB1;ACTG1
114,BioPlanet_2019,RANKL regulation of apoptosis and immune response,12 of 74,2.6373946980699765e-05,0.0002369068454875031,0,0,4.8412364187652654,51.04180376522704,EGR1;JUN;ITGA3;TRAF3;CD70;CCL5;HLA-C;TXNIP;CCL2;TXN;ICAM1;RELB
115,BioPlanet_2019,Alternative NF-kappaB pathway,4 of 6,3.2013914509205925e-05,0.0002850894283449114,0,0,49.6640826873385,513.9904736089461,MAP3K14;NFKB1;NFKB2;RELB
116,BioPlanet_2019,Type 1 diabetes mellitus,9 of 43,3.342351005157166e-05,0.0002950981699425088,0,0,6.604910885030215,68.07186949194914,GAD1;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-DOB;HLA-E
117,BioPlanet_2019,RANKL signaling pathway,10 of 54,3.793089708730469e-05,0.00033205607365411645,0,0,5.675307765151516,57.77318329990229,LYN;NFKBIA;JUN;TRAF3;RAC1;RELA;NFKB1;ICAM1;RELB;NFKB2
118,BioPlanet_2019,Fas signaling pathway,15 of 115,3.970471433087455e-05,0.0003446636126369194,0,0,3.759239842726082,38.09628929820904,CXCL8;RIPK2;CFLAR;ACTB;NFKB1;ACTG1;NFKB2;CASP7;PAK1;CASP3;FAS;RIPK1;CD47;MAP3K14;BIRC3
119,BioPlanet_2019,MAPK signaling pathway,28 of 314,4.209856131011495e-05,0.0003604699306495537,0,0,2.471832167832168,24.90493756929023,RALA;MAX;TRADD;RELA;RELB;RASGRP3;RAP1B;PAK1;CASP7;RRAS;CASP3;MAP3K8;RIPK1;RAC1;DUSP5;HSPA8;NTRK2;JUN;GADD45B;H3F3B;HSPA5;STAT1;CACNA2D1;NFKB1;NFKB2;TNFRSF1A;FAS;MAP3K14
120,BioPlanet_2019,Bone remodeling,6 of 18,4.222348655236786e-05,0.0003604699306495537,0,0,12.441709844559586,125.31954466064188,NFKBIA;EIF2AK2;NFKB1;RELA;IRF9;FOSL2
121,BioPlanet_2019,Toll-like receptor endosomal trafficking and processing,5 of 12,5.543748774664558e-05,0.0004694010232974171,0,0,17.755498059508408,174.00840009345367,CTSL;UNC93B1;CTSS;HSP90B1;LGMN
122,BioPlanet_2019,GM-CSF-mediated signaling events,8 of 36,5.810581937088872e-05,0.0004879944017083581,0,0,7.1220779220779225,69.46336901594488,LYN;STAT5A;STAT1;STAT3;CCL2;IRF8;JAK2;YWHAZ
123,BioPlanet_2019,Apoptosis modulation by HSP70,6 of 19,5.968611668417453e-05,0.0004972238591512281,0,0,11.484057393383818,111.69866348737504,CASP7;CASP3;FAS;RIPK1;NFKB1;TNFRSF1A
124,BioPlanet_2019,Keratinocyte differentiation,10 of 57,6.161082628392925e-05,0.0005091518684103912,0,0,5.312222960992908,51.50026425230055,NFKBIA;JUN;FAS;RIPK1;MAP3K14;ETS2;RELA;NFKB1;TNFRSF1A;BIRC3
125,BioPlanet_2019,MAP kinase signaling pathway,12 of 81,6.62912918070404e-05,0.0005434833685450216,0,0,4.348507208536724,41.83895344248058,NFKBIA;PAK1;JUN;MAX;STAT1;TRADD;MAP3K8;RIPK1;RAC1;MAP3K14;RELA;NFKB1
126,BioPlanet_2019,Notch signaling pathway,15 of 121,7.210352744186534e-05,0.0005864798728145425,0,0,3.545339894656149,33.813351622452736,PSENEN;CDKN1A;MAML2;DTX3L;STAT3;CFLAR;HIF1A;NFKB1;NUMB;RBBP8;CIR1;HES1;JAK2;EPS15;BIRC3
127,BioPlanet_2019,Signaling by Hippo,6 of 20,8.246979983879508e-05,0.0006655570565115259,0,0,10.66321243523316,100.26702246251588,TJP1;YWHAB;CASP3;AMOT;SAV1;TJP2
128,BioPlanet_2019,Diurnally regulated genes with circadian orthologs,9 of 48,8.353755598701355e-05,0.0006689480258494961,0,0,5.756626988096429,54.05596080390988,DNAJA1;HSPA8;CEBPB;BTG1;PSMA4;RBPMS;G0S2;QKI;ETV6
129,BioPlanet_2019,Double stranded RNA-induced gene expression,5 of 13,8.720288097690689e-05,0.0006929275080703448,0,0,15.535252263906855,145.21224696873472,NFKBIA;EIF2AK2;MAP3K14;NFKB1;RELA
130,BioPlanet_2019,Integrated breast cancer pathway,17 of 152,9.082008033988033e-05,0.0007161613968785983,0,0,3.158407553414124,29.39413095529337,JUN;RALA;USP15;APOBEC3G;MAX;STAT1;TRADD;MYCBP2;BACH1;NFKB1;PML;RASGRP3;PAK1;RRAS;CASP3;RAC1;JAK1
131,BioPlanet_2019,Sema4D in semaphorin signaling,7 of 29,9.673359349489026e-05,0.0007570136521228912,0,0,7.923593915811814,73.24213508822059,RRAS;LIMK2;MYH9;RAC1;MYL12B;RND1;RHOB
132,BioPlanet_2019,Leishmaniasis,11 of 72,9.962214341268248e-05,0.0007737569484609099,0,0,4.504905208711822,41.50876463757669,NFKBIA;JUN;MARCKSL1;STAT1;IFNGR2;HLA-DRA;JAK2;HLA-DOB;RELA;NFKB1;JAK1
133,BioPlanet_2019,Cytosolic sensors of pathogen-associated DNA,6 of 21,0.00011167434133375056,0.0008608924969982413,0,0,9.951813471502591,90.56074216073428,NFKBIA;TBK1;RIPK1;NFKB1;RELA;NFKB2
134,BioPlanet_2019,Integrin signaling pathway,17 of 155,0.00011575999002808148,0.0008857782940667272,0,0,3.089260888609572,28.00103462650678,JUN;RALA;CDKN2A;ACTN1;ILK;ARPC5;ACTB;MYL12A;ACTG1;MYL12B;RHOB;RAP1B;PAK1;RRAS;ARPC2;ZYX;RAC1
135,BioPlanet_2019,TNFR1 signaling pathway,7 of 30,0.00012196828377111848,0.000926420861290922,0,0,7.578695088253538,68.29730179437493,PAK1;JUN;TRADD;CASP3;RIPK1;TNFRSF1A;BIRC3
136,BioPlanet_2019,Graft-versus-host disease,8 of 41,0.00015450391545929326,0.0011649820778791,0,0,6.041401023219205,53.01505274639399,HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-DOB;HLA-E
137,BioPlanet_2019,Autoimmune thyroid disease,9 of 52,0.00015950057679268542,0.0011939427233829,0,0,5.220038104454592,45.64121012663175,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-DOB;HLA-E
138,BioPlanet_2019,DNA replication,20 of 207,0.0001761032362248105,0.0013087384389944,0,0,2.685790075204944,23.21715160201916,CDKN1A;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;PSMA1;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2
139,BioPlanet_2019,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,5 of 15,0.00019067611508682863,0.0014069173348906,0,0,12.426908150064683,106.43565188016956,TBK1;UBB;TRAF3;UBC;IRF7
140,BioPlanet_2019,Modulation of interferon signaling by chaperones,6 of 23,0.0001943696782502692,0.0014239991321455,0,0,8.780097531240475,75.0325066611879,NFKBIA;IFNGR2;JAK2;NFKB1;RELA;TNFRSF1A
141,BioPlanet_2019,Growth hormone receptor signaling,8 of 43,0.0002189328027235714,0.0015926590507989,0,0,5.695584415584416,47.99524155198942,SOCS2;LYN;STAT5A;SOCS3;SOCS1;STAT1;STAT3;JAK2
142,BioPlanet_2019,Amino acid metabolism,19 of 195,0.00022733449948307937,0.0016422135522099,0,0,2.708962151155827,22.725722034845305,INHBA;PSMB8;PSMB10;PSMB9;CNDP2;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;PSMA2;PSMB3;ETHE1;PSME1;PSME2;GLUL;IDO1
143,BioPlanet_2019,TAp63 pathway,9 of 55,0.00024843655565627126,0.001782187236062,0,0,4.878837564312772,40.495927913029824,CDKN1A;TRAF4;ITGA3;CDKN2A;IGFBP3;PMAIP1;FAS;PML;BBC3
144,BioPlanet_2019,Integrin-linked kinase signaling,8 of 45,0.0003038804727876049,0.0021648864026868,0,0,5.387153387153387,43.62988789771881,HSP90AA1;JUN;ZEB1;ACTN1;ZYX;ILK;RAC1;LIMS1
145,BioPlanet_2019,Interferon alpha signaling regulation,6 of 25,0.0003190739004338798,0.0022575571174534,0,0,7.855058631033542,63.2339118048398,SOCS3;SOCS1;STAT1;STAT2;USP18;JAK1
146,BioPlanet_2019,TGF-beta signaling pathway,18 of 185,0.00033482667346292934,0.0023528976441306,0,0,2.702410967538607,21.62441570748532,KLF10;PPP1R15A;JUN;STAT1;LIMK2;STAT3;INHBA;NFKB1;PML;RBX1;KLF6;ZEB1;RAC1;E2F5;JUNB;SKIL;ATF3;JAK1
147,BioPlanet_2019,Atypical NF-kappaB pathway,5 of 17,0.00036824366219419805,0.0025702412368013,0,0,10.354678740836569,81.87201884107021,NFKBIA;BCL3;REL;NFKB1;RELA
148,BioPlanet_2019,Interferon-alpha signaling pathway,4 of 10,0.00039544391322882686,0.0027415675326535,0,0,16.551248923341948,129.6873373071267,STAT1;STAT2;IRF9;JAK1
149,BioPlanet_2019,Interleukin-9 regulation of target genes,6 of 26,0.0004012547621190699,0.0027623180353335,0,0,7.461917098445596,58.35901201684396,SOCS2;SOCS3;BCL3;LCN2;CCL2;JUNB
150,BioPlanet_2019,Rac1 cell motility signaling pathway,10 of 71,0.0004037851145550544,0.0027623180353335,0,0,4.090035860655738,31.962107596829917,ACTR3;STAT5A;PAK1;JUN;ARPC2;CFL1;STAT3;CTNNA1;RAC1;ARPC5
151,BioPlanet_2019,Regulation of NFAT transcription factors,8 of 47,0.0004139730872608991,0.0028133828890822,0,0,5.110356310356311,39.80819157375693,EGR1;BATF3;JUN;CXCL8;CASP3;TBX21;JUNB;GBP3
152,BioPlanet_2019,Costimulation by the CD28 family,10 of 72,0.00045284385431579554,0.00305743595757,0,0,4.02385752688172,30.98355481610296,LYN;CD274;PAK1;PPP2R1B;PPP2R5E;HLA-DRA;MAP3K8;TNFRSF14;RAC1;MAP3K14
153,BioPlanet_2019,ATM pathway,8 of 48,0.0004800604866740658,0.0032201459917812,0,0,4.982337662337662,38.07302374841531,NFKBIA;CDKN1A;JUN;YWHAB;RBBP8;NBN;RELA;NFKB1
154,BioPlanet_2019,Myc repressed pathway,10 of 73,0.0005067502686357025,0.003377245338714,0,0,3.959780092592593,30.04480073462133,CDKN1A;CEBPD;MAX;FTH1;CSDE1;CCL5;IRF8;CFLAR;ZFP36L1;TJP2
155,BioPlanet_2019,Ceramide signaling pathway,8 of 49,0.0005544452346865707,0.003648037754339,0,0,4.860563826417485,36.442283965909695,NFKBIA;TRADD;EIF2AK2;RIPK1;RELA;NFKB1;TNFRSF1A;BIRC3
156,BioPlanet_2019,Interleukin-5 signaling pathway,8 of 49,0.0005544452346865707,0.003648037754339,0,0,4.860563826417485,36.442283965909695,LYN;STAT5A;JUN;STAT1;STAT3;HLA-DRA;JAK2;JAK1
157,BioPlanet_2019,TP53 network,5 of 19,0.0006486199911380399,0.0042406610813012,0,0,8.874514877102198,65.14482781645678,CDKN1A;CDKN2A;TNFSF10;PMAIP1;BBC3
158,BioPlanet_2019,FAS pathway and stress induction of heat shock protein regulation,7 of 39,0.0006798112001878507,0.0043916890214169,0,0,5.4446335927367056,39.711499235732965,CASP7;PAK1;JUN;RIPK2;CASP3;FAS;CFLAR
159,BioPlanet_2019,Cell adhesion molecules (CAMs),14 of 133,0.0006844742811695388,0.0043916890214169,0,0,2.941638435478904,21.435305941202824,CD274;CD40;SDC4;HLA-B;HLA-C;HLA-A;F11R;HLA-F;ICAM1;HLA-E;HLA-DRA;ITGAV;HLA-DOB;MPZL1
160,BioPlanet_2019,Tight junction,14 of 133,0.0006844742811695388,0.0043916890214169,0,0,2.941638435478904,21.435305941202824,RAB3B;ACTN1;F11R;ACTB;MYL12A;ACTG1;MYL12B;TJP1;PPP2R1B;RRAS;RAB13;CTNNA1;MYH9;TJP2
161,BioPlanet_2019,Chagas disease,12 of 104,0.0007182524084185628,0.0045799675178788,0,0,3.257463957316381,23.579770167043858,NFKBIA;JUN;CXCL8;PPP2R1B;IFNGR2;CCL5;CCL2;FAS;CFLAR;NFKB1;RELA;TNFRSF1A
162,BioPlanet_2019,Influence of Ras and Rho proteins on G1 to S transition,6 of 29,0.0007495401460720185,0.0047501531956588,0,0,6.487609822031989,46.68516905876286,NFKBIA;CDKN1A;PAK1;RAC1;RELA;NFKB1
163,BioPlanet_2019,Jak-STAT signaling pathway,18 of 199,0.0007994793122741052,0.0050357446925557,0,0,2.4915527769700496,17.768632962066842,STAT5A;IL15RA;CXCL8;IL15;IL10RB;STAT1;IFNGR2;STAT2;STAT3;SOCS2;SOCS3;SOCS1;STAT6;JAK2;IL6ST;IRF9;PTPN2;JAK1
164,BioPlanet_2019,ID regulation of gene expression,5 of 20,0.0008373376871765884,0.0052422413991116,0,0,8.282449331608452,58.683498436566325,CDKN1A;CXCL8;CDKN2A;CXCL1;ICAM1
165,BioPlanet_2019,ERBB1 downstream pathway,12 of 106,0.000852219935688883,0.0053032722504013,0,0,3.1878228987278483,22.53046727298233,ACTR3;EGR1;ZFP36;JUN;RALA;ARPC2;YWHAB;STAT1;STAT3;ARPC5;RAC1;YWHAZ
166,BioPlanet_2019,NF-kappaB activation through FADD/RIP-1 pathway,4 of 12,0.0008757666684738258,0.0053849224317467,0,0,12.412144702842378,87.38659839526787,IFIH1;DDX58;TRIM25;RIPK1
167,BioPlanet_2019,SODD/TNFR1 signaling pathway,4 of 12,0.0008757666684738258,0.0053849224317467,0,0,12.412144702842378,87.38659839526787,TRADD;RIPK1;BIRC3;TNFRSF1A
168,BioPlanet_2019,Apoptosis intrinsic pathway,6 of 30,0.0009064338155147288,0.0055405096534125,0,0,6.216968911917099,43.55603782731768,CASP7;YWHAB;CASP3;NMT1;PMAIP1;BBC3
169,BioPlanet_2019,Signaling events mediated by hepatocyte growth factor receptor (c-Met),10 of 79,0.0009535569139496432,0.0057942605418234,0,0,3.614319142512077,25.13871529849512,RAP1B;EGR1;PAK1;JUN;NUMB;CTNNA1;RAC1;EPS15;KPNB1;PTPN2
170,BioPlanet_2019,Signaling by TGF-beta receptor complex,9 of 66,0.0009889497799973565,0.0059741820043115,0,0,3.935048935733352,27.226080249218928,PPP1R15A;USP15;UBB;UBE2D3;UBC;F11R;E2F5;JUNB;SKIL
171,BioPlanet_2019,Fc gamma receptor-mediated phagocytosis,11 of 94,0.0010508026511285,0.0063109252245102,0,0,3.307032563107711,22.68029395591776,LYN;PAK1;MARCKSL1;MARCKS;ARPC2;CFL2;SPHK1;LIMK2;CFL1;RAC1;ARPC5
172,BioPlanet_2019,NF-kappaB activation,3 of 6,0.001073746572689,0.0064114462981953,0,0,24.798709677419357,169.5388902381483,NFKBIA;NFKB1;RELA
173,BioPlanet_2019,Adipocytokine signaling pathway,9 of 67,0.0011037142517075,0.0065150675543649,0,0,3.867001479754271,26.330699986292483,NFKBIA;SOCS3;TRADD;STAT3;JAK2;NFKBIE;RELA;NFKB1;TNFRSF1A
174,BioPlanet_2019,Telomerase regulation,9 of 67,0.0011037142517075,0.0065150675543649,0,0,3.867001479754271,26.330699986292483,HSP90AA1;JUN;ZNFX1;MAX;IRF1;NCL;NBN;MXD1;NFKB1
175,BioPlanet_2019,CTL mediated immune response against target cells,4 of 13,0.0012262413521617,0.0071565385128989,0,0,11.032443296009188,73.95931101278,FAS;HLA-A;B2M;ICAM1
176,BioPlanet_2019,TACI and BCMA stimulation of B cell immune responses,4 of 13,0.0012262413521617,0.0071565385128989,0,0,11.032443296009188,73.95931101278,TRAF3;MAP3K14;NFKB1;RELA
177,BioPlanet_2019,Syndecan 4 pathway,6 of 32,0.001294886499153,0.0075147064810396,0,0,5.738142686329215,38.15481712241286,SDCBP;SDC4;MDK;CCL5;ACTN1;RAC1
178,BioPlanet_2019,CDC42 signaling events,9 of 70,0.0015140103860476,0.0086887373821515,0,0,3.6762454965998,23.86983724617889,ACTR3;PAK1;JUN;ARPC2;LIMK2;CFL1;CTNNA1;RAC1;ARPC5
179,BioPlanet_2019,MicroRNA regulation of DNA damage response,9 of 70,0.0015140103860476,0.0086887373821515,0,0,3.6762454965998,23.86983724617889,CDKN1A;GADD45B;CASP3;PMAIP1;TNFRSF10B;FAS;NBN;PML;BBC3
180,BioPlanet_2019,Small cell lung cancer,10 of 84,0.0015361593945701,0.0087671417380716,0,0,3.369228603603604,21.82744601762434,NFKBIA;TRAF4;LAMB3;ITGA3;TRAF3;MAX;ITGAV;RELA;NFKB1;BIRC3
181,BioPlanet_2019,Antigen-activated B-cell receptor generation of second messengers,18 of 211,0.001560309060643,0.0088560398881553,0,0,2.3351649850013634,15.091870906050774,LYN;JUN;CD40;BCL2A1;MAX;DAPP1;RELA;NFKB1;RASGRP3;NFKB2;NFKBIA;BCL6;REL;FAS;HLA-DRA;RAC1;NFKBIE;PIK3AP1
182,BioPlanet_2019,Interleukin-3 signaling pathway,7 of 45,0.0016391515173257,0.009162586506254,0,0,4.583521059457984,29.396763130711104,LYN;STAT5A;JUN;CXCL8;STAT3;JAK2;JAK1
183,BioPlanet_2019,Wnt interactions in lipid metabolism and immune response,7 of 45,0.0016391515173257,0.009162586506254,0,0,4.583521059457984,29.396763130711104,IL32;KLF10;RBP1;CREM;CXCL1;HES1;IFI30
184,BioPlanet_2019,Hypoxia and p53 in the cardiovascular system,5 of 23,0.0016497977639528,0.009162586506254,0,0,6.900963058789708,44.215178121035066,CDKN1A;HSP90AA1;ABCB1;IGFBP3;HIF1A
185,BioPlanet_2019,Interleukin-11 pathway,5 of 23,0.0016497977639528,0.009162586506254,0,0,6.900963058789708,44.215178121035066,SOCS3;JUN;TIMP1;STX11;ICAM1
186,BioPlanet_2019,EPO receptor signaling,6 of 34,0.0017990662343276,0.0099381573265265,0,0,5.327720207253886,33.67378901281069,STAT5A;JUN;SOCS1;STAT1;STAT3;JAK2
187,BioPlanet_2019,Activation of PKC through G-protein coupled receptors,3 of 7,0.0018247667162076,0.0099734604118653,0,0,18.598064516129032,117.28503241149184,NFKBIA;NFKB1;RELA
188,BioPlanet_2019,Interleukin-1 processing,3 of 7,0.0018247667162076,0.0099734604118653,0,0,18.598064516129032,117.28503241149184,NFKB1;RELA;NFKB2
189,BioPlanet_2019,ATF2 transcription factor network,8 of 59,0.0019386972656698,0.0105403909233525,0,0,3.9054749172396233,24.39257717601981,ACHE;DUSP5;SOCS3;JUN;CXCL8;HES1;JUNB;ATF3
190,BioPlanet_2019,TAK1 activates NF-kappaB by phosphorylation and activation of IKK complex,5 of 24,0.002017986488732,0.0109140316380117,0,0,6.5374140396268805,40.568936464959705,NFKBIA;RIPK2;NFKB1;RELA;NFKB2
191,BioPlanet_2019,Cytokines and inflammatory response,6 of 35,0.0021009090963807,0.0112407582921991,0,0,5.143737716633911,31.71312400446926,CXCL8;CSF1;IL15;HLA-DRA;CXCL1;CXCL2
192,BioPlanet_2019,Interleukin-2/PI3K pathway,6 of 35,0.0021009090963807,0.0112407582921991,0,0,5.143737716633911,31.71312400446926,HSP90AA1;SGMS1;RAC1;RELA;NFKB1;JAK1
193,BioPlanet_2019,Delta Np63 pathway,7 of 47,0.0021242844501477,0.0112407582921991,0,0,4.353891050583657,26.795239913995182,CEBPD;RRAD;CDKN2A;ITGA3;IGFBP3;HES1;FOSL2
194,BioPlanet_2019,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",7 of 47,0.0021242844501477,0.0112407582921991,0,0,4.353891050583657,26.795239913995182,CYLD;RIPK2;CASP4;TNFAIP3;TXNIP;TXN;BIRC3
195,BioPlanet_2019,Protein processing in the endoplasmic reticulum,15 of 166,0.0021328060263998,0.0112407582921991,0,0,2.482922934043901,15.270762592052694,PDIA3;PPP1R15A;HSPA8;VCP;HSP90AA1;HSPA5;UBE2D3;EIF2AK2;PDIA6;RBX1;HSP90B1;DNAJA1;DNAJB11;FBXO6;NFE2L2
196,BioPlanet_2019,Sema3A/PAK-dependent axon repulsion,4 of 15,0.0022000501875839,0.0115363037755034,0,0,9.025604886070004,55.23015929898816,HSP90AA1;PAK1;CFL1;RAC1
197,BioPlanet_2019,Cellular response to hypoxia,5 of 25,0.0024427162526978,0.0126166294451844,0,0,6.210219922380336,37.35226597263437,UBB;UBE2D3;UBC;HIF1A;RBX1
198,BioPlanet_2019,Metal ion solute carrier family (SLC) transporters,5 of 25,0.0024427162526978,0.0126166294451844,0,0,6.210219922380336,37.35226597263437,SLC30A7;SLC30A2;SLC39A1;CP;SLC39A14
199,BioPlanet_2019,TPO signaling pathway,5 of 25,0.0024427162526978,0.0126166294451844,0,0,6.210219922380336,37.35226597263437,STAT5A;JUN;STAT1;STAT3;JAK2
200,BioPlanet_2019,FRA pathway,6 of 37,0.0028173760054232,0.0141920432139193,0,0,4.8113822497075045,28.252192737809708,JUN;CXCL8;CDKN2A;CCL2;JUNB;FOSL2
201,BioPlanet_2019,Bystander B cell activation,3 of 8,0.0028354401198111,0.0141920432139193,0,0,14.87767741935484,87.26588142673744,CD40;FAS;HLA-DRA
202,BioPlanet_2019,Cytoskeletal remodeling regulation and cell spreading by IPP complex components,3 of 8,0.0028354401198111,0.0141920432139193,0,0,14.87767741935484,87.26588142673744,ACTN1;RSU1;LIMS1
203,BioPlanet_2019,Sema4D-mediated inhibition of cell attachment and migration,3 of 8,0.0028354401198111,0.0141920432139193,0,0,14.87767741935484,87.26588142673744,RRAS;RAC1;RND1
204,BioPlanet_2019,Cell-extracellular matrix interactions,4 of 16,0.0028439041096624,0.0141920432139193,0,0,8.273040482342807,48.501340858688856,ACTN1;ILK;RSU1;LIMS1
205,BioPlanet_2019,PI3K subunit p85 role in regulation of actin organization and cell migration,4 of 16,0.0028439041096624,0.0141920432139193,0,0,8.273040482342807,48.501340858688856,ACTR3;PAK1;ARPC2;RAC1
206,BioPlanet_2019,Selenium metabolism and selenoproteins,4 of 16,0.0028439041096624,0.0141920432139193,0,0,8.273040482342807,48.501340858688856,JUN;CREM;NFKB1;RELA
207,BioPlanet_2019,Myometrial relaxation and contraction pathways,14 of 155,0.0029653308624626,0.0147268595236724,0,0,2.4798002302179643,14.434338511931069,JUN;YWHAB;GSTO1;IGFBP3;ADM;YWHAZ;ACTB;ETS2;NFKB1;ACTG1;CREB3;GNG5;CALD1;ATF3
208,BioPlanet_2019,Signaling by SCF-KIT,9 of 78,0.0032258888514884,0.0159252344183073,0,0,3.248657205857409,18.63607394861326,LYN;STAT5A;CDKN1A;SOCS1;YWHAB;STAT1;STAT3;RAC1;JAK2
209,BioPlanet_2019,Cyclin D-associated events in G1,6 of 38,0.0032374629504787,0.0159252344183073,0,0,4.660783678756476,26.72011108195923,CDKN1A;PPP2R1B;UBB;CDKN2A;UBC;E2F5
210,BioPlanet_2019,Actin cytoskeleton regulation,18 of 226,0.0032991763945266,0.0161518920168059,0,0,2.1650556680161945,12.371306528931068,ITGA3;ACTN1;LIMK2;ITGA1;ARPC5;ACTB;MYL12A;MYL12B;ACTG1;PAK1;RRAS;ARPC2;CFL2;CFL1;MYH9;ITGAV;RAC1;PFN1
211,BioPlanet_2019,Oxidative stress,5 of 27,0.0034809890139189,0.0168819795839356,0,0,5.645066447136305,31.953553293684138,MT1X;SOD2;JUNB;NFKB1;NFE2L2
212,BioPlanet_2019,TWEAK regulation of gene expression,5 of 27,0.0034809890139189,0.0168819795839356,0,0,5.645066447136305,31.953553293684138,CXCL10;CXCL8;CCL5;CCL2;ICAM1
213,BioPlanet_2019,LPA receptor mediated events,8 of 65,0.0035998913376996,0.0172436812085327,0,0,3.493278651173388,19.65616063029792,LYN;NFKBIA;JUN;CXCL8;CASP3;RAC1;RELA;NFKB1
214,BioPlanet_2019,Cadmium-induced DNA biosynthesis and proliferation in macrophages,4 of 17,0.0036056487328587,0.0172436812085327,0,0,7.636255217650566,42.95587193061886,NFKBIA;JUN;NFKB1;RELA
215,BioPlanet_2019,Zinc transporters,4 of 17,0.0036056487328587,0.0172436812085327,0,0,7.636255217650566,42.95587193061886,SLC30A7;SLC30A2;SLC39A14;SLC39A1
216,BioPlanet_2019,Interleukin-2 receptor beta chain in T cell activation,7 of 52,0.0038226018287018,0.0180308113655206,0,0,3.869116587404525,21.53869100490631,STAT5A;SOCS3;SOCS1;FAS;CFLAR;NMI;JAK1
217,BioPlanet_2019,Signaling events mediated by PTP1B,7 of 52,0.0038226018287018,0.0180308113655206,0,0,3.869116587404525,21.53869100490631,LYN;STAT5A;SOCS3;CSF1;STAT3;TXN;JAK2
218,BioPlanet_2019,Vitamin B12 metabolism,7 of 52,0.0038226018287018,0.0180308113655206,0,0,3.869116587404525,21.53869100490631,CCL5;CCL2;SOD2;RELA;NFKB1;ICAM1;NFKB2
219,BioPlanet_2019,Thyroid-stimulating hormone signaling pathway,8 of 66,0.0039600221235523,0.0185941038801346,0,0,3.432870577698164,18.988943054531543,RAP1B;JUN;STAT1;STAT3;TTF2;JAK2;JAK1;MYL12B
220,BioPlanet_2019,Spliceosome,12 of 127,0.0039832032690781,0.0186183211627047,0,0,2.602838006584175,14.382421133831368,HSPA8;HNRNPM;LSM8;DDX5;HNRNPK;LSM6;RBM8A;DDX23;SNRPG;HNRNPU;SRSF7;U2SURP
221,BioPlanet_2019,TRAIL signaling pathway,5 of 28,0.0041041459854495,0.0190972198331955,0,0,5.399347544856291,29.6735053059974,TRADD;TNFSF10;TNFRSF10B;RIPK1;CFLAR
222,BioPlanet_2019,Transcriptional activity regulation by PML,4 of 18,0.0044947982007348,0.0207543759797502,0,0,7.090439276485788,38.32265086587793,SP100;FAS;PML;TNFRSF1A
223,BioPlanet_2019,Cell-cell communication,12 of 129,0.0045186686180702,0.0207543759797502,0,0,2.558077257816161,13.812435058793262,PAK1;LAMB3;ACTN1;CTNND1;CTNNA1;ILK;RSU1;RAC1;CD47;F11R;CD2AP;LIMS1
224,BioPlanet_2019,SMAD2/3 nuclear pathway,9 of 82,0.004520556239539,0.0207543759797502,0,0,3.0700073035609314,16.57533854155781,HSPA8;CDKN1A;CEBPB;JUN;MAX;IRF7;E2F5;SKIL;ATF3
225,BioPlanet_2019,Kit receptor signaling pathway,7 of 54,0.0047334501478454,0.0216356371801962,0,0,3.704086982918012,19.82835145166924,LYN;STAT5A;SOCS1;STAT1;STAT3;JAK2;JUNB
226,BioPlanet_2019,Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer,6 of 41,0.0047786525410607,0.0217460267617433,0,0,4.260621761658031,22.76704424662333,UBB;UBE2D3;UBC;E2F5;JUNB;SKIL
227,BioPlanet_2019,Response to elevated platelet cytosolic calcium,9 of 83,0.0048999544187415,0.0222002320814034,0,0,3.0283625628229007,16.10643525217752,CD63;HSPA5;ACTN1;CFL1;SERPING1;SCG3;STX4;TIMP1;PFN1
228,BioPlanet_2019,Destabilization of mRNA by butyrate response factor 1 (BRF1),4 of 19,0.0055204491497439,0.0246434277921377,0,0,6.61739879414298,34.40581544009113,ZFP36;XRN1;YWHAB;ZFP36L1
229,BioPlanet_2019,Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,4 of 19,0.0055204491497439,0.0246434277921377,0,0,6.61739879414298,34.40581544009113,HSP90AA1;CDKN2A;HIF1A;RBX1
230,BioPlanet_2019,STAT3 pathway,4 of 19,0.0055204491497439,0.0246434277921377,0,0,6.61739879414298,34.40581544009113,STAT3;RAC1;JAK2;JAK1
231,BioPlanet_2019,Nectin adhesion pathway,5 of 30,0.0055823447273574,0.0246434277921377,0,0,4.966882276843467,25.768912348268135,RAP1B;CTNNA1;ITGAV;RAC1;F11R
232,BioPlanet_2019,PDGFA signaling pathway,5 of 30,0.0055823447273574,0.0246434277921377,0,0,4.966882276843467,25.768912348268135,STAT5A;JUN;STAT1;STAT3;JAK1
233,BioPlanet_2019,p38-alpha and p38-beta regulation,5 of 30,0.0055823447273574,0.0246434277921377,0,0,4.966882276843467,25.768912348268135,LYN;RALA;PAK1;RIPK1;RAC1
234,BioPlanet_2019,Pancreatic cancer,8 of 70,0.0056854086915172,0.0248857083827852,0,0,3.210724759111856,16.598972667911863,RALA;CDKN2A;STAT1;STAT3;RAC1;RELA;NFKB1;JAK1
235,BioPlanet_2019,Signaling events mediated by HDAC class I,8 of 70,0.0056854086915172,0.0248857083827852,0,0,3.210724759111856,16.598972667911863,NFKBIA;MAX;STAT3;RANGAP1;MXD1;RELA;NFKB1;TNFRSF1A
236,BioPlanet_2019,Free radical-induced apoptosis,3 of 10,0.0057316275076885,0.0249821570271827,0,0,10.625806451612902,54.84781761194556,CXCL8;NFKB1;RELA
237,BioPlanet_2019,Leukocyte transendothelial migration,11 of 117,0.0059248599430535,0.025715883702413,0,0,2.586357039187228,13.26438613472942,RAP1B;ACTN1;CTNND1;CTNNA1;RAC1;F11R;ACTB;MYL12A;ACTG1;ICAM1;MYL12B
238,BioPlanet_2019,Bacterial invasion of epithelial cells,8 of 71,0.0061946461362856,0.0267682313673055,0,0,3.1595959595959595,16.0636066713424,ARPC2;CTNNA1;ILK;RAC1;ARPC5;ACTB;ACTG1;CD2AP
239,BioPlanet_2019,Cell cycle,29 of 453,0.0062191437833042,0.0267682313673055,0,0,1.716571781242915,8.720395850768671,CDKN1A;MAX;YWHAB;PSMB10;PSMB4;PSMB2;PPP2R1B;UBB;PSMB3;PPP2R5E;UBC;E2F5;HSP90AA1;GADD45B;CDKN2A;SMARCA5;RANGAP1;YWHAZ;PSMB8;PSMB9;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2
240,BioPlanet_2019,Pathogenic Escherichia coli infection,7 of 57,0.0063941373811675,0.0272930206498319,0,0,3.481297016861219,17.588813638267645,TUBA1C;ARPC2;NCL;ARPC5;YWHAZ;ACTB;ACTG1
241,BioPlanet_2019,CD28 co-stimulation,5 of 31,0.0064467541515575,0.0272930206498319,0,0,4.775599562145487,24.088976670153038,LYN;PAK1;MAP3K8;RAC1;MAP3K14
242,BioPlanet_2019,Keratan sulfate/keratin metabolism,5 of 31,0.0064467541515575,0.0272930206498319,0,0,4.775599562145487,24.088976670153038,B4GALT1;B3GNT2;B4GALT6;GNS;B4GALT5
243,BioPlanet_2019,NF-kappaB activation by non-typeable Hemophilus influenzae,5 of 31,0.0064467541515575,0.0272930206498319,0,0,4.775599562145487,24.088976670153038,NFKBIA;CXCL8;MAP3K14;RELA;NFKB1
244,BioPlanet_2019,4-1BB-dependent immune response,4 of 20,0.0066912306600728,0.0282063519953112,0,0,6.203488372093023,31.060602423566824,NFKBIA;JUN;NFKB1;RELA
245,BioPlanet_2019,Signaling by NOTCH,11 of 119,0.0067170983454468,0.0282063519953112,0,0,2.538195953450191,12.698845665774058,PSENEN;MOV10;JUN;B4GALT1;MAML2;UBB;UBC;NUMB;HES1;HIF1A;RBX1
246,BioPlanet_2019,Diabetes pathways,12 of 137,0.0072621409235905,0.030249159572859,0,0,2.3933577023498693,11.787479590047289,SLC30A7;CXCL8;HSPA5;IGFBP3;DNAJB11;RAB27A;CCL2;HDGF;PDIA6;ACTB;ATF3;HSP90B1
247,BioPlanet_2019,Natural killer cell-mediated cytotoxicity,12 of 137,0.0072621409235905,0.030249159572859,0,0,2.3933577023498693,11.787479590047289,PAK1;CASP3;IFNGR2;TNFSF10;HLA-B;HLA-C;TNFRSF10B;FAS;HLA-A;RAC1;ICAM1;HLA-E
248,BioPlanet_2019,Signaling by NOTCH1,8 of 73,0.0073161056965346,0.0303515549579126,0,0,3.062057942057942,15.058212224346416,PSENEN;MAML2;UBB;UBC;NUMB;HES1;HIF1A;RBX1
249,BioPlanet_2019,Interleukin-12/STAT4 pathway,6 of 45,0.0075947905220764,0.0311328458537409,0,0,3.82283778397768,18.656567423496888,JUN;TBX21;IRF1;STAT3;HLA-DRA;JAK2
250,BioPlanet_2019,Apoptotic cleavage of cell adhesion  proteins,3 of 11,0.0076551237626817,0.0311328458537409,0,0,9.297096774193548,45.298989147115385,TJP1;CASP3;TJP2
251,BioPlanet_2019,B lymphocyte cell surface molecules,3 of 11,0.0076551237626817,0.0311328458537409,0,0,9.297096774193548,45.298989147115385,CD40;HLA-DRA;ICAM1
252,BioPlanet_2019,Osteopontin signaling,3 of 11,0.0076551237626817,0.0311328458537409,0,0,9.297096774193548,45.298989147115385,MAP3K14;NFKB1;RELA
253,BioPlanet_2019,Regulated proteolysis of p75 neurotrophin receptor,3 of 11,0.0076551237626817,0.0311328458537409,0,0,9.297096774193548,45.298989147115385,PSENEN;NFKB1;RELA
254,BioPlanet_2019,Adherens junction cell adhesion,8 of 74,0.0079310794317858,0.0321286472668029,0,0,3.015505706414797,14.585898974516343,TJP1;ACTN1;CTNND1;CTNNA1;LMO7;RAC1;ACTB;ACTG1
255,BioPlanet_2019,E-cadherin keratinocyte pathway,4 of 21,0.0080152632342738,0.0323428395351754,0,0,5.83827329381365,28.177886892465256,CTNND1;CTNNA1;ZYX;RAC1
256,BioPlanet_2019,Selenium pathway,7 of 60,0.0084536804523263,0.0339791903005957,0,0,3.283728556395761,15.673740044670168,CCL2;TXN;SOD2;RELA;NFKB1;ICAM1;NFKB2
257,BioPlanet_2019,Arrhythmogenic right ventricular cardiomyopathy (ARVC),8 of 75,0.0085840570892867,0.0343694998962527,0,0,2.9703430897460747,14.132442779425654,ITGA3;ACTN1;CACNA2D1;ITGA1;CTNNA1;ITGAV;ACTB;ACTG1
258,BioPlanet_2019,EGF/EGFR signaling pathway,12 of 141,0.0090535950252192,0.036003035220548,0,0,2.3186592992895743,10.908349143061516,STAT5A;JUN;PLSCR1;RALA;STAT1;LIMK2;CFL1;STAT3;RAC1;JAK2;EPS15;JAK1
259,BioPlanet_2019,p75 neurotrophin receptor-mediated signaling,11 of 124,0.0090617513623838,0.036003035220548,0,0,2.4252518143323605,11.407639668247835,NFKBIA;PSENEN;UBB;RIPK2;CASP3;UBC;RAC1;NFKB1;RELA;RHOB;BIRC3
260,BioPlanet_2019,Agrin in postsynaptic differentiation,6 of 47,0.0093798176123983,0.0369822579908683,0,0,3.635978769114116,16.977093745088123,PAK1;JUN;LAMB3;ITGA1;RAC1;UTRN
261,BioPlanet_2019,Regulation of transcription by NOTCH1 intracellular domain,6 of 47,0.0093798176123983,0.0369822579908683,0,0,3.635978769114116,16.977093745088123,MAML2;UBB;UBC;HES1;HIF1A;RBX1
262,BioPlanet_2019,AKT signaling pathway,4 of 22,0.0095001259233973,0.0370325663353565,0,0,5.513637668676428,25.673979364911524,NFKBIA;HSP90AA1;NFKB1;RELA
263,BioPlanet_2019,Smooth muscle contraction,4 of 22,0.0095001259233973,0.0370325663353565,0,0,5.513637668676428,25.673979364911524,CALD1;ITGA1;TPM1;MYL12B
264,BioPlanet_2019,T cell receptor downstream signaling,4 of 22,0.0095001259233973,0.0370325663353565,0,0,5.513637668676428,25.673979364911524,NFKBIA;RIPK2;NFKB1;RELA
265,BioPlanet_2019,Focal adhesion,17 of 233,0.0098830578325731,0.0382168245368436,0,0,1.9656275855356011,9.075171490208731,JUN;LAMB3;ITGA3;ACTN1;ITGA1;ILK;ACTB;MYL12A;MYL12B;RHOB;ACTG1;RAP1B;PAK1;ZYX;ITGAV;RAC1;BIRC3
266,BioPlanet_2019,Assembly of HIV virion,3 of 12,0.0099149167239826,0.0382168245368436,0,0,8.263655913978495,38.12615255133503,UBB;UBC;NMT1
267,BioPlanet_2019,Salmonella infection,3 of 12,0.0099149167239826,0.0382168245368436,0,0,8.263655913978495,38.12615255133503,ACTR3;ARPC2;RAC1
268,BioPlanet_2019,Mitochondrial pathway of apoptosis: caspases,8 of 77,0.010009553377399,0.038398793667691,0,0,2.8839450404667795,13.27830389205664,ACHE;CASP7;HSP90AA1;CASP3;COMMD1;XAF1;PTMA;BIRC3
269,BioPlanet_2019,Circadian rhythm,7 of 62,0.0100736428692587,0.038398793667691,0,0,3.163990095507605,14.54749770269259,HELZ2;UBB;NAMPT;UBC;HIF1A;ARNTL2;RBX1
270,BioPlanet_2019,Signaling events mediated by focal adhesion kinase,7 of 62,0.0100736428692587,0.038398793667691,0,0,3.163990095507605,14.54749770269259,RAP1B;PAK1;JUN;RRAS;ACTN1;ITGAV;RAC1
271,BioPlanet_2019,Neurotrophin signaling pathway,11 of 126,0.010159241110002,0.0385827061273239,0,0,2.3828241029420103,10.935665107424926,RAP1B;NFKBIA;NTRK2;JUN;YWHAB;RIPK2;RAC1;NFKBIE;YWHAZ;NFKB1;RELA
272,BioPlanet_2019,Signaling by ERBB4,9 of 93,0.0101970822514656,0.0385845639771574,0,0,2.666449934980494,12.22741588592744,PSENEN;BTC;STAT5A;CDKN1A;UBB;YWHAB;UBC;JAK2;RBX1
273,BioPlanet_2019,HES/HEY pathway,6 of 48,0.0103762212862032,0.0389768603223563,0,0,3.5492227979274613,16.213696249949827,MAML2;STAT3;RBBP8;HES1;JAK2;HIF1A
274,BioPlanet_2019,Intestinal immune network for IgA production,6 of 48,0.0103762212862032,0.0389768603223563,0,0,3.5492227979274613,16.213696249949827,IL15RA;CD40;IL15;HLA-DRA;HLA-DOB;MAP3K14
275,BioPlanet_2019,Interleukin-7 signaling pathway,5 of 35,0.0108445730319744,0.0404420358918035,0,0,4.1379905131522206,18.72064359245463,STAT5A;STAT1;STAT3;NMI;JAK1
276,BioPlanet_2019,fMLP induced chemokine gene expression in HMC-1 cells,5 of 35,0.0108445730319744,0.0404420358918035,0,0,4.1379905131522206,18.72064359245463,NFKBIA;PAK1;RAC1;RELA;NFKB1
277,BioPlanet_2019,Folate metabolism,7 of 63,0.0109633531173608,0.0407379272310567,0,0,3.1073281452658885,14.023984382935543,CSF1;CCL2;SOD2;RELA;NFKB1;ICAM1;NFKB2
278,BioPlanet_2019,Downregulation of SMAD2/3-SMAD4 transcriptional activity,4 of 23,0.0111528307932012,0.041145979319203,0,0,5.223174214606283,23.483714742663043,UBB;UBE2D3;UBC;SKIL
279,BioPlanet_2019,Signaling events mediated by PRL,4 of 23,0.0111528307932012,0.041145979319203,0,0,5.223174214606283,23.483714742663043,EGR1;CDKN1A;ITGA1;RAC1
280,BioPlanet_2019,Angiopoietin receptor Tie2-mediated signaling,6 of 49,0.0114454495289442,0.0419260615723383,0,0,3.4665019881913484,15.495829096993218,STAT5A;CDKN1A;PAK1;RAC1;RELA;NFKB1
281,BioPlanet_2019,Arf6 integrin-mediated signaling pathway,6 of 49,0.0114454495289442,0.0419260615723383,0,0,3.4665019881913484,15.495829096993218,RALA;ITGA3;CTNND1;ITGA1;CTNNA1;ITGAV
282,BioPlanet_2019,Unfolded protein response,8 of 79,0.0116036247053109,0.0423552802847567,0,0,2.802414486921529,12.488785724911653,CXCL8;HSPA5;DNAJB11;CCL2;HDGF;PDIA6;ATF3;HSP90B1
283,BioPlanet_2019,Validated nuclear estrogen receptor alpha network,7 of 64,0.0119086888845116,0.0433157592172554,0,0,3.0526543336291443,13.524745300764613,STAT5A;CEBPB;JUN;CD82;NRIP1;LCOR;NCOA7
284,BioPlanet_2019,SNARE interactions in vesicular transport,5 of 36,0.0122002421688836,0.0442205268787956,0,0,4.00429829320202,17.6441374772161,VAMP8;STX17;STX4;VAMP5;STX11
285,BioPlanet_2019,Cytosolic tRNA aminoacylation,4 of 24,0.0129798040121886,0.0462349570503132,0,0,4.961757105943152,21.55566241044204,WARS;KARS;PPA1;HARS
286,BioPlanet_2019,Inhibition of cellular proliferation by Gleevec,4 of 24,0.0129798040121886,0.0462349570503132,0,0,4.961757105943152,21.55566241044204,STAT5A;JUN;STAT1;JAK2
287,BioPlanet_2019,Nicotinate and nicotinamide metabolism,4 of 24,0.0129798040121886,0.0462349570503132,0,0,4.961757105943152,21.55566241044204,NT5C3A;NNMT;NAMPT;CD38
288,BioPlanet_2019,Plexin D1 signaling,4 of 24,0.0129798040121886,0.0462349570503132,0,0,4.961757105943152,21.55566241044204,RRAS;ITGA3;ITGA1;ITGAV
289,BioPlanet_2019,Ras-independent pathway in NK cell-mediated cytotoxicity,4 of 24,0.0129798040121886,0.0462349570503132,0,0,4.961757105943152,21.55566241044204,PAK1;HLA-A;RAC1;B2M
290,BioPlanet_2019,Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family,9 of 97,0.0132272546761128,0.0469544813760294,0,0,2.544715687433502,11.007106199865277,JUN;CTSO;PAK1;NMT1;PIM2;CD47;HIF1A;CTSS;BBC3
291,BioPlanet_2019,Developmental biology,26 of 420,0.013776105784231,0.0487353331339405,0,0,1.6522032616913274,7.079393005533167,CEBPB;CEBPD;YWHAB;RELA;MYL12B;RND1;HELZ2;SDCBP;PAK1;RRAS;CHL1;DPYSL3;CFL1;CTNNA1;ITGAV;HES1;PLXNC1;RAC1;HSP90AA1;LIMK2;ITGA1;NFKB1;RHOB;NUMB;MYH9;PFN1
292,BioPlanet_2019,HIF-1 transcriptional activity in hypoxia,7 of 66,0.0139735153565878,0.0490994561687445,0,0,2.9488667589966804,12.593405319286717,JUN;PKM;ABCB1;ADM;HIF1A;CP;MCL1
293,BioPlanet_2019,Activation of NOXA and translocation to mitochondria,2 of 5,0.0139740949792941,0.0490994561687445,0,0,16.511168384879724,70.51177050957355,PMAIP1;BBC3
1033,Panther_2016,Apoptosis signaling pathway Homo sapiens P00006,24 of 102,7.865893272709485e-13,5.5061252908966397e-11,0,0,7.812283207508671,217.73669294239605,HSPA8;JUN;HSPA5;BCL2A1;TRADD;TNFRSF10B;EIF2AK2;CFLAR;NFKB1;RELA;NFKB2;TNFRSF1A;RELB;NFKBIA;CASP7;CASP3;TNFSF10;REL;FAS;RIPK1;MAP3K14;ATF3;MCL1;BIRC3
1034,Panther_2016,JAK/STAT signaling pathway Homo sapiens P00038,7 of 14,3.545366148563679e-07,1.0726364544616538e-05,0,0,24.92217898832685,370.1555222473745,STAT5A;SOCS1;STAT1;STAT3;STAT6;JAK2;JAK1
1035,Panther_2016,Parkinson disease Homo sapiens P00049,15 of 81,4.597013376264231e-07,1.0726364544616538e-05,0,0,5.705945430716073,83.26508611920276,LYN;STX12;HSPA8;HSPA5;YWHAB;UBE2L6;YWHAZ;PSMB10;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSMB3
1036,Panther_2016,Inflammation mediated by chemokine and cytokine signaling pathway Homo sapiens P00031,22 of 188,4.262974884965984e-06,7.460206048690473e-05,0,0,3.340600497227004,41.3083401352049,JUN;CXCL8;CCL20;STAT3;ARPC5;ACTB;CX3CL1;RELA;ACTG1;NFKB2;RELB;CXCL10;PAK1;RRAS;ARPC2;GNG5;CCL5;MYH9;CCL2;RAC1;JAK2;JUNB
1037,Panther_2016,CCKR signaling map ST Homo sapiens P06959,20 of 165,6.765499413224983e-06,9.471699178514975e-05,0,0,3.4713856791920663,41.32224510565745,LYN;CHGA;JUN;CXCL8;YWHAB;STAT3;CREM;CXCL1;CXCL2;NFKBIA;PAK1;CASP3;CD38;ITGAV;RAC1;JAK2;MAP3K14;IER3;MCL1;BIRC3
1038,Panther_2016,Integrin signalling pathway Homo sapiens P00034,18 of 156,3.764840767860235e-05,0.0004392314229170274,0,0,3.2752860411899314,33.36605912830883,LAMB3;ITGA3;ACTN1;ITGA1;ILK;ARPC5;RND3;ACTB;ACTG1;RND1;RHOB;RAP1B;RAP2C;RRAS;ARPC2;ITGAV;RAC1;LIMS1
1039,Panther_2016,Toll receptor signaling pathway Homo sapiens P00054,9 of 49,9.884029103503114e-05,0.0009884029103503114,0,0,5.612418725617685,51.757754853738334,NFKBIA;JUN;TBK1;TNFAIP3;MAP3K8;NFKBIE;TANK;RELA;NFKB2
1040,Panther_2016,Cytoskeletal regulation by Rho GTPase Homo sapiens P00016,10 of 70,0.00035922803337088137,0.0031432452919952,0,0,4.158420138888889,32.98273047919099,PAK1;ARPC2;CFL2;CFL1;MYH9;RAC1;ARPC5;PFN1;ACTB;ACTG1
1041,Panther_2016,Interleukin signaling pathway Homo sapiens P00036,11 of 86,0.0004928291648775986,0.0038331157268257,0,0,3.661312472837897,27.88216849116091,STAT5A;IL15RA;CDKN1A;CXCL8;IL15;IL10RB;STAT1;STAT2;STAT3;STAT6;IL6ST
1042,Panther_2016,Interferon-gamma signaling pathway Homo sapiens P00035,6 of 28,0.0006144762177470234,0.0043013335242291,0,0,6.782854451248234,50.15744737335342,SOCS2;SOCS3;STAT1;IFNGR2;JAK2;JAK1
1043,Panther_2016,FAS signaling pathway Homo sapiens P00020,6 of 31,0.0010874281765501,0.0063687895605515,0,0,5.967979274611399,40.72513154666362,CASP7;JUN;PARP3;CASP3;FAS;CFLAR
1044,Panther_2016,EGF receptor signaling pathway Homo sapiens P00018,12 of 109,0.0010917924960945,0.0063687895605515,0,0,3.088745928777153,21.06504474104167,BTC;STAT5A;RRAS;YWHAB;PPP2R5E;STAT1;STAT2;STAT3;DAB2IP;STAT6;RAC1;YWHAZ
1045,Panther_2016,p53 pathway Homo sapiens P00059,8 of 71,0.0061946461362856,0.0333557868876918,0,0,3.1595959595959595,16.0636066713424,CDKN1A;CD82;GADD45B;IGFBP3;PMAIP1;TNFRSF10B;FAS;PML
1046,Panther_2016,T cell activation Homo sapiens P00053,8 of 73,0.0073161056965346,0.036580528482673,0,0,3.062057942057942,15.058212224346416,NFKBIA;CD74;PAK1;JUN;HLA-DRA;RAC1;NFKB1;NFKB2
1103,KEGG_2019_Human,Epstein-Barr virus infection,48 of 201,1.177589840080123e-24,3.1323889746131283e-22,0,0,8.195111469245232,451.53894253684473,CD40;CDKN1A;TRADD;TNFAIP3;RELA;ICAM1;RELB;TBK1;CASP3;CIR1;RIPK1;HES1;RAC1;B2M;HLA-DOB;JAK1;LYN;PDIA3;JUN;GADD45B;STAT1;DDX58;STAT2;STAT3;HLA-B;TAP2;HLA-C;EIF2AK2;TAP1;ISG15;HLA-A;HLA-F;NFKB1;HLA-E;NFKB2;TAPBP;NFKBIA;CXCL10;OAS1;TRAF3;OAS2;OAS3;IRF7;FAS;HLA-DRA;NFKBIE;MAP3K14;IRF9
1104,KEGG_2019_Human,TNF signaling pathway,35 of 110,8.210316115661083e-23,1.0919720433829238e-20,0,0,12.025930910722296,611.5674807867185,CEBPB;CSF1;TRADD;TNFAIP3;CXCL1;CXCL3;CXCL2;CX3CL1;RELA;ICAM1;SOCS3;CASP7;CASP3;CCL5;CCL2;MAP3K8;RIPK1;JUNB;JUN;MLKL;IL15;CCL20;DAB2IP;CFLAR;NFKB1;TNFRSF1A;NFKBIA;CXCL10;CREB3;TRAF3;IRF1;BCL3;FAS;MAP3K14;BIRC3
1105,KEGG_2019_Human,NOD-like receptor signaling pathway,39 of 178,7.62848095792266e-19,6.763919782691426e-17,0,0,7.245227363440777,302.25080204619354,CXCL8;TNFAIP3;CXCL1;TXN;CXCL3;CXCL2;TANK;RELA;TBK1;CCL5;NAMPT;CASP4;CCL2;RIPK1;GBP2;GBP1;GBP4;JAK1;GBP3;GSDMD;GBP5;JUN;HSP90AA1;GBP7;RIPK2;STAT1;STAT2;TMEM173;NFKB1;NFKBIA;OAS1;TRAF3;OAS2;OAS3;IRF7;TXNIP;RBCK1;IRF9;BIRC3
1106,KEGG_2019_Human,Influenza A,38 of 171,1.2850174185102646e-18,8.54536583309326e-17,0,0,7.370270270270271,303.6238807698027,CXCL8;ADAR;ACTB;RELA;ACTG1;ICAM1;IFIH1;SOCS3;TBK1;CCL5;TNFSF10;TRIM25;CCL2;JAK2;HLA-DOB;JAK1;HSPA8;JUN;RSAD2;DDX58;STAT1;IFNGR2;STAT2;MX1;TNFRSF10B;EIF2AK2;NFKB1;PML;TNFRSF1A;NFKBIA;CXCL10;OAS1;OAS2;OAS3;IRF7;HLA-DRA;FAS;IRF9
1107,KEGG_2019_Human,Kaposi sarcoma-associated herpesvirus infection,37 of 186,1.7542606568988974e-16,9.332666694702134e-15,0,0,6.391698140550137,231.88642382061855,CDKN1A;CXCL8;TRADD;CXCL1;CXCL3;HIF1A;CXCL2;RELA;ICAM1;ZFP36;TBK1;UBB;GNG5;CASP3;RAC1;JAK2;JAK1;LYN;ATG3;JUN;STAT1;STAT2;STAT3;HLA-B;HLA-C;EIF2AK2;HLA-A;HLA-F;NFKB1;HLA-E;TNFRSF1A;NFKBIA;TRAF3;IRF7;FAS;IL6ST;IRF9
1108,KEGG_2019_Human,Antigen processing and presentation,23 of 77,8.972942761780491e-15,3.978004624389351e-13,0,0,10.813441255825362,349.75602876186906,PDIA3;CD74;HSPA8;HSP90AA1;HSPA5;TAP2;HLA-B;TAP1;HLA-C;HLA-A;IFI30;HLA-F;CTSS;TAPBP;HLA-E;CTSL;RFX5;PSME1;PSME2;HLA-DRA;B2M;HLA-DOB;LGMN
1109,KEGG_2019_Human,Hepatitis C,31 of 155,4.3041619466853984e-14,1.635581539740451e-12,0,0,6.391566265060241,196.71073489617245,CDKN1A;YWHAB;TRADD;IFIT1;RELA;SOCS3;TBK1;PPP2R1B;CASP3;RIPK1;JAK1;RSAD2;DDX58;STAT1;STAT2;MX1;STAT3;EIF2AK2;CFLAR;YWHAZ;NFKB1;TNFRSF1A;NFKBIA;CXCL10;OAS1;TRAF3;OAS2;OAS3;IRF7;FAS;IRF9
1110,KEGG_2019_Human,Viral carcinogenesis,34 of 201,4.247217871349994e-13,1.4121999422238728e-11,0,0,5.21432940570472,148.54238538782204,CDKN1A;SP100;YWHAB;GTF2B;TRADD;RELA;CASP3;PMAIP1;RAC1;JAK1;STAT5A;LYN;JUN;CDKN2A;ACTN1;STAT3;HLA-B;HLA-C;EIF2AK2;HLA-A;HLA-F;YWHAZ;NFKB1;HLA-E;NFKB2;NFKBIA;CREB3;HNRNPK;PKM;TRAF3;REL;IRF7;IL6ST;IRF9
1111,KEGG_2019_Human,Measles,28 of 138,5.055860380338914e-13,1.4942876235223898e-11,0,0,6.48649696969697,183.65256600379675,TRADD;TNFAIP3;ADAR;RELA;BBC3;IFIH1;TBK1;CASP3;JAK1;STAT5A;HSPA8;JUN;DDX58;STAT1;STAT2;MX1;STAT3;EIF2AK2;NFKB1;NFKBIA;OAS1;TRAF3;OAS2;OAS3;IRF7;FAS;IRF9;RAB9B
1112,KEGG_2019_Human,IL-17 signaling pathway,23 of 93,7.643160063559907e-13,2.0330805769069357e-11,0,0,8.334834437086093,232.54017274022212,HSP90AA1;CEBPB;JUN;CXCL8;TRAF3IP2;CCL20;TRADD;TNFAIP3;CXCL1;CXCL3;CXCL2;IL17RB;RELA;NFKB1;HSP90B1;NFKBIA;CXCL10;TBK1;TRAF4;TRAF3;CASP3;LCN2;CCL2
1113,KEGG_2019_Human,Apoptosis,28 of 143,1.2717680241554205e-12,3.075366312957653e-11,0,0,6.202852173913043,169.89992363122408,BCL2A1;TRADD;ACTB;CTSS;RELA;ACTG1;BBC3;TUBA1C;CTSO;CASP7;CTSL;CASP3;TNFSF10;PMAIP1;RIPK1;MCL1;JUN;PARP3;GADD45B;DAB2IP;TNFRSF10B;CFLAR;NFKB1;TNFRSF1A;NFKBIA;FAS;MAP3K14;BIRC3
1114,KEGG_2019_Human,NF-kappa B signaling pathway,22 of 95,9.977782034140288e-12,2.2117416842344303e-10,0,0,7.633507284192215,193.3617798475904,LYN;CD40;CXCL8;BCL2A1;GADD45B;DDX58;TRADD;TNFAIP3;CFLAR;CXCL2;RELA;NFKB1;ICAM1;TNFRSF1A;RELB;NFKB2;NFKBIA;TRAF3;TRIM25;RIPK1;MAP3K14;BIRC3
1115,KEGG_2019_Human,Necroptosis,28 of 162,2.9536819712039186e-11,6.04368772569417e-10,0,0,5.318049751243781,128.93815571764165,TRADD;TNFAIP3;FTH1;TNFSF10;RIPK1;STAT6;JAK2;GLUL;JAK1;STAT5A;HSP90AA1;PARP3;MLKL;STAT1;IFNGR2;STAT2;STAT3;TNFRSF10B;EIF2AK2;CFLAR;TNFRSF1A;CYLD;CHMP4B;FAS;RBCK1;IRF9;CHMP5;BIRC3
1116,KEGG_2019_Human,Human immunodeficiency virus 1 infection,32 of 212,4.7155347318604385e-11,8.959515990534834e-10,0,0,4.537861185582365,107.8993287918654,TRADD;SAMHD1;RELA;PAK1;TBK1;GNG5;TRIM5;CFL2;CASP3;CFL1;RIPK1;RAC1;B2M;PDIA3;JUN;APOBEC3G;LIMK2;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;TMEM173;NFKB1;HLA-E;RBX1;TNFRSF1A;TAPBP;BST2;NFKBIA;FAS
1117,KEGG_2019_Human,Human cytomegalovirus infection,33 of 225,5.1644297998649584e-11,9.158255511760527e-10,0,0,4.390310402684563,103.99170780671724,CDKN1A;CXCL8;TRADD;CX3CL1;RELA;TBK1;GNG5;CASP3;CCL5;CCL2;RIPK1;ITGAV;RAC1;B2M;JAK1;PDIA3;IL10RB;CDKN2A;STAT3;HLA-B;TAP2;HLA-C;TAP1;HLA-A;HLA-F;TMEM173;NFKB1;HLA-E;TNFRSF1A;TAPBP;NFKBIA;CREB3;FAS
1118,KEGG_2019_Human,Proteasome,15 of 45,7.176746803363302e-11,1.193134156059149e-09,0,0,12.576671035386632,293.7607235217706,POMP;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMB4;PSMA3;PSMA4;PSMB2;PSMA1;PSMB3;PSMA2;PSME1;PSME2
1119,KEGG_2019_Human,RIG-I-like receptor signaling pathway,18 of 70,1.1864956990604903e-10,1.856516799706414e-09,0,0,8.731275303643725,199.551959066248,CXCL8;DDX58;TRADD;ISG15;TMEM173;TANK;RELA;NFKB1;IFIH1;NFKBIA;CXCL10;CYLD;TBK1;TRAF3;DHX58;IRF7;TRIM25;RIPK1
1120,KEGG_2019_Human,Herpes simplex virus 1 infection,47 of 492,1.4260148487779648e-08,2.1073330543052147e-07,0,0,2.71298052536928,49.01215546103533,SP100;TRADD;RELA;IFIH1;SOCS3;TBK1;CCL5;CASP3;CCL2;TNFRSF14;JAK2;HLA-DOB;B2M;ZNF267;JAK1;PDIA3;CD74;STAT1;DDX58;IFNGR2;STAT2;TAP2;HLA-B;EIF2AK2;TAP1;HLA-C;HLA-A;TMEM173;HLA-F;NFKB1;PML;TNFRSF1A;HLA-E;SRPK1;TAPBP;BST2;NFKBIA;OAS1;TRAF3;OAS2;OAS3;IRF7;HLA-DRA;FAS;SRSF7;IRF9;BIRC3
1121,KEGG_2019_Human,Pathways in cancer,49 of 530,1.9991163711425473e-08,2.798762919599566e-07,0,0,2.6188838411060638,46.42750850818032,CDKN1A;CXCL8;BBC3;CASP7;CASP3;ITGAV;PIM2;RAC1;JAK2;JAK1;IL15RA;HSP90AA1;GSTO1;ITGA3;IL15;IFNGR2;RBX1;EML4;TRAF4;TRAF3;IL6ST;BIRC3;RALA;MAX;HIF1A;RELA;HSP90B1;RASGRP3;GNG5;CTNNA1;PMAIP1;STAT6;HES1;STAT5A;JUN;GADD45B;LAMB3;STAT1;CDKN2A;STAT2;PTCH1;STAT3;NFKB1;PML;NFKB2;NFKBIA;LPAR6;FAS;NFE2L2
1122,KEGG_2019_Human,Human T-cell leukemia virus 1 infection,28 of 219,3.2839205566237015e-08,4.367614340309522e-07,0,0,3.719846422338569,64.0990646111505,CD40;CDKN1A;RELA;ETS2;ICAM1;RELB;ZFP36;B2M;HLA-DOB;JAK1;STAT5A;IL15RA;EGR1;JUN;IL15;CDKN2A;HLA-B;HLA-C;HLA-A;HLA-F;NFKB1;HLA-E;NFKB2;TNFRSF1A;NFKBIA;CREB3;HLA-DRA;MAP3K14
1123,KEGG_2019_Human,Epithelial cell signaling in Helicobacter pylori infection,15 of 68,4.008502619252876e-08,5.077436651053643e-07,0,0,7.110339029155024,121.10516425015972,ATP6V1A;LYN;JUN;CXCL8;CXCL1;F11R;RELA;NFKB1;NFKBIA;TJP1;PAK1;CASP3;CCL5;RAC1;MAP3K14
1124,KEGG_2019_Human,Human papillomavirus infection,35 of 330,8.237560865167098e-08,9.95995995515658e-07,0,0,3.0223099208431234,49.29984826959363,ATP6V1A;CDKN1A;MAML2;TRADD;RELA;OASL;TBK1;PPP2R1B;PPP2R5E;CASP3;ITGAV;HES1;JAK1;HES4;LAMB3;STAT1;ITGA3;STAT2;ITGA1;MX1;HLA-B;HLA-C;EIF2AK2;ISG15;HLA-A;HLA-F;NFKB1;HLA-E;TNFRSF1A;CREB3;PKM;TRAF3;IRF1;FAS;IRF9
1125,KEGG_2019_Human,Hepatitis B,23 of 163,8.98334688088792e-08,1.0389435957896464e-06,0,0,4.152185430463576,67.37048842571924,STAT5A;JUN;CDKN1A;CXCL8;YWHAB;DDX58;STAT1;STAT2;STAT3;YWHAZ;NFKB1;RELA;NFKBIA;IFIH1;CREB3;TBK1;TRAF3;CASP3;IRF7;FAS;STAT6;JAK2;JAK1
1126,KEGG_2019_Human,Osteoclast differentiation,20 of 127,9.87768052217887e-08,1.0947762578748248e-06,0,0,4.713584691638103,76.03202076725358,JUN;CSF1;STAT1;IFNGR2;STAT2;NFKB1;RELA;NFKB2;FOSL2;TNFRSF1A;RELB;NFKBIA;SOCS3;CYLD;SOCS1;RAC1;JUNB;MAP3K14;IRF9;JAK1
1127,KEGG_2019_Human,Th17 cell differentiation,18 of 107,1.5376219558561353e-07,1.636029761030928e-06,0,0,5.091573033707865,79.87587786814623,STAT5A;JUN;HSP90AA1;STAT1;IFNGR2;STAT3;HIF1A;NFKB1;RELA;NFKBIA;TBX21;HLA-DRA;STAT6;IL6ST;NFKBIE;JAK2;HLA-DOB;JAK1
1128,KEGG_2019_Human,Salmonella infection,16 of 86,1.7873859543138388e-07,1.828633322490312e-06,0,0,5.7448818897637794,89.26019156397761,JUN;CXCL8;IFNGR2;CXCL1;ARPC5;CXCL3;CXCL2;ACTB;RELA;NFKB1;ACTG1;TJP1;ARPC2;MYH9;RAC1;PFN1
1129,KEGG_2019_Human,Viral myocarditis,13 of 59,3.2660216843033255e-07,3.217636177869202e-06,0,0,7.084057971014492,105.79702682205584,CD40;HLA-B;HLA-C;HLA-A;HLA-F;ACTB;ACTG1;ICAM1;HLA-E;CASP3;HLA-DRA;RAC1;HLA-DOB
1130,KEGG_2019_Human,Toxoplasmosis,18 of 113,3.592215500744977e-07,3.412604725707728e-06,0,0,4.768504155124654,70.76139011111636,HSPA8;CD40;LAMB3;IL10RB;STAT1;IFNGR2;STAT3;NFKB1;RELA;TNFRSF1A;NFKBIA;SOCS1;CASP3;HLA-DRA;JAK2;HLA-DOB;JAK1;BIRC3
1131,KEGG_2019_Human,Chemokine signaling pathway,24 of 190,3.910848200679792e-07,3.587191797864913e-06,0,0,3.653958007094692,53.91174378600718,LYN;CXCL9;CXCL8;CCL20;STAT1;STAT2;STAT3;CXCL1;CXCL3;CXCL2;NFKB1;CX3CL1;RELA;CXCL16;RAP1B;NFKBIA;CXCL10;CXCL11;PAK1;GNG5;CCL5;CCL2;RAC1;JAK2
1132,KEGG_2019_Human,Toll-like receptor signaling pathway,17 of 104,5.181588605948337e-07,4.594341897274192e-06,0,0,4.913302218798616,71.1101442083106,JUN;CD40;CXCL9;CXCL8;STAT1;NFKB1;RELA;NFKBIA;CXCL10;CXCL11;TBK1;TRAF3;CCL5;IRF7;MAP3K8;RIPK1;RAC1
1133,KEGG_2019_Human,Legionellosis,12 of 55,1.0376729163678643e-06,8.903903088833932e-06,0,0,6.987309490558018,96.27485296224822,NFKBIA;HSPA8;CASP7;VCP;CXCL8;CASP3;CXCL1;CXCL3;CXCL2;RELA;NFKB1;NFKB2
1134,KEGG_2019_Human,Th1 and Th2 cell differentiation,15 of 92,2.485477532281644e-06,2.0660531987091164e-05,0,0,4.88800190635053,63.07988823227766,STAT5A;JUN;MAML2;STAT1;IFNGR2;RELA;NFKB1;NFKBIA;TBX21;HLA-DRA;STAT6;JAK2;NFKBIE;HLA-DOB;JAK1
1135,KEGG_2019_Human,Transcriptional misregulation in cancer,22 of 186,3.5733842270968875e-06,2.8803642557811275e-05,0,0,3.381694412182217,42.413202688971,DDX5;CD40;CDKN1A;CEBPB;CXCL8;KMT2A;GADD45B;H3F3B;BCL2A1;MAX;IGFBP3;NFKB1;RELA;PML;ETV6;ETV7;ZEB1;SPINT1;BCL6;NFKBIZ;REL;BIRC3
1136,KEGG_2019_Human,Pertussis,13 of 76,6.699687928992136e-06,5.241520556211494e-05,0,0,5.167901234567902,61.56753094962358,JUN;CXCL8;C1S;C1R;RELA;NFKB1;CASP7;CFL2;CASP3;IRF1;CFL1;IRF8;SERPING1
1137,KEGG_2019_Human,Phagosome,19 of 152,7.290187250423604e-06,5.540542310321939e-05,0,0,3.5928853754940717,42.50017401441533,ATP6V1A;STX12;C1R;TAP2;HLA-B;TAP1;HLA-C;HLA-A;HLA-F;ACTB;CTSS;ACTG1;HLA-E;TUBA1C;CTSL;HLA-DRA;ITGAV;RAC1;HLA-DOB
1138,KEGG_2019_Human,Allograft rejection,9 of 38,1.1500438511332696e-05,8.441481114673506e-05,0,0,7.745706470561858,88.09289093856529,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-DOB;HLA-E
1139,KEGG_2019_Human,C-type lectin receptor signaling pathway,15 of 104,1.1741909821162396e-05,8.441481114673506e-05,0,0,4.226294785515484,47.97836104285776,JUN;STAT1;STAT2;NFKB1;RELA;NFKB2;RELB;NFKBIA;CYLD;PAK1;RRAS;IRF1;BCL3;MAP3K14;IRF9
1140,KEGG_2019_Human,Cytokine-cytokine receptor interaction,28 of 294,1.2739844972686927e-05,8.91789148088085e-05,0,0,2.660491228070176,29.98580088492033,CD40;CXCL9;CXCL8;CSF1;CXCL1;CXCL3;CXCL2;CX3CL1;CXCL16;CCL5;TNFSF10;CCL2;TNFRSF14;IL32;IL15RA;IL15;CCL20;IL10RB;CD70;IFNGR2;TNFRSF10B;INHBA;IL17RB;TNFRSF1A;CXCL10;CXCL11;FAS;IL6ST
1141,KEGG_2019_Human,JAK-STAT signaling pathway,19 of 162,1.833548996644992e-05,0.00012505744438655585,0,0,3.3398840948248063,36.42702045310798,STAT5A;IL15RA;CDKN1A;IL15;IL10RB;STAT1;IFNGR2;STAT2;STAT3;SOCS2;SOCS3;SOCS1;STAT6;IL6ST;JAK2;IRF9;PTPN2;MCL1;JAK1
1142,KEGG_2019_Human,Cytosolic DNA-sensing pathway,11 of 63,2.7888672236158725e-05,0.00018545967037045556,0,0,5.287082539364156,55.44716765720969,NFKBIA;CXCL10;TBK1;DDX58;CCL5;IRF7;ADAR;RIPK1;TMEM173;RELA;NFKB1
1143,KEGG_2019_Human,Fluid shear stress and atherosclerosis,17 of 139,2.902539868555912e-05,0.00018831112317948116,0,0,3.4973395661446327,36.537893075725584,JUN;HSP90AA1;SDC4;GSTO1;TXN;ACTB;NFKB1;RELA;ACTG1;ICAM1;HSP90B1;TNFRSF1A;CTSL;CCL2;ITGAV;RAC1;NFE2L2
1144,KEGG_2019_Human,Type I diabetes mellitus,9 of 43,3.342351005157166e-05,0.0002116822303266205,0,0,6.604910885030215,68.07186949194914,GAD1;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-DOB;HLA-E
1145,KEGG_2019_Human,Shigellosis,11 of 65,3.7771000392634975e-05,0.0002336531652195559,0,0,5.090733497513159,51.84387179583239,NFKBIA;CXCL8;ARPC2;RIPK2;RAC1;ARPC5;PFN1;ACTB;RELA;NFKB1;ACTG1
1146,KEGG_2019_Human,Rheumatoid arthritis,13 of 91,4.921004563822449e-05,0.0002974970940856299,0,0,4.170806100217865,41.371947315339824,ATP6V1A;JUN;CXCL8;CSF1;IL15;CCL20;CXCL1;ICAM1;CTSL;CCL5;CCL2;HLA-DRA;HLA-DOB
1147,KEGG_2019_Human,Small cell lung cancer,13 of 93,6.203393867264221e-05,0.0003666895041538407,0,0,4.066111111111111,39.39178883343276,CDKN1A;LAMB3;GADD45B;ITGA3;MAX;RELA;NFKB1;NFKBIA;TRAF4;TRAF3;CASP3;ITGAV;BIRC3
1148,KEGG_2019_Human,Tight junction,18 of 170,0.00011621131499992023,0.0006720045606517127,0,0,2.97143351800554,26.9214858358996,ACTR3;JUN;ACTN1;F11R;ACTB;MYL12A;AMOT;ACTG1;MYL12B;RAP2C;TJP1;TUBA1C;PPP2R1B;RAB13;MYH9;RAC1;RAB8B;TJP2
1149,KEGG_2019_Human,Leishmaniasis,11 of 74,0.00012840101747282355,0.0007266951201653418,0,0,4.361437056352311,39.08001230839436,NFKBIA;JUN;MARCKSL1;STAT1;IFNGR2;HLA-DRA;JAK2;HLA-DOB;RELA;NFKB1;JAK1
1150,KEGG_2019_Human,AGE-RAGE signaling pathway in diabetic complications,13 of 100,0.00013242915046271698,0.0007338782088142233,0,0,3.737585455638194,33.374630172216065,STAT5A;EGR1;JUN;CXCL8;STAT1;STAT3;NFKB1;RELA;ICAM1;CASP3;CCL2;RAC1;JAK2
1151,KEGG_2019_Human,Graft-versus-host disease,8 of 41,0.00015450391545929326,0.0008387355410647349,0,0,6.041401023219205,53.01505274639399,HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-DOB;HLA-E
1152,KEGG_2019_Human,Cellular senescence,17 of 160,0.00017078079045842686,0.000908553805238831,0,0,2.9804636887422697,25.85590921791414,CDKN1A;CXCL8;TRAF3IP2;GADD45B;CDKN2A;IGFBP3;HLA-B;HLA-C;HLA-A;HLA-F;NFKB1;RELA;HLA-E;ZFP36L1;RRAS;NBN;E2F5
1153,KEGG_2019_Human,Autoimmune thyroid disease,9 of 53,0.0001855782070710625,0.0009679177074686788,0,0,5.101134885920321,43.829125211451576,CD40;HLA-B;HLA-C;FAS;HLA-DRA;HLA-A;HLA-F;HLA-DOB;HLA-E
1154,KEGG_2019_Human,Inflammatory bowel disease (IBD),10 of 65,0.00019302671524551213,0.0009687755897227592,0,0,4.537642045454546,38.80900925255785,JUN;STAT1;IFNGR2;TBX21;STAT3;HLA-DRA;STAT6;HLA-DOB;RELA;NFKB1
1155,KEGG_2019_Human,Mitophagy,10 of 65,0.00019302671524551213,0.0009687755897227592,0,0,4.537642045454546,38.80900925255785,USP15;JUN;TBK1;RRAS;UBB;CALCOCO2;TAX1BP1;HIF1A;OPTN;RELA
1156,KEGG_2019_Human,Fc gamma R-mediated phagocytosis,12 of 91,0.0002074894613172573,0.001022077716859,0,0,3.796080245893512,32.19239283162982,LYN;PAK1;MARCKSL1;MARCKS;ARPC2;CFL2;SPHK1;LIMK2;CFL1;RAC1;ARPC5;PLPP3
1157,KEGG_2019_Human,Tuberculosis,18 of 179,0.000222998748605397,0.0010785030387097,0,0,2.8040045766590387,23.577036174551708,CD74;CEBPB;RIPK2;IL10RB;STAT1;TRADD;SPHK1;IFNGR2;NFKB1;CTSS;RELA;TNFRSF1A;CASP3;RFX5;HLA-DRA;JAK2;HLA-DOB;JAK1
1158,KEGG_2019_Human,Prolactin signaling pathway,10 of 70,0.00035922803337088137,0.0017063331585116,0,0,4.158420138888889,32.98273047919099,SOCS2;STAT5A;SOCS3;SOCS1;STAT1;IRF1;STAT3;JAK2;RELA;NFKB1
1159,KEGG_2019_Human,B cell receptor signaling pathway,10 of 71,0.0004037851145550544,0.0018843305345902,0,0,4.090035860655738,31.962107596829917,LYN;NFKBIA;JUN;DAPP1;RAC1;NFKBIE;PIK3AP1;RELA;NFKB1;RASGRP3
1160,KEGG_2019_Human,p53 signaling pathway,10 of 72,0.00045284385431579554,0.0020768356077241,0,0,4.02385752688172,30.98355481610296,CDKN1A;CD82;GADD45B;CDKN2A;CASP3;IGFBP3;PMAIP1;TNFRSF10B;FAS;BBC3
1161,KEGG_2019_Human,Cell adhesion molecules (CAMs),15 of 145,0.0005377700416416564,0.0024245225606217,0,0,2.8871862082871256,21.73496736812313,CD274;CD40;SDC4;HLA-B;HLA-C;HLA-A;F11R;HLA-F;ICAM1;HLA-E;HLA-DRA;ITGAV;HLA-DOB;MPZL1;NECTIN2
1162,KEGG_2019_Human,Pancreatic cancer,10 of 75,0.0006305763514537239,0.0027955551581115,0,0,3.837540064102564,28.278358079381626,CDKN1A;RALA;GADD45B;STAT1;CDKN2A;STAT3;RAC1;RELA;NFKB1;JAK1
1163,KEGG_2019_Human,Chagas disease (American trypanosomiasis),12 of 103,0.0006581782064899018,0.0028700885725625,0,0,3.293432416147821,24.127800600089788,NFKBIA;JUN;CXCL8;PPP2R1B;IFNGR2;CCL5;CCL2;FAS;CFLAR;NFKB1;RELA;TNFRSF1A
1164,KEGG_2019_Human,Mineral absorption,8 of 51,0.0007311488989846675,0.0031368646311277,0,0,4.634007852612504,33.46167684255542,MT2A;FTH1;FXYD2;MT1F;MT1X;ATP1B1;ATOX1;MT1E
1165,KEGG_2019_Human,MAPK signaling pathway,23 of 295,0.0012874511072791,0.0054359046751787,0,0,2.122370471367355,14.12456841270977,DUSP5;HSPA8;NTRK2;JUN;GADD45B;CSF1;MAX;CACNA2D1;TRADD;RELA;NFKB1;RELB;RASGRP3;NFKB2;TNFRSF1A;RAP1B;PAK1;RRAS;CASP3;FAS;MAP3K8;RAC1;MAP3K14
1166,KEGG_2019_Human,Adipocytokine signaling pathway,9 of 69,0.0013655379603763,0.005675517147814,0,0,3.7377113133940174,24.65471684845417,NFKBIA;SOCS3;TRADD;STAT3;JAK2;NFKBIE;RELA;NFKB1;TNFRSF1A
1167,KEGG_2019_Human,Endocytosis,20 of 244,0.0014343359518847,0.0058697440492515,0,0,2.237796833773087,14.650975118816753,HSPA8;HLA-B;ARAP2;HLA-C;HLA-A;ARPC5;HLA-F;PML;HLA-E;EHD1;SPART;RAB10;RAB11FIP1;EHD4;UBB;ARPC2;CHMP4B;EPS15;SNX6;CHMP5
1168,KEGG_2019_Human,Regulation of actin cytoskeleton,18 of 214,0.0018257537573023,0.0073439484724288,0,0,2.29906015037594,14.497326958504058,ITGA3;ACTN1;LIMK2;ITGA1;ARPC5;ACTB;MYL12A;MYL12B;ACTG1;PAK1;RRAS;ARPC2;CFL2;CFL1;MYH9;ITGAV;RAC1;PFN1
1169,KEGG_2019_Human,Adherens junction,9 of 72,0.001849791532529,0.0073439484724288,0,0,3.5591677503250976,22.396712016819816,TJP1;ACTN1;CTNND1;CTNNA1;LMO7;RAC1;ACTB;NECTIN2;ACTG1
1170,KEGG_2019_Human,Protein processing in endoplasmic reticulum,15 of 165,0.0020103421474824,0.0078639854592695,0,0,2.499606815203145,15.5211844104493,PDIA3;PPP1R15A;HSPA8;VCP;HSP90AA1;HSPA5;UBE2D3;EIF2AK2;PDIA6;RBX1;HSP90B1;DNAJA1;DNAJB11;FBXO6;NFE2L2
1171,KEGG_2019_Human,Spliceosome,13 of 134,0.0022070515385875,0.008508343612526,0,0,2.682579808783017,16.40692046588962,HSPA8;DDX5;RBM8A;DDX23;HNRNPU;U2SURP;HNRNPM;LSM8;RBMXL1;HNRNPK;LSM6;SNRPG;SRSF7
1172,KEGG_2019_Human,Leukocyte transendothelial migration,11 of 112,0.0042630588917502,0.0161996237886509,0,0,2.71510449610802,14.818411322453787,RAP1B;ACTN1;CTNND1;CTNNA1;RAC1;F11R;ACTB;MYL12A;ACTG1;ICAM1;MYL12B
1173,KEGG_2019_Human,Focal adhesion,16 of 199,0.0049473576249548,0.0185351708202534,0,0,2.184530212411973,11.597456066779957,JUN;LAMB3;ITGA3;ACTN1;ITGA1;ILK;ACTB;MYL12A;MYL12B;ACTG1;RAP1B;PAK1;ZYX;ITGAV;RAC1;BIRC3
1174,KEGG_2019_Human,Natural killer cell mediated cytotoxicity,12 of 131,0.0051102253064433,0.018879443493249,0,0,2.514821072031946,13.2694830223799,PAK1;CASP3;IFNGR2;TNFSF10;HLA-B;HLA-C;TNFRSF10B;FAS;HLA-A;RAC1;ICAM1;HLA-E
1175,KEGG_2019_Human,Pathogenic Escherichia coli infection,7 of 55,0.0052458676936628,0.0191150795412921,0,0,3.626729355814959,19.04147015337369,TUBA1C;ARPC2;NCL;ARPC5;YWHAZ;ACTB;ACTG1
1176,KEGG_2019_Human,Proteoglycans in cancer,16 of 201,0.0054416932655197,0.019560681197679,0,0,2.160686670922892,11.265096481885038,CD63;CDKN1A;DDX5;SDC4;PTCH1;STAT3;HIF1A;ACTB;ACTG1;PAK1;RRAS;CTSL;CASP3;FAS;ITGAV;RAC1
1177,KEGG_2019_Human,Bacterial invasion of epithelial cells,8 of 74,0.0079310794317858,0.0281288950514003,0,0,3.015505706414797,14.585898974516343,ARPC2;CTNNA1;ILK;RAC1;ARPC5;ACTB;ACTG1;CD2AP
1178,KEGG_2019_Human,Lysosome,11 of 123,0.0085485601950032,0.0299199606825113,0,0,2.4470338983050848,11.652756846971334,CD63;CTSO;CTSL;LAMP3;ACP2;AP3B1;CD68;GNS;LITAF;CTSS;LGMN
1179,KEGG_2019_Human,SNARE interactions in vesicular transport,5 of 34,0.0095954757539417,0.0331480071499804,0,0,4.280902886202436,19.891059295566603,VAMP8;STX17;STX4;VAMP5;STX11
1180,KEGG_2019_Human,Intestinal immune network for IgA production,6 of 48,0.0103762212862032,0.0349376564826591,0,0,3.5492227979274613,16.213696249949827,IL15RA;CD40;IL15;HLA-DRA;HLA-DOB;MAP3K14
1181,KEGG_2019_Human,Notch signaling pathway,6 of 48,0.0103762212862032,0.0349376564826591,0,0,3.5492227979274613,16.213696249949827,PSENEN;MAML2;DTX3L;NUMB;CIR1;HES1
1182,KEGG_2019_Human,PI3K-Akt signaling pathway,23 of 354,0.0117341005572774,0.0390158843529476,0,0,1.738632680418559,7.728667526168109,NTRK2;CDKN1A;HSP90AA1;CSF1;LAMB3;YWHAB;ITGA3;ITGA1;YWHAZ;RELA;NFKB1;HSP90B1;CREB3;PPP2R1B;GNG5;LPAR6;PPP2R5E;ITGAV;RAC1;JAK2;PIK3AP1;JAK1;MCL1
1183,KEGG_2019_Human,Prostate cancer,9 of 97,0.0132272546761128,0.0434376511585928,0,0,2.544715687433502,11.007106199865277,NFKBIA;CREB3;CDKN1A;HSP90AA1;ZEB1;SPINT1;NFKB1;RELA;HSP90B1
1184,KEGG_2019_Human,Acute myeloid leukemia,7 of 66,0.0139735153565878,0.0453287205469801,0,0,2.9488667589966804,12.593405319286717,STAT5A;BCL2A1;STAT3;PIM2;RELA;PML;NFKB1
1369,Reactome_2022,Cytokine Signaling In Immune System R-HSA-1280215,149 of 702,8.403054610259494e-69,9.999634986208798e-66,0,0,7.997081966553299,1253.5408079725926,IFITM3;CSF1;UBE2D3;IFIT5;UBE2L6;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;MT2A;TBK1;PPP2R1B;TRIM25;MAP3K8;TRIM26;B2M;TRIM21;TRIM22;GBP6;GBP5;IL15RA;GBP7;RSAD2;HLA-B;HLA-C;HLA-A;HLA-F;RBX1;HLA-E;IFI27;PSME1;PSME2;TRIM14;IL6ST;ALPK1;KPNB1;EBI3;HIF1A;HSP90B1;RAP1B;SOCS2;SOCS3;SOCS1;UBB;UBC;TNFRSF14;N4BP1;MCL1;GSDMD;LYN;STAT5A;EGR1;HSPA8;JUN;EIF2AK2;ISG15;NFKB1;NFKB2;BST2;ISG20;NFKBIA;CXCL10;BCL6;HNRNPF;LCN2;HLA-DRA;XAF1;MAP3K14;CDKN1A;CD40;CXCL8;ADAR;CXCL1;CXCL2;IL18BP;OASL;TRIM5;CASP3;TIMP1;JAK2;JAK1;HSP90AA1;GSTO1;RIPK2;IL15;IFNGR2;YWHAZ;IL17RB;TNFRSF1A;PSMA5;TOX4;PSMA6;PSMA3;PSMA4;ZEB1;PSMA1;OAS1;PSMA2;TRAF3;OAS2;IRF1;OAS3;IRF2;PELI1;IRF7;IRF8;IRF9;BIRC3;SP100;RALA;CEBPD;NLRC5;IFI6;SAMHD1;TANK;USP18;RELA;PSMB10;RELB;PSMB4;PSMB2;PSMB3;CCL5;TIFA;CCL2;STAT6;STX4;GBP2;GBP1;GBP4;IL32;CCL20;IL10RB;STAT1;CD70;STAT2;MX2;STAT3;MX1;PSMB8;PML;PSMB9;TNIP2;HNRNPA2B1;TRIM38;PTPN2
1370,Reactome_2022,Immune System R-HSA-168256,246 of 1943,7.763241096988695e-68,4.619128452708273e-65,0,0,4.775288988529072,737.9081514582871,IFITM3;IFIT5;UBE2L6;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;HERC5;LGALS3;MT2A;TBK1;RNF114;PPP2R1B;FTH1;DHX58;TRIM25;TRIM26;FBXO6;TRIM21;B2M;TRIM22;HERC6;GBP6;GBP5;IL15RA;GBP7;RSAD2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;IFI27;PSME1;PSME2;TXNIP;TRIM14;SERPING1;RBCK1;ALPK1;CFB;EBI3;GNS;HIF1A;RNF213;DHX36;N4BP1;S100A11;LYN;STAT5A;GSDMD;EGR1;JUN;EIF2AK2;RAB27A;BST2;CYLD;HNRNPF;REL;LGMN;CD40;CDKN1A;CTSS;IL18BP;IFIH1;CTSO;CTSL;TRIM5;QSOX1;TIMP1;JAK2;JAK1;SERPINB1;BTN3A1;RIPK2;GSTO1;IL15;IFNGR2;BTN3A3;BTN3A2;AMPD3;IL17RB;VAMP8;PSMA5;TOX4;RAP2C;PSMA6;RNF144B;PSMA3;CEACAM1;PSMA4;ZEB1;PSMA1;PSMA2;PELI1;TAX1BP1;CD47;CD63;CSTB;SP100;IFI6;TANK;RELA;RELB;PSMB4;PSMB2;PSMB3;CREG1;STAT6;STX4;IL32;CD74;GCA;STAT1;CD70;CCL20;IL10RB;STAT2;STAT3;PSMB8;PSMB9;ERP44;KLHL5;HNRNPA2B1;CD68;RAB9B;CSF1;UBE2D3;RNF19B;TTF2;UBE2Z;ACTG1;RNF19A;MAP3K8;HLA-DOB;GYG1;PDIA3;LMO7;RBX1;IL6ST;KPNB1;ATP6V1A;CD274;VCP;UBA6;DAPP1;UBR2;HSP90B1;RASGRP3;SOCS2;RAP1B;SOCS3;SDCBP;SOCS1;UBB;UBC;RIPK1;TNFRSF14;MCL1;HSPA8;UBE2B;BTN2A2;HSPA5;ISG15;ARPC5;NFKB1;NFKB2;ISG20;NFKBIA;CXCL10;ARPC2;BCL6;LCN2;HLA-DRA;XAF1;NFKBIE;MAP3K14;CXCL8;B4GALT1;YWHAB;TNFAIP3;ADAR;CXCL1;CXCL2;OASL;HEBP2;PPP2R5E;CASP3;CASP4;TRIM69;ITGAV;ACTR3;HSP90AA1;DYNLT1;DTX3L;YWHAZ;TNFRSF1A;TAPBP;PKM;OAS1;TRAF3;OAS2;IRF1;OAS3;TMBIM1;IRF2;IRF7;IRF8;MYH9;IRF9;BIRC3;TRIM56;RALA;C1S;CEBPD;C1R;UNC93B1;NLRC5;MOSPD2;SAMHD1;USP18;PSMB10;CCL5;TIFA;RAB24;STOM;CCL2;GBP2;GBP1;GBP4;CHGA;ERAP2;MX2;ERAP1;MX1;CMTM6;ATOX1;PML;RAB10;TNIP2;TRIM38;PIK3AP1;PTPN2;NECTIN2
1371,Reactome_2022,Interferon Signaling R-HSA-913531,68 of 200,1.7922338475534072e-45,7.109194261961847e-43,0,0,13.851045667947076,1427.1129375760538,IFITM3;IFIT5;UBE2L6;ADAR;IFI35;IFI30;IFIT1;IFIT3;ICAM1;IFIT2;OASL;HERC5;MT2A;TRIM5;TRIM25;TRIM26;JAK2;B2M;TRIM21;TRIM22;JAK1;GBP6;GBP5;GBP7;RSAD2;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;HLA-E;IFI27;OAS1;OAS2;IRF1;OAS3;IRF2;IRF7;TRIM14;IRF8;KPNB1;IRF9;SP100;IFI6;SAMHD1;USP18;SOCS3;SOCS1;UBB;UBC;GBP2;GBP1;GBP4;EGR1;STAT1;STAT2;MX2;MX1;EIF2AK2;ISG15;PSMB8;PML;BST2;ISG20;HLA-DRA;TRIM38;XAF1;PTPN2
1372,Reactome_2022,Interferon Alpha/Beta Signaling R-HSA-909733,41 of 72,3.90219115401595e-39,1.1609018683197451e-36,0,0,34.43913861776163,3045.7726368487133,IFITM3;IFIT5;IFI6;ADAR;IFI35;IFIT1;SAMHD1;USP18;IFIT3;IFIT2;OASL;SOCS3;SOCS1;GBP2;JAK1;EGR1;RSAD2;STAT1;MX2;STAT2;MX1;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PSMB8;HLA-E;BST2;ISG20;IFI27;OAS1;OAS2;IRF1;OAS3;IRF2;IRF7;IRF8;XAF1;IRF9;KPNB1
1373,Reactome_2022,Signaling By Interleukins R-HSA-449147,85 of 453,1.4910249922646263e-34,3.548639481589811e-32,0,0,6.284075224292615,489.45674922583777,CDKN1A;CXCL8;CSF1;CXCL1;CXCL2;IL18BP;ICAM1;TBK1;PPP2R1B;CASP3;MAP3K8;TIMP1;JAK2;JAK1;IL15RA;HSP90AA1;GSTO1;RIPK2;IL15;YWHAZ;IL17RB;RBX1;TNFRSF1A;PSMA5;TOX4;PSMA6;PSMA3;PSMA4;ZEB1;PSMA1;PSMA2;PSME1;PELI1;PSME2;IL6ST;ALPK1;RALA;CEBPD;EBI3;NLRC5;HIF1A;TANK;USP18;RELA;PSMB10;HSP90B1;RAP1B;SOCS2;SOCS3;PSMB4;SOCS1;PSMB2;UBB;PSMB3;CCL5;TIFA;UBC;CCL2;STAT6;STX4;N4BP1;MCL1;GSDMD;LYN;STAT5A;IL32;HSPA8;JUN;CCL20;IL10RB;STAT1;STAT2;STAT3;PSMB8;NFKB1;PSMB9;NFKB2;NFKBIA;CXCL10;BCL6;TNIP2;HNRNPF;HNRNPA2B1;LCN2;PTPN2
1374,Reactome_2022,Interferon Gamma Signaling R-HSA-877300,41 of 89,3.733994950411722e-34,7.405756651649916e-32,0,0,22.22224106739032,1710.4551053871933,SP100;IFI30;ICAM1;OASL;SOCS3;MT2A;SOCS1;TRIM5;TRIM25;TRIM26;JAK2;GBP2;B2M;TRIM21;GBP1;TRIM22;GBP4;JAK1;GBP6;GBP5;GBP7;STAT1;IFNGR2;HLA-B;HLA-C;HLA-A;HLA-F;PML;HLA-E;OAS1;OAS2;IRF1;OAS3;IRF2;IRF7;IRF8;TRIM14;HLA-DRA;TRIM38;IRF9;PTPN2
1375,Reactome_2022,Innate Immune System R-HSA-168249,121 of 1035,2.896545436567496e-28,4.924127242164743e-26,0,0,3.6890514206541902,233.91855910444005,UBE2D3;UBE2L6;TTF2;ACTG1;HERC5;LGALS3;TBK1;PPP2R1B;FTH1;DHX58;TRIM25;MAP3K8;TRIM21;GYG1;B2M;HLA-B;HLA-C;HLA-A;HLA-E;PSME1;PSME2;TXNIP;SERPING1;ALPK1;KPNB1;CFB;ATP6V1A;VCP;GNS;HSP90B1;RAP1B;SDCBP;SOCS1;UBB;DHX36;UBC;RIPK1;N4BP1;S100A11;LYN;GSDMD;HSPA8;JUN;RAB27A;ISG15;ARPC5;NFKB1;NFKB2;BST2;NFKBIA;CYLD;ARPC2;LCN2;MAP3K14;LGMN;B4GALT1;TNFAIP3;CXCL1;CTSS;IFIH1;HEBP2;CTSL;CASP4;ITGAV;QSOX1;ACTR3;HSP90AA1;SERPINB1;DYNLT1;RIPK2;AMPD3;VAMP8;PSMA5;RAP2C;PSMA6;PSMA3;CEACAM1;PSMA4;PKM;PSMA1;PSMA2;TRAF3;TMBIM1;PELI1;TAX1BP1;IRF7;MYH9;CD47;BIRC3;TRIM56;CD63;CSTB;C1S;C1R;UNC93B1;NLRC5;MOSPD2;TANK;USP18;PSMB10;RELA;RELB;PSMB4;PSMB2;PSMB3;CREG1;TIFA;RAB24;STOM;STAT6;CHGA;GCA;CMTM6;PSMB8;ATOX1;PSMB9;RAB10;ERP44;TNIP2;CD68;RAB9B
1376,Reactome_2022,Programmed Cell Death R-HSA-5357801,46 of 208,3.492821233173865e-22,5.195571584346123e-20,0,0,7.393577548404506,365.2882920379757,YWHAB;TRADD;TANK;PSMB10;BBC3;SDCBP;PSMB4;CASP7;PSMB2;FNTA;UBB;PSMB3;CASP3;UBC;CASP4;TNFSF10;TP53BP2;PMAIP1;RIPK1;GSDMD;HSP90AA1;MLKL;CDKN2A;STAT3;TNFRSF10B;CFLAR;YWHAZ;PSMB8;PSMB9;PSMA5;TJP1;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;IRF1;IRF2;PSME1;NMT1;PELI1;PSME2;CHMP4B;KPNB1;TJP2;BIRC3
1377,Reactome_2022,Adaptive Immune System R-HSA-1280218,87 of 733,8.499581025694538e-21,1.1238334911751669e-18,0,0,3.62043612478886,167.31581288449334,CD40;YWHAB;UBE2D3;RNF19B;UBE2L6;IFI30;UBE2Z;CTSS;ICAM1;HERC5;CTSO;RNF114;PPP2R1B;CTSL;PPP2R5E;RNF19A;TRIM69;MAP3K8;ITGAV;FBXO6;HLA-DOB;B2M;TRIM21;HERC6;PDIA3;DTX3L;BTN3A1;RIPK2;HLA-B;HLA-C;BTN3A3;LMO7;HLA-A;BTN3A2;HLA-F;YWHAZ;RBX1;HLA-E;TAPBP;PSMA5;VAMP8;PSMA6;RNF144B;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;RBCK1;CD274;UBA6;DAPP1;UBR2;RELA;PSMB10;RASGRP3;RAP1B;SOCS3;PSMB4;RNF213;SOCS1;PSMB2;UBB;PSMB3;UBC;STX4;TNFRSF14;LYN;CD74;BTN2A2;ERAP2;HSPA5;UBE2B;ERAP1;PSMB8;NFKB1;PSMB9;NFKBIA;KLHL5;REL;HLA-DRA;PIK3AP1;NFKBIE;MAP3K14;NECTIN2;LGMN
1378,Reactome_2022,Interleukin-1 Family Signaling R-HSA-446652,36 of 152,1.1306336618370748e-18,1.3454540575861186e-16,0,0,7.991170183102519,330.22514630884285,NLRC5;TANK;USP18;PSMB10;RELA;IL18BP;PSMB4;TBK1;UBB;PSMB2;PSMB3;UBC;TIFA;MAP3K8;N4BP1;GSDMD;RIPK2;STAT3;NFKB1;PSMB8;RBX1;NFKB2;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;TNIP2;PSME1;PELI1;PSME2;ALPK1;PTPN2
1379,Reactome_2022,Interleukin-1 Signaling R-HSA-9020702,31 of 114,3.966656011750273e-18,4.29120059452984e-16,0,0,9.56934565571523,383.4303622739172,NLRC5;TANK;USP18;PSMB10;RELA;PSMB4;UBB;PSMB2;PSMB3;UBC;TIFA;MAP3K8;N4BP1;RIPK2;NFKB1;PSMB8;RBX1;NFKB2;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;TNIP2;PSME1;PELI1;PSME2;ALPK1
1380,Reactome_2022,Antigen processing-Cross Presentation R-HSA-1236975,29 of 104,2.2711580891649536e-17,2.190317694425141e-15,0,0,9.884521584334667,378.8110119214548,CTSS;PSMB10;PSMB4;UBB;PSMB2;CTSL;PSMB3;UBC;ITGAV;STX4;B2M;PDIA3;HLA-B;HLA-C;HLA-A;HLA-F;PSMB8;HLA-E;TAPBP;PSMB9;PSMA5;VAMP8;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2
1381,Reactome_2022,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,55 of 378,2.3927840359266246e-17,2.190317694425141e-15,0,0,4.451031777637895,170.34761382467838,UBE2D3;RNF19B;UBE2L6;UBE2Z;CTSS;HERC5;RNF114;CTSL;RNF19A;TRIM69;FBXO6;ITGAV;B2M;TRIM21;HERC6;PDIA3;DTX3L;HLA-B;HLA-C;LMO7;HLA-A;HLA-F;HLA-E;RBX1;TAPBP;PSMA5;VAMP8;PSMA6;RNF144B;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;RBCK1;UBA6;UBR2;PSMB10;SOCS3;PSMB4;RNF213;SOCS1;PSMB2;UBB;PSMB3;UBC;STX4;HSPA5;UBE2B;ERAP2;ERAP1;PSMB8;PSMB9;KLHL5
1382,Reactome_2022,Apoptosis R-HSA-109581,37 of 178,3.8455618087708055e-17,3.2687275374551854e-15,0,0,6.757180731424852,255.40134170151973,YWHAB;TRADD;TANK;PSMB10;BBC3;CASP7;PSMB4;FNTA;UBB;PSMB2;PSMB3;CASP3;UBC;TNFSF10;TP53BP2;PMAIP1;RIPK1;GSDMD;CDKN2A;STAT3;TNFRSF10B;CFLAR;YWHAZ;PSMB8;PSMB9;PSMA5;TJP1;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;NMT1;PSME2;KPNB1;TJP2
1383,Reactome_2022,ER-Phagosome Pathway R-HSA-1236974,26 of 89,2.9289672772122173e-16,2.323647373255025e-14,0,0,10.514479905437351,376.0683703189344,PSMB10;PSMB4;PSMB2;UBB;PSMB3;UBC;STX4;B2M;PDIA3;HLA-B;HLA-C;HLA-A;HLA-F;PSMB8;HLA-E;TAPBP;PSMB9;PSMA5;VAMP8;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2
1384,Reactome_2022,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,26 of 100,6.613715463241048e-15,4.918950875785529e-13,0,0,8.946377228292121,292.09591351603814,CD40;TANK;PSMB10;RELB;PSMB4;UBB;PSMB2;PSMB3;UBC;TNFRSF14;CD70;PSMB8;NFKB2;TNFRSF1A;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;TRAF3;PSME1;PSME2;MAP3K14;BIRC3
1385,Reactome_2022,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,23 of 81,3.036627518491096e-14,2.116582847163623e-12,0,0,10.065585750171271,313.29582329136014,HSP90AA1;UBE2D3;NLRC5;TNFAIP3;UBE2L6;ISG15;TANK;RELA;NFKB1;NFKB2;HERC5;IFIH1;NFKBIA;CYLD;TBK1;UBB;TRAF3;DHX58;UBC;IRF7;TAX1BP1;TRIM25;RIPK1
1386,Reactome_2022,Activation Of NF-kappaB In B Cells R-HSA-1169091,21 of 66,3.201553886465984e-14,2.116582847163623e-12,0,0,11.822016732716865,367.3402653800345,PSMB10;RELA;NFKB1;PSMB8;PSMB9;PSMA5;NFKBIA;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;REL;PSME2;NFKBIE
1387,Reactome_2022,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,20 of 61,6.858052400267341e-14,4.295306503325334e-12,0,0,12.34378016603385,374.14945447521154,PSMB10;RELA;PSMB8;RELB;NFKB2;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;MAP3K14
1388,Reactome_2022,Toll-like Receptor Cascades R-HSA-168898,31 of 162,1.5172235181771945e-13,9.027479933154306e-12,0,0,6.047814668342581,178.51167744011437,UNC93B1;UBE2D3;NLRC5;TANK;USP18;CTSS;RELA;HSP90B1;TBK1;SOCS1;PPP2R1B;UBB;CTSL;UBC;TIFA;MAP3K8;RIPK1;N4BP1;GSDMD;JUN;RIPK2;NFKB1;NFKB2;NFKBIA;TRAF3;TNIP2;IRF7;PELI1;ALPK1;LGMN;BIRC3
1389,Reactome_2022,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,22 of 79,1.7169770881140385e-13,9.729536832646218e-12,0,0,9.784414740555093,287.5937033486903,PSMB10;RELA;NFKB1;PSMB8;RASGRP3;PSMB9;PSMA5;NFKBIA;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;REL;PSME2;NFKBIE
1390,Reactome_2022,Regulated Necrosis R-HSA-5218859,19 of 57,2.063004987250407e-13,1.1158981521945385e-11,0,0,12.63768115942029,369.1396218843385,GSDMD;HSP90AA1;MLKL;TRADD;TNFRSF10B;CFLAR;TANK;SDCBP;UBB;CASP3;IRF1;CASP4;IRF2;UBC;TNFSF10;PELI1;CHMP4B;RIPK1;BIRC3
1391,Reactome_2022,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,18 of 51,2.860096583717987e-13,1.466473127283914e-11,0,0,13.77200956937799,397.7735206021621,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;NFE2L2
1392,Reactome_2022,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,19 of 58,2.95759286174907e-13,1.466473127283914e-11,0,0,12.3129961825614,355.2204649401583,PSMB10;PSMB8;RELB;NFKB2;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;MAP3K14
1393,Reactome_2022,Signaling By B Cell Receptor (BCR) R-HSA-983705,25 of 109,4.876802734214834e-13,2.321358101486261e-11,0,0,7.564187693669766,214.4380372570475,DAPP1;PSMB10;RELA;RASGRP3;PSMB4;UBB;PSMB2;PSMB3;UBC;LYN;NFKB1;PSMB8;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;REL;PSME2;NFKBIE;PIK3AP1
1394,Reactome_2022,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,18 of 53,6.156232785575228e-13,2.7133025980868598e-11,0,0,12.983684210526317,365.0510982898269,YWHAZ;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1395,Reactome_2022,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,18 of 53,6.156232785575228e-13,2.7133025980868598e-11,0,0,12.983684210526317,365.0510982898269,APOBEC3G;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1396,Reactome_2022,Regulation Of TNFR1 Signaling R-HSA-5357905,15 of 35,9.72109322069697e-13,4.131464618796211e-11,0,0,18.87483617300131,522.0649095275566,TRADD;SPPL2A;TNFAIP3;CFLAR;TANK;TNFRSF1A;CLIP3;CYLD;UBB;UBC;OTULIN;TAX1BP1;RIPK1;RBCK1;BIRC3
1397,Reactome_2022,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,22 of 88,1.9032542052352976e-12,7.809905187000014e-11,0,0,8.44620811287478,227.9416694348678,HSPA8;YWHAB;YWHAZ;PSMB10;PSMB8;ZFP36L1;PSMB9;PSMA5;PSMA6;ZFP36;PSMA3;PSMB4;PSMA4;PSMA1;XRN1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1398,Reactome_2022,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,19 of 64,2.18485669391717e-12,8.666598219204774e-11,0,0,10.667925633143025,286.42815859269854,UBE2D3;HIF1A;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1399,Reactome_2022,Cellular Response To Hypoxia R-HSA-1234174,20 of 73,3.042156809743508e-12,1.1677956785789595e-10,0,0,9.542988002190471,253.06529193898635,UBE2D3;MIA3;HIF1A;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1400,Reactome_2022,Degradation Of GLI1 By Proteasome R-HSA-5610780,18 of 59,4.952769797024158e-12,1.78599880559356e-10,0,0,11.080166880616174,288.42864556271,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;NUMB;PSME1;PSME2
1401,Reactome_2022,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,18 of 59,4.952769797024158e-12,1.78599880559356e-10,0,0,11.080166880616174,288.42864556271,CDKN1A;HSP90AA1;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1402,Reactome_2022,Signal Transduction R-HSA-162582,162 of 2465,6.131683382947466e-12,2.1460891840316127e-10,0,0,1.932035289938025,49.88042115773922,ITSN2;ANKLE2;MAML2;UBE2D3;SPPL2A;TTF2;F11R;CXCL16;ACTG1;AMOT;DOCK10;FNTA;PPP2R1B;EPSTI1;TNFSF10;IER3;ACTN1;RBX1;UHMK1;BTC;CLIP3;SPINT1;RRAGC;PSME1;PSME2;SRFBP1;RBCK1;IL6ST;TRIB1;PFN1;FKBP5;ATP6V1A;CD274;DDX5;VCP;CRABP2;RRAD;HIF1A;SAV1;RASGRP3;MYL12B;RAP1B;SOCS3;SOCS1;UBB;UBD;UBC;STAP2;RIPK1;SKIL;BCL9L;LYN;STAT5A;EGR1;JUN;PTCH1;TNFRSF10B;ARPC5;INHBA;NFKB1;NFKBIA;MOV10;CXCL10;HNRNPM;CYLD;CXCL11;ARHGAP31;FAM135A;ARPC2;LPAR6;HNRNPF;ID4;CDC42SE2;CDKN1A;CXCL9;CXCL8;B4GALT1;YWHAB;CHD8;TRADD;TNFAIP3;ECE1;ADM;CXCL1;CXCL3;RND3;CXCL2;CX3CL1;RND1;PPP2R5E;CASP3;EFHD2;ITGAV;JAK2;JAK1;ACTR3;PSENEN;DUSP5;HSP90AA1;RIPK2;ITGA3;SPHK1;ARAP2;SSTR2;RANGAP1;YWHAZ;TNFRSF1A;RHOB;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;ELF3;VGF;PSMA2;CDC42EP4;TAX1BP1;NUMB;MYH9;BIRC3;PPP1R15A;RALA;USP15;MOSPD2;TANK;PSMB10;RELA;FSTL3;PSMB4;PSMB2;GNG5;PSMB3;CCL5;NRIP1;CTNNA1;STOM;CCL2;STAT6;E2F5;EPS15;IL32;CHGA;NTRK2;LAMB3;STAT1;CCL20;LIMK2;STAT3;DAB2IP;CFLAR;PSMB8;PML;PSMB9;TJP1;FMNL2;OTULIN;TRIP10;PIK3AP1;PTPN2;RAB9B;TJP2
1403,Reactome_2022,Infectious Disease R-HSA-5663205,83 of 961,6.533676206908731e-12,2.2214499103489682e-10,0,0,2.4951279067861885,64.25965225886512,YWHAB;GTF2B;ADM;ARID4B;ACTG1;IFIH1;TBK1;FNTA;CTSL;TRIM25;JAK2;B2M;JAK1;ACTR3;HSP90AA1;RIPK2;IFNGR2;RHBDF2;HLA-B;HLA-C;HLA-A;RANGAP1;HLA-F;PARP9;ATP1B1;YWHAZ;RBX1;HLA-E;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;TRAF3;PSME1;IRF7;SNRPG;PSME2;TXNIP;CHMP4B;MYH9;KPNB1;CHMP5;DDX5;VCP;SDC4;CEBPD;PSMB10;RELA;PSMB4;RNF213;PSMB2;GNG5;UBB;PSMB3;UBC;RIPK1;EPS15;LYN;CHGA;GSDMD;UVRAG;JUN;APOBEC3G;STAT1;STAT2;EIF2AK2;ISG15;ARPC5;PARP14;PSMB8;NFKB1;PML;PSMB9;NFKB2;SRPK1;TJP1;HNRNPK;ARPC2;FXYD2;NMT1;NFE2L2
1404,Reactome_2022,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,18 of 60,6.821167888141952e-12,2.2547749408024784e-10,0,0,10.81578947368421,278.0846594792323,VCP;ERLIN1;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1405,Reactome_2022,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,23 of 103,7.578485275511224e-12,2.4374047237455016e-10,0,0,7.289172185430464,186.64441285054795,JUN;RIPK2;UBE2D3;NLRC5;TANK;USP18;NFKB1;RELA;NFKB2;NFKBIA;TBK1;PPP2R1B;UBB;TRAF3;TNIP2;UBC;TIFA;IRF7;MAP3K8;RIPK1;ALPK1;N4BP1;BIRC3
1406,Reactome_2022,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,17 of 54,1.0995441977401595e-11,3.2711439882769743e-10,0,0,11.583087686898462,292.28230988432773,HSPA8;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1407,Reactome_2022,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,17 of 54,1.0995441977401595e-11,3.2711439882769743e-10,0,0,11.583087686898462,292.28230988432773,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1408,Reactome_2022,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,17 of 54,1.0995441977401595e-11,3.2711439882769743e-10,0,0,11.583087686898462,292.28230988432773,CDKN2A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1409,Reactome_2022,FCERI Mediated NF-kB Activation R-HSA-2871837,20 of 78,1.166634103139937e-11,3.386084348137866e-10,0,0,8.718042034391775,219.47072114483043,LYN;PSMB10;RELA;NFKB1;PSMB8;PSMB9;PSMA5;NFKBIA;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1410,Reactome_2022,Degradation Of DVL R-HSA-4641258,17 of 55,1.5343805482590994e-11,4.2463089591356465e-10,0,0,11.277681720727577,280.81776275075805,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1411,Reactome_2022,Hh Mutants Are Degraded By ERAD R-HSA-5362768,17 of 55,1.5343805482590994e-11,4.2463089591356465e-10,0,0,11.277681720727577,280.81776275075805,VCP;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1412,Reactome_2022,Regulation Of Necroptotic Cell Death R-HSA-5675482,13 of 29,1.6128483538273373e-11,4.3620216842148436e-10,0,0,20.398529411764702,506.91231380498425,HSP90AA1;MLKL;TRADD;TNFRSF10B;CFLAR;TANK;SDCBP;UBB;UBC;TNFSF10;PELI1;RIPK1;BIRC3
1413,Reactome_2022,MyD88-independent TLR4 Cascade R-HSA-166166,23 of 107,1.7494440335268277e-11,4.543517672391619e-10,0,0,6.940618101545254,171.91312742784103,JUN;RIPK2;UBE2D3;NLRC5;TANK;USP18;NFKB1;RELA;NFKB2;NFKBIA;TBK1;PPP2R1B;UBB;TRAF3;TNIP2;UBC;TIFA;IRF7;MAP3K8;RIPK1;ALPK1;N4BP1;BIRC3
1414,Reactome_2022,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,14 of 35,1.7563177557144074e-11,4.543517672391619e-10,0,0,16.75479930191972,414.9362336308821,UBE2D3;NLRC5;TNFAIP3;UBE2L6;ISG15;HERC5;IFIH1;CYLD;TBK1;UBB;TRAF3;UBC;TAX1BP1;TRIM25
1415,Reactome_2022,Stabilization Of P53 R-HSA-69541,17 of 56,2.1242179115586752e-11,5.378338967563453e-10,0,0,10.987937598975709,270.0289217339881,CDKN2A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1416,Reactome_2022,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,16 of 49,2.376829389486857e-11,5.818506434023567e-10,0,0,12.209655611230414,298.6807590926664,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1417,Reactome_2022,CLEC7A (Dectin-1) Signaling R-HSA-5607764,22 of 99,2.3958555904802925e-11,5.818506434023567e-10,0,0,7.235449735449736,176.94072092227162,NFKB1;PSMB10;RELA;PSMB8;NFKB2;RELB;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;MAP3K14
1418,Reactome_2022,Signaling By NOTCH4 R-HSA-9013694,20 of 81,2.477414800780413e-11,5.896247225857384e-10,0,0,8.287988234785242,202.4027875655944,PSENEN;MAML2;YWHAZ;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1419,Reactome_2022,Regulation Of RAS By GAPs R-HSA-5658442,18 of 65,3.059034258020054e-11,7.000482244315122e-10,0,0,9.66265397536394,233.936106726712,DAB2IP;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1420,Reactome_2022,p53-Dependent G1 DNA Damage Response R-HSA-69563,18 of 65,3.059034258020054e-11,7.000482244315122e-10,0,0,9.66265397536394,233.936106726712,CDKN1A;CDKN2A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1421,Reactome_2022,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,17 of 58,3.980586253746124e-11,8.937542720675258e-10,0,0,10.450850934264928,250.2665995857685,VCP;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1422,Reactome_2022,RIPK1-mediated Regulated Necrosis R-HSA-5213460,13 of 31,4.5604928180664464e-11,9.715624219095962e-10,0,0,18.130137981118374,431.6968121221771,HSP90AA1;MLKL;TRADD;TNFRSF10B;CFLAR;TANK;SDCBP;UBB;UBC;TNFSF10;PELI1;RIPK1;BIRC3
1423,Reactome_2022,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,16 of 51,4.7353462580467725e-11,9.715624219095962e-10,0,0,11.510761154855643,273.6497125097534,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1424,Reactome_2022,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,16 of 51,4.7353462580467725e-11,9.715624219095962e-10,0,0,11.510761154855643,273.6497125097534,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1425,Reactome_2022,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,16 of 51,4.7353462580467725e-11,9.715624219095962e-10,0,0,11.510761154855643,273.6497125097534,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1426,Reactome_2022,Vpu Mediated Degradation Of CD4 R-HSA-180534,16 of 51,4.7353462580467725e-11,9.715624219095962e-10,0,0,11.510761154855643,273.6497125097534,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1427,Reactome_2022,TNF Signaling R-HSA-75893,15 of 44,4.961489873548107e-11,1.000707279580042e-09,0,0,13.01102725177385,308.70912996934123,TRADD;SPPL2A;TNFAIP3;CFLAR;TANK;TNFRSF1A;CLIP3;CYLD;UBB;UBC;OTULIN;TAX1BP1;RIPK1;RBCK1;BIRC3
1428,Reactome_2022,G1/S DNA Damage Checkpoints R-HSA-69615,18 of 67,5.3456119977480394e-11,1.018362994635065e-09,0,0,9.267293233082707,219.19150218513053,CDKN1A;CDKN2A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1429,Reactome_2022,Degradation Of GLI2 By Proteasome R-HSA-5610783,17 of 59,5.3913335010091685e-11,1.018362994635065e-09,0,0,10.201489268506352,241.20037304473664,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1430,Reactome_2022,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,17 of 59,5.3913335010091685e-11,1.018362994635065e-09,0,0,10.201489268506352,241.20037304473664,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1431,Reactome_2022,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,17 of 59,5.3913335010091685e-11,1.018362994635065e-09,0,0,10.201489268506352,241.20037304473664,CDKN1A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1432,Reactome_2022,Downstream TCR Signaling R-HSA-202424,21 of 94,6.116372478191842e-11,1.1372630076637955e-09,0,0,7.27690414578093,171.13435190599927,RIPK2;PSMB10;RELA;NFKB1;PSMB8;PSMB9;PSMA5;NFKBIA;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;HLA-DRA
1433,Reactome_2022,Regulation Of Apoptosis R-HSA-169911,16 of 52,6.595307932094556e-11,1.2074486829526956e-09,0,0,11.190434529017208,262.3270340038295,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1434,Reactome_2022,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,39 of 307,8.054958021028933e-11,1.452333340155217e-09,0,0,3.732383414456809,86.74860852469195,UBA6;UBE2D3;RNF19B;UBE2L6;UBR2;UBE2Z;PSMB10;HERC5;SOCS3;PSMB4;RNF114;RNF213;SOCS1;PSMB2;UBB;PSMB3;RNF19A;UBC;TRIM69;FBXO6;TRIM21;HERC6;UBE2B;DTX3L;LMO7;PSMB8;PSMB9;RBX1;PSMA5;PSMA6;RNF144B;PSMA3;PSMA4;PSMA1;KLHL5;PSMA2;PSME1;PSME2;RBCK1
1435,Reactome_2022,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,19 of 78,1.0069822374147524e-10,1.773128731158776e-09,0,0,8.130613429802818,187.15772020294656,CDKN2A;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;NFE2L2
1436,Reactome_2022,Cellular Response To Chemical Stress R-HSA-9711123,29 of 182,1.013216417805015e-10,1.773128731158776e-09,0,0,4.8256149811949705,111.05053163555134,VCP;HM13;PSMB10;HELZ2;PSMB4;UBB;PSMB2;PSMB3;UBC;STAP2;TRIM21;CDKN2A;STAT3;ATOX1;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;SCO2;PSMA2;PSME1;PSME2;TXNIP;BLVRA;NFE2L2
1437,Reactome_2022,Neutrophil Degranulation R-HSA-6798695,50 of 468,1.0417774197137973e-10,1.7966885934194475e-09,0,0,3.0896734844103264,71.01590595451145,B4GALT1;CXCL1;CTSS;LGALS3;HEBP2;FTH1;ITGAV;QSOX1;GYG1;B2M;SERPINB1;HSP90AA1;DYNLT1;HLA-B;HLA-C;HLA-A;AMPD3;PSMA5;VAMP8;RAP2C;CEACAM1;PKM;PSMA2;TMBIM1;CD47;KPNB1;CD63;CSTB;VCP;MOSPD2;GNS;RAP1B;SDCBP;CREG1;RAB24;STOM;S100A11;GSDMD;HSPA8;GCA;CMTM6;RAB27A;ARPC5;NFKB1;RAB10;BST2;ERP44;LCN2;CD68;RAB9B
1438,Reactome_2022,Degradation Of AXIN R-HSA-4641257,16 of 54,1.2482136643672168e-10,2.0920764233760403e-09,0,0,10.600359165630612,241.73204763619705,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1439,Reactome_2022,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,16 of 54,1.2482136643672168e-10,2.0920764233760403e-09,0,0,10.600359165630612,241.73204763619705,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1440,Reactome_2022,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,25 of 140,1.64353103339733e-10,2.716391569087254e-09,0,0,5.51619608522432,124.2744033019284,UBE2D3;NLRC5;TANK;USP18;RELA;TBK1;SOCS1;PPP2R1B;UBB;UBC;TIFA;MAP3K8;RIPK1;N4BP1;JUN;RIPK2;NFKB1;NFKB2;NFKBIA;TRAF3;TNIP2;IRF7;PELI1;ALPK1;BIRC3
1441,Reactome_2022,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,18 of 72,1.9698392882267227e-10,3.2111078808079447e-09,0,0,8.407017543859649,187.87917871002276,STAT1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1442,Reactome_2022,KEAP1-NFE2L2 Pathway R-HSA-9755511,21 of 100,2.1043630837803817e-10,3.3840433374306143e-09,0,0,6.722120963831246,149.78121088112775,VCP;CDKN2A;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;TRIM21;NFE2L2
1443,Reactome_2022,Hedgehog Ligand Biogenesis R-HSA-5358346,17 of 64,2.232813298484256e-10,3.5427304335950203e-09,0,0,9.113847960410434,202.53329352057656,VCP;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1444,Reactome_2022,Cyclin E Associated Events During G1/S Transition R-HSA-69202,19 of 82,2.5539261909230087e-10,3.998910746313659e-09,0,0,7.612794612794612,168.15307515870126,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;E2F5
1445,Reactome_2022,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,19 of 84,3.9780547561152677e-10,6.0690835381758574e-09,0,0,7.377784534306273,159.6925740449257,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;E2F5
1446,Reactome_2022,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,19 of 84,3.9780547561152677e-10,6.0690835381758574e-09,0,0,7.377784534306273,159.6925740449257,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;PSMA1;PSMB2;UBB;PPP2R5E;PSMA2;PSMB3;UBC;PSME1;PSME2
1447,Reactome_2022,Hedgehog On State R-HSA-5632684,19 of 85,4.939085735295681e-10,7.439888639242862e-09,0,0,7.265620633209566,155.69259190530605,PTCH1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;NUMB;PSME1;PSME2
1448,Reactome_2022,ABC Transporter Disorders R-HSA-5619084,18 of 77,6.475529587868186e-10,9.632350261953928e-09,0,0,7.692551293487957,162.7576197321105,VCP;ERLIN1;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1449,Reactome_2022,Endosomal/Vacuolar Pathway R-HSA-1236977,8 of 11,7.52571491271171e-10,1.1056297217440662e-08,0,0,66.55930735930735,1398.2463212410237,CTSL;HLA-B;HLA-C;HLA-A;HLA-F;B2M;CTSS;HLA-E
1450,Reactome_2022,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,11 of 25,7.78726893670205e-10,1.1301036627652977e-08,0,0,19.67666232073012,412.6857365655042,LYN;STAT5A;SOCS3;SOCS1;UBB;STAT1;UBE2D3;UBC;STAT3;JAK2;JAK1
1451,Reactome_2022,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,21 of 107,7.898352226327076e-10,1.1324143553408702e-08,0,0,6.172713587908206,129.37511870103688,HSPA8;CDKN1A;HSP90AA1;CXCL8;CEBPD;STAT1;STAT3;HIF1A;ICAM1;HSP90B1;SOCS3;SOCS1;ZEB1;BCL6;LCN2;CCL2;STAT6;TIMP1;JAK2;MCL1;JAK1
1452,Reactome_2022,Orc1 Removal From Chromatin R-HSA-68949,17 of 69,8.045416395217281e-10,1.1397673226557814e-08,0,0,8.235368442332963,172.4547784710352,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1453,Reactome_2022,Interleukin-10 Signaling R-HSA-6783783,14 of 45,8.795954513023887e-10,1.2314336318233445e-08,0,0,11.344114169903731,236.54246624077197,CXCL8;CSF1;CCL20;IL10RB;STAT3;CXCL1;CXCL2;ICAM1;TNFRSF1A;CXCL10;CCL5;CCL2;TIMP1;JAK1
1454,Reactome_2022,Asymmetric Localization Of PCP Proteins R-HSA-4608870,16 of 62,1.2088136024261286e-09,1.672660682426852e-08,0,0,8.753166723724751,179.73425577878268,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1455,Reactome_2022,Cellular Responses To Stimuli R-HSA-8953897,64 of 736,1.5166605579828415e-09,2.0745127172408983e-08,0,0,2.4743230625583568,50.24547202517553,CDKN1A;CXCL8;UBE2D3;MT1X;MIA3;ETS2;MT2A;CSRP1;TRIM21;KDM6B;HSP90AA1;PDIA6;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;DNAJC7;RRAGC;SCO2;PSMA2;DNAJB11;PSME1;MT1F;PSME2;TXNIP;ATF3;BLVRA;FKBP5;MT1E;PPP1R15A;ATP6V1A;CEBPB;VCP;HM13;HIF1A;RELA;PSMB10;HSP90B1;HELZ2;EXTL2;PSMB4;PSMB2;UBB;PSMB3;UBC;NRIP1;CCL2;STAP2;FNIP2;HSPA8;JUN;HSPA5;CDKN2A;STAT3;PSMB8;NFKB1;ATOX1;PSMB9;DNAJA1;MOV10;HDGF;NFE2L2
1456,Reactome_2022,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,16 of 63,1.562435254875804e-09,2.1128385832979624e-08,0,0,8.566482381191713,173.70273604698676,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1457,Reactome_2022,SARS-CoV Infections R-HSA-9679506,41 of 369,1.6281340770405343e-09,2.1769433164924e-08,0,0,3.2045454545454546,64.8466409417098,DDX5;VCP;SDC4;YWHAB;ARID4B;IFIH1;TBK1;FNTA;UBB;CTSL;UBC;TRIM25;RIPK1;JAK2;B2M;JAK1;UVRAG;HSP90AA1;RIPK2;STAT1;IFNGR2;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PARP14;PARP9;ATP1B1;YWHAZ;HLA-E;SRPK1;RBX1;TJP1;TRAF3;FXYD2;SNRPG;IRF7;CHMP4B;NFE2L2
1458,Reactome_2022,ABC-family Proteins Mediated Transport R-HSA-382556,20 of 102,2.0313464132736673e-09,2.6858913686618487e-08,0,0,6.158697470879722,123.26366320048584,VCP;ABCB1;ERLIN1;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;ABCF1
1459,Reactome_2022,Post-translational Protein Modification R-HSA-597592,99 of 1383,2.2561025700287972e-09,2.9502879761915037e-08,0,0,2.0369220816759115,40.55435895347907,RAB3B;CSF1;UBE2D3;TTF2;UBE2Z;TPGS2;NUB1;TRIM25;TRIM26;FBXO6;PDIA3;RAB2B;IGFBP3;HLA-B;LMO7;HLA-A;PDIA6;RBX1;PSME1;PSME2;SCG3;LY6E;DDX5;VCP;UBA6;LYPD1;HIF1A;HSP90B1;SOCS2;SOCS3;UBB;UBD;UBC;RIPK1;HSPA8;UBE2B;RAB27A;INO80;CP;NFKB2;NFKBIA;CYLD;HNRNPK;RNF181;NFE2L2;B4GALT1;TNFAIP3;MIA3;IFIH1;TUBA1C;QSOX1;TIMP1;RAB8B;RIPK2;COMMD1;RANGAP1;UCHL3;PSMA5;PSMA6;PSMA3;PSMA4;NSMCE4A;PSMA1;VGF;PSMA2;TRAF3;B3GNT2;TOP1;B4GALT6;BIRC3;B4GALT5;SP100;USP15;STX17;TANK;USP18;PSMB10;RELA;FSTL3;PSMB4;PSMB2;PSMB3;RAB24;NRIP1;RAB29;APOL1;CHGA;CDKN2A;PSMB8;PML;PSMB9;RAB10;KLHL5;TNIP1;TNIP2;OTULIN;RAB13;NUCB1;RAB9B
1460,Reactome_2022,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,14 of 48,2.2809264516221326e-09,2.950328779815585e-08,0,0,10.34154604250077,205.78315819915892,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMB4;PSMA3;PSMA4;PSMB2;PSMA1;PSMB3;PSMA2;PSME1;PSME2
1461,Reactome_2022,Disease R-HSA-1643685,117 of 1736,2.322898968530563e-09,2.9723115833885697e-08,0,0,1.9245280374224765,38.26048318276426,MAML2;GTF2B;ARID4B;TTF2;ACTG1;TBK1;FNTA;PPP2R1B;TRIM25;GYG1;B2M;HLA-B;HLA-C;LMO7;HLA-A;HLA-F;ATP1B1;RBX1;HLA-E;EML4;BTC;CYP27A1;RBP1;PSME1;SNRPG;PSME2;TXNIP;SERPING1;CHMP4B;KPNB1;DDX5;VCP;SDC4;RRAD;GNS;RAP1B;RNF213;UBB;UBC;RIPK1;LYN;STAT5A;GSDMD;UVRAG;JUN;APOBEC3G;ERLIN1;EIF2AK2;ISG15;ARPC5;PARP14;CP;NFKB1;QKI;NFKB2;SRPK1;NFKBIA;HNRNPK;ARPC2;FXYD2;NMT1;NFE2L2;CDKN1A;B4GALT1;YWHAB;TRADD;ADM;IFIH1;CTSL;PPP2R5E;JAK2;JAK1;ACTR3;PSENEN;HSP90AA1;RIPK2;IFNGR2;RHBDF2;AP3B1;RANGAP1;PARP9;YWHAZ;ETV6;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;TRAF3;IRF7;MYH9;KDM7A;CHMP5;CEBPB;BCL2A1;CEBPD;UNC93B1;TANK;PSMB10;RELA;PSMB4;PSMB2;GNG5;PSMB3;RBBP8;EPS15;CHGA;STAT1;CDKN2A;STAT2;STAT3;PSMB8;PML;PSMB9;TJP1;PIK3AP1
1462,Reactome_2022,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,18 of 83,2.3765938155705773e-09,3.008666638860625e-08,0,0,6.980283400809717,138.61165851838973,STAT1;MX2;MX1;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;OASL;HERC5;OAS1;UBB;OAS2;OAS3;UBC;TRIM25;KPNB1;JAK1
1463,Reactome_2022,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",11 of 28,3.3708176892190063e-09,4.2223926843901246e-08,0,0,16.20177927755196,316.06610018813404,PDIA3;ERAP2;HSPA5;ERAP1;HLA-B;HLA-C;HLA-A;HLA-F;B2M;HLA-E;TAPBP
1464,Reactome_2022,Transcriptional Regulation By RUNX3 R-HSA-8878159,19 of 95,3.626286788023298e-09,4.4487435853069344e-08,0,0,6.3063241106719365,122.5637662535003,CDKN1A;MAML2;CDKN2A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1465,Reactome_2022,UCH Proteinases R-HSA-5689603,19 of 95,3.626286788023298e-09,4.4487435853069344e-08,0,0,6.3063241106719365,122.5637662535003,USP15;INO80;UCHL3;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1466,Reactome_2022,TCR Signaling R-HSA-202403,21 of 116,3.6834051957574485e-09,4.472706309134045e-08,0,0,5.585302092748384,108.46337289662988,RIPK2;NFKB1;PSMB10;RELA;PSMB8;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;HLA-DRA
1467,Reactome_2022,Deubiquitination R-HSA-5688426,34 of 279,3.925285478630097e-09,4.7182724440099146e-08,0,0,3.5397081413210447,68.51397754648929,VCP;USP15;TNFAIP3;HIF1A;TANK;USP18;PSMB10;IFIH1;PSMB4;PSMB2;UBB;PSMB3;UBC;TRIM25;RIPK1;RIPK2;INO80;UCHL3;PSMB8;PSMB9;PSMA5;NFKBIA;CYLD;PSMA6;PSMA3;PSMA4;PSMA1;TNIP1;PSMA2;TRAF3;TNIP2;PSME1;PSME2;BIRC3
1468,Reactome_2022,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,14 of 50,4.125728245270472e-09,4.786998038315566e-08,0,0,9.765997673065735,188.5425785109982,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;PSMA2;PSMB3;PSME1;PSME2
1469,Reactome_2022,Death Receptor Signaling R-HSA-73887,23 of 139,4.128907777670026e-09,4.786998038315566e-08,0,0,5.0175610870061655,96.86528585411148,PSENEN;RIPK2;TRADD;SPPL2A;TNFRSF10B;TNFAIP3;CFLAR;TANK;NFKB1;RELA;TNFRSF1A;CLIP3;NFKBIA;CYLD;UBB;CASP3;UBC;OTULIN;TNFSF10;TAX1BP1;RIPK1;RBCK1;BIRC3
1470,Reactome_2022,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,16 of 67,4.143368049970616e-09,4.786998038315566e-08,0,0,7.892954557150944,152.34788962086472,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1471,Reactome_2022,Regulation Of PTEN Stability And Activity R-HSA-8948751,16 of 67,4.143368049970616e-09,4.786998038315566e-08,0,0,7.892954557150944,152.34788962086472,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1472,Reactome_2022,C-type Lectin Receptors (CLRs) R-HSA-5621481,23 of 141,5.485169152099805e-09,6.276299318268046e-08,0,0,4.93200134695252,93.81267232646564,LYN;NFKB1;PSMB10;RELA;PSMB8;NFKB2;RELB;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;MAP3K14
1473,Reactome_2022,Host Interactions Of HIV Factors R-HSA-162909,22 of 130,5.8247701028074415e-09,6.601406116515101e-08,0,0,5.150254752106604,97.65473386581888,APOBEC3G;HLA-A;RANGAP1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;B2M;KPNB1
1474,Reactome_2022,Hedgehog Off State R-HSA-5610787,19 of 98,6.2497492969689555e-09,7.016227984333073e-08,0,0,6.06589283033972,114.5891102225081,PTCH1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;NUMB;PSME2
1475,Reactome_2022,Signaling By CSF3 (G-CSF) R-HSA-9674555,11 of 30,7.984639282280781e-09,8.880112846648717e-08,0,0,14.4948191861662,270.26672020537944,LYN;STAT5A;SOCS3;SOCS1;UBB;STAT1;UBE2D3;UBC;STAT3;JAK2;JAK1
1476,Reactome_2022,MAPK6/MAPK4 Signaling R-HSA-5687128,18 of 90,9.334936708688552e-09,1.028571729938831e-07,0,0,6.2993421052631575,116.47169744590732,JUN;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;MOV10;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1477,Reactome_2022,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,13 of 45,9.746105408520249e-09,1.0640243519393667e-07,0,0,10.19076797385621,187.98296275625893,RIPK2;NLRC5;TANK;USP18;RELA;NFKB1;NFKB2;NFKBIA;UBB;TIFA;UBC;ALPK1;N4BP1
1478,Reactome_2022,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,43 of 424,1.0426202430163408e-08,1.127925535626769e-07,0,0,2.8930776510079097,53.17171136854193,CDKN1A;CEBPB;VCP;MAML2;BCL2A1;YWHAB;PSMB10;RAP1B;PSMB4;RNF213;PSMB2;PPP2R1B;UBB;PSMB3;PPP2R5E;UBC;JAK2;LYN;STAT5A;PSENEN;HSP90AA1;STAT1;STAT3;AP3B1;LMO7;PSMB8;QKI;PSMB9;RBX1;ETV6;EML4;PSMA5;BTC;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;MYH9;PIK3AP1;KDM7A
1479,Reactome_2022,Mitotic G1 Phase And G1/S Transition R-HSA-453279,23 of 147,1.2452585944120146e-08,1.3209275623727688e-07,0,0,4.691882076479385,85.39852932143327,LYN;CDKN1A;MAX;CDKN2A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;JAK2;E2F5
1480,Reactome_2022,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,19 of 102,1.2486129692500288e-08,1.3209275623727688e-07,0,0,5.772354239090751,105.04903965748488,JUN;RIPK2;NLRC5;TANK;USP18;NFKB1;RELA;NFKB2;NFKBIA;PPP2R1B;UBB;TNIP2;UBC;TIFA;IRF7;PELI1;MAP3K8;ALPK1;N4BP1
1481,Reactome_2022,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,16 of 72,1.2654264042898793e-08,1.3209275623727688e-07,0,0,7.186351706036746,130.68575758798403,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1482,Reactome_2022,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,16 of 72,1.2654264042898793e-08,1.3209275623727688e-07,0,0,7.186351706036746,130.68575758798403,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1483,Reactome_2022,Neddylation R-HSA-8951664,30 of 237,1.344438620220342e-08,1.3912017026627886e-07,0,0,3.6842207238626674,66.775410830331,VCP;UBE2D3;HIF1A;PSMB10;SOCS2;SOCS3;NUB1;PSMB4;PSMB2;UBB;PSMB3;UBD;UBC;FBXO6;LMO7;COMMD1;UCHL3;PSMB8;PSMB9;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;KLHL5;PSMA2;PSME1;PSME2;NFE2L2
1484,Reactome_2022,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,19 of 103,1.4760726746495891e-08,1.5142469679594921e-07,0,0,5.703337725076856,102.83856946218468,JUN;RIPK2;NLRC5;TANK;USP18;NFKB1;RELA;NFKB2;NFKBIA;PPP2R1B;UBB;TNIP2;UBC;TIFA;IRF7;PELI1;MAP3K8;ALPK1;N4BP1
1485,Reactome_2022,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,16 of 73,1.56279591460875e-08,1.5760399477834005e-07,0,0,7.059906985311047,126.89621030875304,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1486,Reactome_2022,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,16 of 73,1.56279591460875e-08,1.5760399477834005e-07,0,0,7.059906985311047,126.89621030875304,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1487,Reactome_2022,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,16 of 75,2.3569774244247065e-08,2.3569774244247065e-07,0,0,6.819876329018195,119.77953869068412,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1488,Reactome_2022,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,19 of 106,2.40753751566977e-08,2.3874747030391883e-07,0,0,5.505807702209501,96.58329878629674,JUN;RIPK2;NLRC5;TANK;USP18;NFKB1;RELA;NFKB2;NFKBIA;PPP2R1B;UBB;TNIP2;UBC;TIFA;IRF7;PELI1;MAP3K8;ALPK1;N4BP1
1489,Reactome_2022,Signaling By NOTCH R-HSA-157118,27 of 203,2.4929098756716368e-08,2.451704753759709e-07,0,0,3.8905852802324175,68.11337168975831,B4GALT1;MAML2;HIF1A;PSMB10;PSMB4;PSMB2;UBB;PSMB3;UBC;PSENEN;JUN;STAT1;YWHAZ;PSMB8;PSMB9;RBX1;PSMA5;MOV10;PSMA6;PSMA3;PSMA4;PSMA1;ELF3;PSMA2;PSME1;NUMB;PSME2
1490,Reactome_2022,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,18 of 96,2.7066676759124453e-08,2.6401102740457455e-07,0,0,5.812955465587044,101.29053103441932,JUN;RIPK2;NLRC5;TANK;USP18;RELA;NFKB1;NFKB2;NFKBIA;PPP2R1B;UBB;TNIP2;TIFA;UBC;PELI1;MAP3K8;ALPK1;N4BP1
1491,Reactome_2022,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,16 of 76,2.878992919330616e-08,2.785367133336124e-07,0,0,6.705861767279091,116.43548855790696,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1492,Reactome_2022,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,21 of 130,3.0059769859185635e-08,2.884768236486363e-07,0,0,4.864360767394229,84.25110844016038,LYN;JUN;NFKB1;PSMB10;RELA;PSMB8;PSMB9;NFKBIA;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1493,Reactome_2022,Transcriptional Regulation By RUNX2 R-HSA-8878166,20 of 119,3.218943568103219e-08,3.0644342768342644e-07,0,0,5.096612563631033,87.92486157511017,CDKN1A;STAT1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;LGALS3;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1494,Reactome_2022,Metabolism Of Polyamines R-HSA-351202,14 of 58,3.34194694070478e-08,3.156283221776737e-07,0,0,7.987029985721085,137.48975004785996,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;PSMA2;PSMB3;PSME1;PSME2
1495,Reactome_2022,PCP/CE Pathway R-HSA-4086400,17 of 88,4.138675355020428e-08,3.877971395649062e-07,0,0,6.025559401084562,102.436347432502,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PFN1
1496,Reactome_2022,Switching Of Origins To A Post-Replicative State R-HSA-69052,17 of 90,5.8643879596844366e-08,5.452048181269124e-07,0,0,5.859863553723471,97.57717409113836,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1497,Reactome_2022,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,19 of 112,6.068692673765622e-08,5.598251381225652e-07,0,0,5.148979273803958,85.56335636005798,JUN;RIPK2;NLRC5;TANK;USP18;NFKB1;RELA;NFKB2;NFKBIA;SOCS1;PPP2R1B;UBB;TNIP2;UBC;TIFA;PELI1;MAP3K8;ALPK1;N4BP1
1498,Reactome_2022,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,18 of 101,6.15301370951121e-08,5.629716576670083e-07,0,0,5.46135066582118,90.67883966702716,JUN;RIPK2;NLRC5;TANK;USP18;NFKB1;RELA;NFKB2;NFKBIA;PPP2R1B;UBB;TNIP2;UBC;TIFA;PELI1;MAP3K8;ALPK1;N4BP1
1499,Reactome_2022,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,16 of 80,6.197419088603201e-08,5.629716576670083e-07,0,0,6.285433070866142,104.3164904960979,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1500,Reactome_2022,Cellular Responses To Stress R-HSA-2262752,59 of 722,6.298906828428013e-08,5.678559943810102e-07,0,0,2.297016763268911,38.085237709459605,CDKN1A;CXCL8;UBE2D3;MIA3;ETS2;TRIM21;KDM6B;HSP90AA1;PDIA6;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;DNAJC7;RRAGC;SCO2;PSMA2;DNAJB11;PSME1;PSME2;TXNIP;ATF3;BLVRA;FKBP5;PPP1R15A;ATP6V1A;CEBPB;VCP;HM13;HIF1A;RELA;PSMB10;HSP90B1;HELZ2;EXTL2;PSMB4;PSMB2;UBB;PSMB3;UBC;NRIP1;CCL2;STAP2;FNIP2;HSPA8;JUN;HSPA5;CDKN2A;STAT3;PSMB8;NFKB1;ATOX1;PSMB9;DNAJA1;MOV10;HDGF;NFE2L2
1501,Reactome_2022,SARS-CoV-2 Infection R-HSA-9694516,32 of 283,6.742596897032079e-08,6.032849855239229e-07,0,0,3.242109310746291,53.53447277007599,DDX5;VCP;SDC4;YWHAB;IFIH1;TBK1;UBB;CTSL;UBC;TRIM25;B2M;JAK1;UVRAG;HSP90AA1;RIPK2;STAT1;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;PARP14;PARP9;YWHAZ;HLA-E;SRPK1;TJP1;TRAF3;SNRPG;IRF7;CHMP4B
1502,Reactome_2022,PTEN Regulation R-HSA-6807070,21 of 139,9.906592410601477e-08,8.797645498966981e-07,0,0,4.491234355058998,72.43229362146248,EGR1;JUN;PSMB10;PML;PSMB8;PSMB9;PSMA5;MOV10;PSMA6;PSMA3;PSMB4;PSMA4;RRAGC;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1503,Reactome_2022,Interleukin-12 Family Signaling R-HSA-447115,13 of 54,1.0702173653297417e-07,9.433767886980683e-07,0,0,7.95003985333971,127.59999898510743,RALA;GSTO1;STAT1;EBI3;STAT3;TOX4;RAP1B;HNRNPF;HNRNPA2B1;PSME2;JAK2;IL6ST;JAK1
1504,Reactome_2022,G1/S Transition R-HSA-69206,20 of 129,1.2877608116541597e-07,1.1267907101973895e-06,0,0,4.626612766575488,73.40209404848372,CDKN1A;MAX;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;E2F5
1505,Reactome_2022,Ovarian Tumor Domain Proteases R-HSA-5689896,11 of 39,1.7779993875366718e-07,1.544393628590248e-06,0,0,9.83116036505867,152.80186051534454,IFIH1;VCP;UBB;TNIP1;RIPK2;TNIP2;TRAF3;UBC;TNFAIP3;TRIM25;RIPK1
1506,Reactome_2022,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,16 of 87,2.1121417789535994e-07,1.821339649967234e-06,0,0,5.66367232264981,87.05287031257247,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2
1507,Reactome_2022,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,17 of 98,2.1446976263553205e-07,1.8361080398293752e-06,0,0,5.278905274087053,81.05810293465167,KMT2A;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1508,Reactome_2022,Signaling By Hedgehog R-HSA-5358351,20 of 135,2.7607140508417334e-07,2.3466069432154733e-06,0,0,4.383847654009407,66.20752515654854,VCP;PTCH1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;NUMB;PSME2
1509,Reactome_2022,Ub-specific Processing Proteases R-HSA-5689880,25 of 201,3.0303933661204866e-07,2.55756603239956e-06,0,0,3.5928256670288543,53.92616912145041,USP15;HIF1A;TANK;USP18;PSMB10;IFIH1;PSMB4;PSMB2;UBB;PSMB3;UBC;RIPK1;PSMB8;PSMB9;PSMA5;NFKBIA;CYLD;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;BIRC3
1510,Reactome_2022,Regulation Of IFNG Signaling R-HSA-877312,7 of 14,3.545366148563679e-07,2.9711167019653365e-06,0,0,24.92217898832685,370.1555222473745,SOCS3;SOCS1;STAT1;IFNGR2;JAK2;PTPN2;JAK1
1511,Reactome_2022,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,13 of 63,7.317546984609778e-07,6.089427210968976e-06,0,0,6.515973856209151,92.05650896157182,RELA;NFKB1;NFKB2;NFKBIA;TBK1;UBB;DHX36;UBC;IRF7;RIPK1;STAT6;TRIM21;TRIM56
1512,Reactome_2022,ISG15 Antiviral Mechanism R-HSA-1169408,14 of 75,1.0006765644136368e-06,8.26947994202936e-06,0,0,5.75602952536263,79.51859367164768,STAT1;MX2;MX1;EIF2AK2;UBE2L6;ISG15;IFIT1;USP18;HERC5;UBB;UBC;TRIM25;KPNB1;JAK1
1513,Reactome_2022,HIV Infection R-HSA-162906,26 of 229,1.049808373824234e-06,8.61566872310923e-06,0,0,3.239269992663243,44.59471549335685,GTF2B;PSMB10;PSMB4;PSMB2;UBB;PSMB3;UBC;B2M;APOBEC3G;HLA-A;RANGAP1;PSMB8;PSMB9;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;NMT1;PSME2;CHMP4B;KPNB1;CHMP5
1514,Reactome_2022,Assembly Of Pre-Replicative Complex R-HSA-68867,17 of 110,1.1708489484646744e-06,9.54322088132166e-06,0,0,4.594873751289334,62.75578160167628,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1515,Reactome_2022,G2/M Checkpoints R-HSA-69481,20 of 148,1.2374106011225729e-06,1.0017133437658923e-05,0,0,3.9359333773087073,53.53849277851201,RRAD;YWHAB;YWHAZ;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;RBBP8;PSME2
1516,Reactome_2022,Chemokine Receptors Bind Chemokines R-HSA-380108,12 of 56,1.2743515609412978e-06,1.0246475388649624e-05,0,0,6.828150961310231,92.67899205634409,CXCL10;CXCL9;CXCL11;CXCL8;CCL20;CCL5;CCL2;CXCL1;CXCL3;CXCL2;CX3CL1;CXCL16
1517,Reactome_2022,CASP8 Activity Is Inhibited R-HSA-5218900,6 of 11,1.3281628133971102e-06,1.0398116762780006e-05,0,0,29.87098445595855,404.2056159868319,TRADD;TNFSF10;TNFRSF10B;RIPK1;CFLAR;TANK
1518,Reactome_2022,Dimerization Of Procaspase-8 R-HSA-69416,6 of 11,1.3281628133971102e-06,1.0398116762780006e-05,0,0,29.87098445595855,404.2056159868319,TRADD;TNFSF10;TNFRSF10B;RIPK1;CFLAR;TANK
1519,Reactome_2022,Interleukin-27 Signaling R-HSA-9020956,6 of 11,1.3281628133971102e-06,1.0398116762780006e-05,0,0,29.87098445595855,404.2056159868319,STAT1;EBI3;STAT3;IL6ST;JAK2;JAK1
1520,Reactome_2022,Interleukin-6 Signaling R-HSA-1059683,6 of 11,1.3281628133971102e-06,1.0398116762780006e-05,0,0,29.87098445595855,404.2056159868319,SOCS3;STAT1;STAT3;IL6ST;JAK2;JAK1
1521,Reactome_2022,Metabolism Of Proteins R-HSA-392499,114 of 1890,1.3380997370659237e-06,1.0407442399401628e-05,0,0,1.686512943666558,22.808839639868378,RAB3B;CSF1;UBE2D3;UBE2L6;TTF2;UBE2Z;TPGS2;NUB1;TRIM25;TRIM26;FBXO6;B2M;SLC30A7;PDIA3;RAB2B;IGFBP3;HLA-B;LMO7;HLA-A;PDIA6;RBX1;PPA1;PSME1;PSME2;SCG3;LY6E;DDX5;VCP;UBA6;LYPD1;HIF1A;GSPT1;HSP90B1;SOCS2;SOCS3;UBB;UBD;UBC;RIPK1;HSPA8;UBE2B;RAB27A;TBCB;INHBA;INO80;CP;NFKB2;NFKBIA;CYLD;EIF5;HNRNPK;RNF181;NFE2L2;ACHE;B4GALT1;TNFAIP3;MIA3;IFIH1;TUBA1C;QSOX1;TIMP1;RAB8B;PSENEN;TSFM;RIPK2;SPHK1;COMMD1;RANGAP1;UCHL3;PSMA5;PSMA6;PSMA3;PSMA4;NSMCE4A;PSMA1;VGF;PSMA2;TRAF3;B3GNT2;TOP1;B4GALT6;BIRC3;B4GALT5;SP100;USP15;STX17;TANK;USP18;PSMB10;RELA;FSTL3;PSMB4;PSMB2;GNG5;PSMB3;RAB24;NRIP1;RAB29;APOL1;CHGA;CDKN2A;STAT3;PSMB8;PML;PSMB9;RAB10;KLHL5;TNIP1;TNIP2;OTULIN;RAB13;NUCB1;RAB9B;MSRB1
1522,Reactome_2022,MAPK1/MAPK3 Signaling R-HSA-5684996,29 of 277,1.3752696143043483e-06,1.0627083383260874e-05,0,0,2.962261509970283,39.98123114347669,YWHAB;PSMB10;RASGRP3;RAP1B;PSMB4;PPP2R1B;PSMB2;FNTA;UBB;PSMB3;PPP2R5E;UBC;JAK2;JAK1;DUSP5;DAB2IP;PSMB8;PSMB9;RBX1;BTC;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;IL6ST
1523,Reactome_2022,Transcriptional Regulation By RUNX1 R-HSA-8878171,24 of 204,1.4362225956472304e-06,1.1026483153678736e-05,0,0,3.367285587975243,45.30175675196394,KMT2A;PCGF5;PSMB8;PSMB10;PML;PSMB9;PSMA5;TJP1;LGALS3;MOV10;PSMA6;SOCS3;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;CTSL;PSMA2;PSMB3;UBC;PSME1;PSME2
1524,Reactome_2022,DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,5 of 7,1.7303113146451045e-06,1.3199169643767142e-05,0,0,62.160413971539455,824.695217050295,DHX36;IRF7;NFKB1;RELA;NFKB2
1525,Reactome_2022,Growth Hormone Receptor Signaling R-HSA-982772,8 of 24,2.1367236506198323e-06,1.619554868941147e-05,0,0,12.471428571428572,162.82992599104642,LYN;STAT5A;SOCS2;SOCS3;SOCS1;STAT1;STAT3;JAK2
1526,Reactome_2022,Interleukin-35 Signaling R-HSA-8984722,6 of 12,2.568732104079248e-06,1.9225101911033364e-05,0,0,24.89119170984456,320.40186214994884,STAT1;EBI3;STAT3;IL6ST;JAK2;JAK1
1527,Reactome_2022,TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,6 of 12,2.568732104079248e-06,1.9225101911033364e-05,0,0,24.89119170984456,320.40186214994884,TBK1;UBB;TRAF3;UBC;IRF7;TANK
1528,Reactome_2022,Beta-catenin Independent WNT Signaling R-HSA-3858494,19 of 142,2.640730691383366e-06,1.9640434517163785e-05,0,0,3.8870250757843543,49.92671828909858,PSMB10;PSMB8;PSMB9;PSMA5;MOV10;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;GNG5;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;PFN1
1529,Reactome_2022,RAF/MAP Kinase Cascade R-HSA-5673001,28 of 271,2.6988516122533843e-06,1.9948033655785884e-05,0,0,2.915840877914952,37.38890676727939,YWHAB;PSMB10;RASGRP3;RAP1B;PSMB4;PPP2R1B;PSMB2;FNTA;UBB;PSMB3;PPP2R5E;UBC;JAK2;JAK1;DUSP5;DAB2IP;PSMB8;PSMB9;RBX1;BTC;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2
1530,Reactome_2022,MAPK Family Signaling Cascades R-HSA-5683057,31 of 318,2.7393530456948967e-06,2.012240817516621e-05,0,0,2.737943644496686,35.067003890677654,YWHAB;PSMB10;RASGRP3;RAP1B;PSMB4;PPP2R1B;PSMB2;FNTA;UBB;PSMB3;PPP2R5E;UBC;JAK2;JAK1;DUSP5;JUN;DAB2IP;PSMB8;PSMB9;RBX1;BTC;PSMA5;MOV10;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;IL6ST
1531,Reactome_2022,Synthesis Of DNA R-HSA-69239,17 of 119,3.56666931027896e-06,2.603887410571756e-05,0,0,4.1874726237406925,52.527147244637,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1532,Reactome_2022,Interleukin-20 Family Signaling R-HSA-8854691,8 of 26,4.235442571201042e-06,3.0546525210480245e-05,0,0,11.084559884559884,137.138426866934,STAT5A;SOCS3;IL10RB;STAT1;STAT2;STAT3;JAK2;JAK1
1533,Reactome_2022,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,8 of 26,4.235442571201042e-06,3.0546525210480245e-05,0,0,11.084559884559884,137.138426866934,CYLD;TRADD;TNFAIP3;RIPK1;RBCK1;TANK;TNFRSF1A;BIRC3
1534,Reactome_2022,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,17 of 121,4.496319540993661e-06,3.2232652131219616e-05,0,0,4.106514707368847,50.56044135477846,HSP90AA1;RIPK2;STAT1;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;HLA-E;IFIH1;TBK1;TRAF3;IRF7;TRIM25;B2M;JAK1
1535,Reactome_2022,TNFR1-induced Proapoptotic Signaling R-HSA-5357786,6 of 13,4.6132966730362586e-06,3.287319186175538e-05,0,0,21.33419689119171,262.1240574810533,CYLD;TRADD;TNFAIP3;RIPK1;TANK;TNFRSF1A
1536,Reactome_2022,S Phase R-HSA-69242,20 of 161,4.64484377067376e-06,3.290097670893913e-05,0,0,3.5706132225528173,43.84624778925114,CDKN1A;MAX;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;E2F5
1537,Reactome_2022,PIP3 Activates AKT Signaling R-HSA-1257604,27 of 268,6.4952989674841255e-06,4.57361288242965e-05,0,0,2.831560685337945,33.821383715845165,CDKN1A;PSMB10;PSMB4;PPP2R1B;PSMB2;UBB;PSMB3;PPP2R5E;UBC;IER3;EGR1;JUN;PSMB8;PML;PSMB9;BTC;PSMA5;MOV10;PSMA6;PSMA3;PSMA4;RRAGC;PSMA1;PSMA2;PSME1;PSME2;PIK3AP1
1538,Reactome_2022,Axon Guidance R-HSA-422475,42 of 519,6.579602147764243e-06,4.60572150343497e-05,0,0,2.2425314465408803,26.756845309677463,RBM8A;GSPT1;MYL12A;PSMB10;MYL12B;ACTG1;RND1;SDCBP;PSMB4;PSMB2;RRAS;UBB;CHL1;PSMB3;DPYSL3;UBC;ITGAV;PLXNC1;LYN;ACTR3;PSENEN;HSPA8;HSP90AA1;LIMK2;ITGA1;ARPC5;PSMB8;PSMB9;RBX1;RHOB;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;ARPC2;PSMA2;PSME1;NUMB;PSME2;MYH9;PFN1
1539,Reactome_2022,Intrinsic Pathway For Apoptosis R-HSA-109606,11 of 55,7.192328176682051e-06,5.0051874445916026e-05,0,0,6.250977835723599,74.02717770928706,GSDMD;CASP7;YWHAB;CDKN2A;CASP3;STAT3;TP53BP2;NMT1;PMAIP1;YWHAZ;BBC3
1540,Reactome_2022,SARS-CoV-2-host Interactions R-HSA-9705683,22 of 196,8.402016771183524e-06,5.81302323122581e-05,0,0,3.1856717144073468,37.23106889569659,UVRAG;HSP90AA1;RIPK2;STAT1;YWHAB;STAT2;HLA-B;HLA-C;ISG15;HLA-A;HLA-F;YWHAZ;HLA-E;IFIH1;TJP1;TBK1;TRAF3;SNRPG;IRF7;TRIM25;B2M;JAK1
1541,Reactome_2022,DNA Replication Pre-Initiation R-HSA-69002,17 of 127,8.730721098691287e-06,5.972190731655062e-05,0,0,3.8813045036435314,45.212006577598544,PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1542,Reactome_2022,G2/M Transition R-HSA-69275,21 of 182,8.732446952167905e-06,5.972190731655062e-05,0,0,3.284303026822124,38.25708864399237,CDKN1A;HSP90AA1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;OPTN
1543,Reactome_2022,Nervous System Development R-HSA-9675108,43 of 545,9.611555549543126e-06,6.535857773689326e-05,0,0,2.1816407838035614,25.203502194889676,RBM8A;GSPT1;MYL12A;PSMB10;MYL12B;ACTG1;RND1;SDCBP;PSMB4;PSMB2;RRAS;UBB;CHL1;PSMB3;DPYSL3;UBC;ITGAV;PLXNC1;LYN;ACTR3;PSENEN;HSPA8;HSP90AA1;LIMK2;ITGA1;ARPC5;PSMB8;PSMB9;RBX1;RHOB;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;ARPC2;PSMA2;PSME1;NUMB;PSME2;MYH9;UTRN;PFN1
1544,Reactome_2022,TCF Dependent Signaling In Response To WNT R-HSA-201681,22 of 198,9.89042787734412e-06,6.687277939795173e-05,0,0,3.149140211640212,36.29051276915907,CHD8;YWHAZ;PSMB8;PSMB10;PSMB9;RBX1;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;PSMA1;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;BCL9L
1545,Reactome_2022,Mitotic G2-G2/M Phases R-HSA-453274,21 of 184,1.0351372198483917e-05,6.959397127794273e-05,0,0,3.243664448784757,37.23205033228985,CDKN1A;HSP90AA1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;OPTN
1546,Reactome_2022,Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,6 of 16,1.947243486612603e-05,0.00012945361726642444,0,0,14.93160621761658,161.95582644441842,TRADD;TNFSF10;TNFRSF10B;RIPK1;CFLAR;TANK
1547,Reactome_2022,p75NTR Signals Via NF-kB R-HSA-193639,6 of 16,1.947243486612603e-05,0.00012945361726642444,0,0,14.93160621761658,161.95582644441842,NFKBIA;UBB;RIPK2;UBC;NFKB1;RELA
1548,Reactome_2022,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,19 of 167,2.818734107594027e-05,0.0001863496437798273,0,0,3.2262044653349,33.79977493848897,RBM8A;GSPT1;PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1549,Reactome_2022,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,6 of 17,2.9104787105311827e-05,0.0001913519152227684,0,0,13.573480923221856,141.76968597231172,TBK1;UBB;TRAF3;UBC;IRF7;TANK
1550,Reactome_2022,TRAF6 Mediated NF-kB Activation R-HSA-933542,7 of 25,3.412657838381677e-05,0.00022313532020187888,0,0,9.686410145554117,99.6289327577882,IFIH1;NFKBIA;TRIM25;TANK;RELA;NFKB1;NFKB2
1551,Reactome_2022,DNA Replication R-HSA-69306,18 of 155,3.453362437388217e-05,0.00022456291259519005,0,0,3.2993661160199768,33.896292137856136,PSMB10;PSMB8;RBX1;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2;KPNB1
1552,Reactome_2022,Protein Ubiquitination R-HSA-8852135,12 of 76,3.472648919644856e-05,0.00022458979425964013,0,0,4.689458224543081,48.15139355618029,VCP;UBB;UBE2B;UBA6;UBE2D3;UBC;OTULIN;HLA-B;RNF181;HLA-A;UBE2Z;UCHL3
1553,Reactome_2022,Separation Of Sister Chromatids R-HSA-2467813,19 of 170,3.61507365514453e-05,0.0002325371702498373,0,0,3.1616103447373245,32.336360126868755,RANGAP1;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;UBB;PSMA1;PSMB2;PPP2R5E;PSMA2;PSMB3;UBC;PSME1;PSME2
1554,Reactome_2022,Mitotic Anaphase R-HSA-68882,23 of 232,3.975318213493818e-05,0.0002543348749493357,0,0,2.7713108780379607,28.081196137888345,ANKLE2;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA5;TUBA1C;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;PSMA1;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;CHMP4B;KPNB1
1555,Reactome_2022,Interleukin-12 Signaling R-HSA-9020591,9 of 44,4.058093713692989e-05,0.0002582423272350084,0,0,6.415864759427828,64.87858544643689,RAP1B;TOX4;RALA;GSTO1;HNRNPF;HNRNPA2B1;PSME2;JAK2;JAK1
1556,Reactome_2022,Regulation Of NF-kappa B Signaling R-HSA-9758274,6 of 18,4.222348655236786e-05,0.00026726568615594547,0,0,12.441709844559586,125.31954466064188,UBB;UBC;NLRC5;TANK;USP18;N4BP1
1557,Reactome_2022,Mitotic Metaphase And Anaphase R-HSA-2555396,23 of 233,4.252464108181496e-05,0.00026774774014476084,0,0,2.7579690949227373,27.76013620677336,ANKLE2;RANGAP1;PSMB8;PSMB10;PSMB9;PSMA5;TUBA1C;PSMA6;PSMA3;PSMB4;PSMA4;PPP2R1B;PSMA1;PSMB2;UBB;PSMA2;PSMB3;PPP2R5E;UBC;PSME1;PSME2;CHMP4B;KPNB1
1558,Reactome_2022,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,7 of 26,4.513918613822333e-05,0.0002827138500236093,0,0,9.176121236944502,91.81406514360476,TRADD;CASP3;TNFSF10;TNFRSF10B;RIPK1;CFLAR;TANK
1559,Reactome_2022,Disorders Of Transmembrane Transporters R-HSA-5619115,19 of 176,5.8313964690803926e-05,0.00036331737163380456,0,0,3.0398277988973086,29.637314739871325,VCP;ERLIN1;CP;PSMB10;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;UBB;PSMA1;PSMB2;PSMA2;PSMB3;UBC;PSME1;PSME2
1560,Reactome_2022,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,6 of 19,5.968611668417453e-05,0.0003699295773654568,0,0,11.484057393383818,111.69866348737504,STAT5A;EML4;CEBPB;BCL2A1;STAT3;RBX1
1561,Reactome_2022,Cell Cycle Checkpoints R-HSA-69620,25 of 271,6.179145093271122e-05,0.00038019841860359937,0,0,2.561029594359689,24.82084714252012,CDKN1A;RRAD;YWHAB;PSMB10;PSMB4;PPP2R1B;PSMB2;UBB;PSMB3;PPP2R5E;UBC;RBBP8;CDKN2A;RANGAP1;YWHAZ;PSMB8;PSMB9;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2
1562,Reactome_2022,Post-translational Protein Phosphorylation R-HSA-8957275,14 of 106,6.198192706646914e-05,0.00038019841860359937,0,0,3.8103232415206008,36.91695577132444,CSF1;IGFBP3;MIA3;PDIA6;CP;HSP90B1;FSTL3;VGF;NUCB1;TRIM26;SCG3;QSOX1;TIMP1;APOL1
1563,Reactome_2022,Intracellular Signaling By Second Messengers R-HSA-9006925,27 of 306,6.870417931008896e-05,0.0004192716583538762,0,0,2.441003393325029,23.39872751228696,CDKN1A;PSMB10;PSMB4;PPP2R1B;PSMB2;UBB;PSMB3;PPP2R5E;UBC;IER3;EGR1;JUN;PSMB8;PML;PSMB9;BTC;PSMA5;MOV10;PSMA6;PSMA3;PSMA4;RRAGC;PSMA1;PSMA2;PSME1;PSME2;PIK3AP1
1564,Reactome_2022,IkBA Variant Leads To EDA-ID R-HSA-5603029,4 of 7,7.23925172102242e-05,0.00043952599734778977,0,0,33.107665805340226,315.6288733817682,NFKBIA;NFKB1;RELA;NFKB2
1565,Reactome_2022,Signaling By Hippo R-HSA-2028269,6 of 20,8.246979983879508e-05,0.0004981678264373916,0,0,10.66321243523316,100.26702246251588,TJP1;YWHAB;CASP3;AMOT;SAV1;TJP2
1566,Reactome_2022,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,15 of 123,8.714139761377339e-05,0.000518857141812596,0,0,3.4793213921654287,32.524621563983786,CSF1;IGFBP3;MIA3;TTF2;PDIA6;CP;HSP90B1;FSTL3;VGF;NUCB1;TRIM26;SCG3;QSOX1;TIMP1;APOL1
1567,Reactome_2022,NF-kB Is Activated And Signals Survival R-HSA-209560,5 of 13,8.720288097690689e-05,0.000518857141812596,0,0,15.535252263906855,145.21224696873472,NFKBIA;UBB;UBC;NFKB1;RELA
1568,Reactome_2022,Trafficking And Processing Of Endosomal TLR R-HSA-1679131,5 of 13,8.720288097690689e-05,0.000518857141812596,0,0,15.535252263906855,145.21224696873472,UNC93B1;CTSL;CTSS;HSP90B1;LGMN
1569,Reactome_2022,Potential Therapeutics For SARS R-HSA-9679191,13 of 97,9.659503162572716e-05,0.0005718810330080364,0,0,3.871677559912854,35.793594192786735,HSP90AA1;IFNGR2;STAT2;ARID4B;ATP1B1;RBX1;TBK1;FNTA;FXYD2;RIPK1;JAK2;NFE2L2;JAK1
1570,Reactome_2022,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,6 of 21,0.00011167434133375056,0.0006578834959760553,0,0,9.951813471502591,90.56074216073428,NFKBIA;TBK1;RIPK1;NFKB1;RELA;NFKB2
1571,Reactome_2022,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,7 of 30,0.00012196828377111848,0.0007149864910720739,0,0,7.578695088253538,68.29730179437493,UBB;UBE2B;UBA6;UBC;OTULIN;UBE2Z;UCHL3
1572,Reactome_2022,Interleukin-15 Signaling R-HSA-8983432,5 of 14,0.00013131182757736103,0.0007622491454490713,0,0,13.808394422883426,123.41854147409448,STAT5A;IL15RA;IL15;STAT3;JAK1
1573,Reactome_2022,Response To Metal Ions R-HSA-5660526,5 of 14,0.00013131182757736103,0.0007622491454490713,0,0,13.808394422883426,123.41854147409448,MT2A;CSRP1;MT1F;MT1X;MT1E
1574,Reactome_2022,SARS-CoV-1 Infection R-HSA-9678108,9 of 52,0.00015950057679268542,0.0009213868271033768,0,0,5.220038104454592,45.64121012663175,UVRAG;DDX5;VCP;UBB;CTSL;UBC;CHMP4B;PARP9;PARP14
1575,Reactome_2022,Semaphorin Interactions R-HSA-373755,10 of 64,0.00016914112435957254,0.000972357188347301,0,0,4.621913580246914,40.14028938686887,HSP90AA1;RRAS;LIMK2;DPYSL3;ITGA1;MYH9;PLXNC1;RND1;RHOB;MYL12B
1576,Reactome_2022,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",9 of 53,0.0001855782070710625,0.0010617214731469,0,0,5.101134885920321,43.829125211451576,CYLD;RIPK2;CASP4;TNFAIP3;TXNIP;RELA;NFKB1;BIRC3;NFKB2
1577,Reactome_2022,Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,5 of 15,0.00019067611508682863,0.001080497985492,0,0,12.426908150064683,106.43565188016956,TBK1;UBB;UBC;TRIM21;TRIM56
1578,Reactome_2022,TRAF3-dependent IRF Activation Pathway R-HSA-918233,5 of 15,0.00019067611508682863,0.001080497985492,0,0,12.426908150064683,106.43565188016956,IFIH1;TBK1;TRAF3;IRF7;TRIM25
1579,Reactome_2022,Signaling By ROBO Receptors R-HSA-376176,20 of 209,0.00020037335967461168,0.0011300677630937,0,0,2.657089807485586,22.625991590508217,RBM8A;GSPT1;PSMB8;PSMB10;PSMB9;RBX1;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;PSMA1;PSMB2;UBB;PSMA2;PSMB3;UBC;PSME1;PSME2;PFN1
1580,Reactome_2022,Signaling By WNT R-HSA-195721,25 of 294,0.0002238947853949708,0.001256767899151,0,0,2.339218096634528,19.659570942071703,CHD8;PSMB10;PSMB4;PPP2R1B;PSMB2;UBB;GNG5;PSMB3;PPP2R5E;UBC;BCL9L;YWHAZ;PSMB8;PSMB9;RBX1;PSMA5;MOV10;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;PFN1
1581,Reactome_2022,Interleukin-1 Processing R-HSA-448706,4 of 9,0.0002447963084547036,0.0013549191026097,0,0,19.8625322997416,165.15862625870022,GSDMD;NFKB1;RELA;NFKB2
1582,Reactome_2022,Interleukin-9 Signaling R-HSA-8985947,4 of 9,0.0002447963084547036,0.0013549191026097,0,0,19.8625322997416,165.15862625870022,STAT5A;STAT1;STAT3;JAK1
1583,Reactome_2022,OAS Antiviral Response R-HSA-8983711,4 of 9,0.0002447963084547036,0.0013549191026097,0,0,19.8625322997416,165.15862625870022,OAS1;OAS2;OAS3;OASL
1584,Reactome_2022,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,9 of 55,0.00024843655565627126,0.0013621764016101,0,0,4.878837564312772,40.495927913029824,EML4;STAT5A;CEBPB;RNF213;BCL2A1;STAT3;MYH9;LMO7;RBX1
1585,Reactome_2022,Interleukin-6 Family Signaling R-HSA-6783589,6 of 24,0.0002506862453383373,0.0013621764016101,0,0,8.291882556131261,68.7505556497446,SOCS3;STAT1;STAT3;IL6ST;JAK2;JAK1
1586,Reactome_2022,Other Interleukin Signaling R-HSA-449836,6 of 24,0.0002506862453383373,0.0013621764016101,0,0,8.291882556131261,68.7505556497446,IL32;CSF1;IL10RB;CASP3;STX4;JAK1
1587,Reactome_2022,Sema4D In Semaphorin Signaling R-HSA-400685,6 of 24,0.0002506862453383373,0.0013621764016101,0,0,8.291882556131261,68.7505556497446,RRAS;LIMK2;MYH9;MYL12B;RHOB;RND1
1588,Reactome_2022,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,5 of 16,0.0002684964936078683,0.0014523219426971,0,0,11.29660119957662,92.8882543237027,UBB;TNIP2;UBC;MAP3K8;NFKB1
1589,Reactome_2022,Regulation Of IFNA/IFNB Signaling R-HSA-912694,6 of 25,0.0003190739004338798,0.0017180902331055,0,0,7.855058631033542,63.2339118048398,SOCS3;SOCS1;STAT1;STAT2;USP18;JAK1
1590,Reactome_2022,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,7 of 35,0.00034016429672335265,0.0018234032121657,0,0,6.223735408560311,49.70326026982568,RAP1B;TOX4;RALA;GSTO1;HNRNPF;HNRNPA2B1;PSME2
1591,Reactome_2022,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,5 of 17,0.00036824366219419805,0.0019562944554066,0,0,10.354678740836569,81.87201884107021,NFKBIA;RIPK1;NFKB1;RELA;NFKB2
1592,Reactome_2022,TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,5 of 17,0.00036824366219419805,0.0019562944554066,0,0,10.354678740836569,81.87201884107021,CD40;TRAF3;TANK;MAP3K14;BIRC3
1593,Reactome_2022,Interleukin-21 Signaling R-HSA-9020958,4 of 10,0.00039544391322882686,0.0020914589188546,0,0,16.551248923341948,129.6873373071267,STAT5A;STAT1;STAT3;JAK1
1594,Reactome_2022,Pyroptosis R-HSA-5620971,6 of 26,0.0004012547621190699,0.0021128016235473,0,0,7.461917098445596,58.35901201684396,GSDMD;CASP3;IRF1;CASP4;IRF2;CHMP4B
1595,Reactome_2022,Cyclin D Associated Events In G1 R-HSA-69231,8 of 47,0.0004139730872608991,0.0021701672856408,0,0,5.110356310356311,39.80819157375693,LYN;CDKN1A;PPP2R1B;UBB;CDKN2A;UBC;E2F5;JAK2
1596,Reactome_2022,DNA Damage Bypass R-HSA-73893,8 of 48,0.0004800604866740658,0.0025055788558865,0,0,4.982337662337662,38.07302374841531,VCP;UBB;UBE2B;UBC;TRIM25;UBE2L6;ISG15;RBX1
1597,Reactome_2022,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,35 of 496,0.0005368350491228079,0.0027896668491534,0,0,1.9170537452959364,14.43506902227425,ATP6V1A;CD274;RALA;RRAD;YWHAB;HIF1A;RAP1B;SOCS1;PPP2R1B;UBB;UBC;CTNNA1;STAT6;ITGAV;JAK2;EPS15;LYN;STAT5A;PSENEN;NTRK2;EGR1;HSP90AA1;LAMB3;STAT1;ITGA3;SPHK1;STAT3;BTC;HNRNPM;SPINT1;VGF;HNRNPF;ID4;TRIB1;PTPN2
1598,Reactome_2022,Defective RIPK1-mediated Regulated Necrosis R-HSA-9693928,3 of 5,0.0005528783160439336,0.002860544330836,0,0,37.2,279.01386161187804,TRADD;RIPK1;TANK
1599,Reactome_2022,Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,4 of 11,0.0006023225273113039,0.0030762395171693,0,0,14.186046511627907,105.18552727550588,UBB;TIFA;UBC;ALPK1
1600,Reactome_2022,Metallothioneins Bind Metals R-HSA-5661231,4 of 11,0.0006023225273113039,0.0030762395171693,0,0,14.186046511627907,105.18552727550588,MT2A;MT1F;MT1X;MT1E
1601,Reactome_2022,Signaling By Leptin R-HSA-2586552,4 of 11,0.0006023225273113039,0.0030762395171693,0,0,14.186046511627907,105.18552727550588,STAT5A;SOCS3;STAT3;JAK2
1602,Reactome_2022,RAB Geranylgeranylation R-HSA-8873719,9 of 62,0.000622218488573347,0.0031642735102661,0,0,4.232917044924799,31.248321731226568,RAB3B;RAB10;RAB2B;RAB24;RAB13;RAB29;RAB27A;RAB9B;RAB8B
1603,Reactome_2022,Signaling By KIT In Disease R-HSA-9669938,5 of 19,0.0006486199911380399,0.0032705838536197,0,0,8.874514877102198,65.14482781645678,LYN;STAT5A;STAT1;STAT3;JAK2
1604,Reactome_2022,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",5 of 19,0.0006486199911380399,0.0032705838536197,0,0,8.874514877102198,65.14482781645678,UBB;UBE2D3;UBC;RIPK1;BIRC3
1605,Reactome_2022,Signaling By MET R-HSA-6806834,9 of 63,0.0007012898676796268,0.0035212444832858,0,0,4.154312960554833,30.171068650278038,RAP1B;SPINT1;UBB;LAMB3;ITGA3;UBC;STAT3;EPS15;PTPN2
1606,Reactome_2022,Signaling By TGFB Family Members R-HSA-9006936,13 of 119,0.0007407867379522684,0.0037039336897613,0,0,3.064594894561598,22.08898026880911,PPP1R15A;USP15;STAT1;UBE2D3;INHBA;F11R;FSTL3;UBB;UBC;SRFBP1;ITGAV;E2F5;SKIL
1607,Reactome_2022,EPH-Ephrin Signaling R-HSA-2682334,11 of 91,0.0008000527699633124,0.0039669283177347,0,0,3.431584093872229,24.47005265281377,ACTR3;PSENEN;LYN;SDCBP;ARPC2;LIMK2;MYH9;ARPC5;MYL12A;ACTG1;MYL12B
1608,Reactome_2022,Signaling By TGF-beta Receptor Complex R-HSA-170834,11 of 91,0.0008000527699633124,0.0039669283177347,0,0,3.431584093872229,24.47005265281377,PPP1R15A;USP15;UBB;STAT1;UBE2D3;UBC;ITGAV;SRFBP1;F11R;E2F5;SKIL
1609,Reactome_2022,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,5 of 20,0.0008373376871765884,0.0041345719823242,0,0,8.282449331608452,58.683498436566325,LIMK2;MYH9;MYL12B;RHOB;RND1
1610,Reactome_2022,Butyrophilin (BTN) Family Interactions R-HSA-8851680,4 of 12,0.0008757666684738258,0.0043064559317514,0,0,12.412144702842378,87.38659839526787,BTN2A2;BTN3A1;BTN3A3;BTN3A2
1611,Reactome_2022,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,6 of 31,0.0010874281765501,0.0053252655559453,0,0,5.967979274611399,40.72513154666362,NFKBIA;UNC93B1;TRAF3;RELA;NFKB1;NFKB2
1612,Reactome_2022,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,10 of 81,0.0011597956092758,0.0056563802255667,0,0,3.5121405516431925,23.740354407317238,CDKN1A;CEBPB;JUN;CXCL8;UBB;CDKN2A;UBC;STAT3;RELA;NFKB1
1613,Reactome_2022,Interleukin-17 Signaling R-HSA-448424,9 of 69,0.0013655379603763,0.0066326129503992,0,0,3.7377113133940174,24.65471684845417,JUN;PPP2R1B;UBB;RIPK2;TNIP2;UBC;MAP3K8;IL17RB;NFKB1
1614,Reactome_2022,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,8 of 56,0.0013753731056824,0.0066532276250494,0,0,4.15021645021645,27.345901672623263,VCP;UBB;UBE2B;UBE2D3;UBC;HLA-B;RNF181;HLA-A
1615,Reactome_2022,Interleukin-2 Family Signaling R-HSA-451927,7 of 44,0.001431442069061,0.0068686131539621,0,0,4.707645388579241,30.830712851001525,STAT5A;IL15RA;IL15;STAT1;STAT3;JAK2;JAK1
1616,Reactome_2022,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,7 of 44,0.001431442069061,0.0068686131539621,0,0,4.707645388579241,30.830712851001525,PRELID1;BCL6;IGFBP3;TP53BP2;PMAIP1;TNFRSF10B;BBC3
1617,Reactome_2022,Cytoprotection By HMOX1 R-HSA-9707564,8 of 57,0.001546374110532,0.0073903019740287,0,0,4.06530612244898,26.31002041832256,HELZ2;SCO2;HM13;STAT3;TXNIP;STAP2;BLVRA;NFE2L2
1618,Reactome_2022,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,5 of 23,0.0016497977639528,0.0078530373564153,0,0,6.900963058789708,44.215178121035066,UBB;UBE2D3;UBC;RIPK1;BIRC3
1619,Reactome_2022,EPHB-mediated Forward Signaling R-HSA-3928662,6 of 34,0.0017990662343276,0.0085294375252984,0,0,5.327720207253886,33.67378901281069,ACTR3;LYN;ARPC2;LIMK2;ARPC5;ACTG1
1620,Reactome_2022,Erythropoietin Activates STAT5 R-HSA-9027283,3 of 7,0.0018247667162076,0.0085828948311745,0,0,18.598064516129032,117.28503241149184,LYN;STAT5A;JAK2
1621,Reactome_2022,Modulation By Mtb Of Host Immune System R-HSA-9637628,3 of 7,0.0018247667162076,0.0085828948311745,0,0,18.598064516129032,117.28503241149184,UBB;UBC;B2M
1622,Reactome_2022,Unfolded Protein Response (UPR) R-HSA-381119,10 of 89,0.0023790424477895,0.0111459075309824,0,0,3.155162183544304,19.06051524221578,CEBPB;EXTL2;CXCL8;HSPA5;DNAJB11;CCL2;HDGF;PDIA6;ATF3;HSP90B1
1623,Reactome_2022,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,5 of 25,0.0024427162526978,0.0113548138309002,0,0,6.210219922380336,37.35226597263437,GSDMD;TXNIP;RELA;NFKB1;NFKB2
1624,Reactome_2022,Interleukin-7 Signaling R-HSA-1266695,5 of 25,0.0024427162526978,0.0113548138309002,0,0,6.210219922380336,37.35226597263437,SOCS2;STAT5A;SOCS1;STAT3;JAK1
1625,Reactome_2022,MAP Kinase Activation R-HSA-450294,8 of 62,0.0026696645311659,0.0123614816812742,0,0,3.687926887926888,21.853926218219737,JUN;PPP2R1B;UBB;RIPK2;TNIP2;UBC;MAP3K8;NFKB1
1626,Reactome_2022,Early SARS-CoV-2 Infection Events R-HSA-9772572,6 of 37,0.0028173760054232,0.0128678550969517,0,0,4.8113822497075045,28.252192737809708,UVRAG;DDX5;VCP;SDC4;CTSL;CHMP4B
1627,Reactome_2022,Myoclonic Epilepsy Of Lafora R-HSA-3785653,3 of 8,0.0028354401198111,0.0128678550969517,0,0,14.87767741935484,87.26588142673744,UBB;UBC;GYG1
1628,Reactome_2022,Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,3 of 8,0.0028354401198111,0.0128678550969517,0,0,14.87767741935484,87.26588142673744,ACTN1;RSU1;LIMS1
1629,Reactome_2022,TRAIL Signaling R-HSA-75158,3 of 8,0.0028354401198111,0.0128678550969517,0,0,14.87767741935484,87.26588142673744,TNFSF10;TNFRSF10B;CFLAR
1630,Reactome_2022,Cell-extracellular Matrix Interactions R-HSA-446353,4 of 16,0.0028439041096624,0.0128678550969517,0,0,8.273040482342807,48.501340858688856,ACTN1;ILK;RSU1;LIMS1
1631,Reactome_2022,NLRP3 Inflammasome R-HSA-844456,4 of 16,0.0028439041096624,0.0128678550969517,0,0,8.273040482342807,48.501340858688856,TXNIP;NFKB1;RELA;NFKB2
1632,Reactome_2022,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,5 of 26,0.0029287802640284,0.013102438023285,0,0,5.914187149633463,34.498454529897806,PPP1R15A;USP15;UBB;UBC;SRFBP1
1633,Reactome_2022,Infection With Mycobacterium Tuberculosis R-HSA-9635486,5 of 26,0.0029287802640284,0.013102438023285,0,0,5.914187149633463,34.498454529897806,RNF213;UBB;UBC;B2M;KPNB1
1634,Reactome_2022,Metal Ion SLC Transporters R-HSA-425410,5 of 26,0.0029287802640284,0.013102438023285,0,0,5.914187149633463,34.498454529897806,SLC30A7;SLC30A2;SLC39A1;CP;SLC39A14
1635,Reactome_2022,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,7 of 51,0.0034204351915322,0.0152446362469038,0,0,3.95725739889164,22.469257993812423,RAB10;RALA;YWHAB;RAB13;MYH9;STX4;YWHAZ
1636,Reactome_2022,FLT3 Signaling In Disease R-HSA-9682385,5 of 27,0.0034809890139189,0.0154566303229983,0,0,5.645066447136305,31.953553293684138,STAT5A;CDKN1A;UBB;UBC;ETV6
1637,Reactome_2022,Zinc Transporters R-HSA-435354,4 of 17,0.0036056487328587,0.0159506393758434,0,0,7.636255217650566,42.95587193061886,SLC30A7;SLC30A2;SLC39A14;SLC39A1
1638,Reactome_2022,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,6 of 39,0.003702491947049,0.0163183904332904,0,0,4.519312293923693,25.30249603062845,VCP;UBB;UBC;TRIM25;UBE2L6;ISG15
1639,Reactome_2022,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,7 of 52,0.0038226018287018,0.0167855947459601,0,0,3.869116587404525,21.53869100490631,BTC;SOCS3;UBB;UBC;STAT3;STAP2;HIF1A
1640,Reactome_2022,TRAF6 Mediated IRF7 Activation R-HSA-933541,5 of 28,0.0041041459854495,0.017810195041574,0,0,5.399347544856291,29.6735053059974,IFIH1;TBK1;IRF7;TRIM25;TANK
1641,Reactome_2022,BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,3 of 9,0.0041307679256087,0.017810195041574,0,0,12.397419354838709,68.05305427631832,STAT3;PMAIP1;BBC3
1642,Reactome_2022,CHL1 Interactions R-HSA-447041,3 of 9,0.0041307679256087,0.017810195041574,0,0,12.397419354838709,68.05305427631832,HSPA8;CHL1;ITGA1
1643,Reactome_2022,MAPK1 (ERK2) Activation R-HSA-112411,3 of 9,0.0041307679256087,0.017810195041574,0,0,12.397419354838709,68.05305427631832,IL6ST;JAK2;JAK1
1644,Reactome_2022,Regulation Of PTEN Localization R-HSA-8948747,3 of 9,0.0041307679256087,0.017810195041574,0,0,12.397419354838709,68.05305427631832,UBB;UBC;PML
1645,Reactome_2022,Peptide Ligand-Binding Receptors R-HSA-375276,16 of 196,0.0042749567570501,0.0183653376927424,0,0,2.221289005540974,12.117089969250191,CXCL9;CXCL8;RIPK2;CCL20;CXCL1;ECE1;TTF2;CXCL3;SSTR2;CXCL2;CX3CL1;CXCL16;CXCL10;CXCL11;CCL5;CCL2
1646,Reactome_2022,Metabolism Of RNA R-HSA-8953854,40 of 666,0.0045012460207801,0.0192679236141306,0,0,1.610085110435769,8.699935539329683,FYTTD1;DDX5;RBM8A;YWHAB;SPPL2A;DDX23;HNRNPU;ADAR;GSPT1;PSMB10;ZFP36L1;PSMB4;ZFP36;PSMB2;UBB;PSMB3;UBC;HSPA8;WTAP;YWHAZ;PSMB8;U2SURP;PSMB9;PSMA5;HNRNPM;PSMA6;LSM8;PSMA3;HNRNPK;PSMA4;LSM6;PSMA1;XRN1;PSMA2;HNRNPF;HNRNPA2B1;PSME1;SNRPG;PSME2;SRSF7
1647,Reactome_2022,"Cell Cycle, Mitotic R-HSA-69278",33 of 523,0.0045713723545955,0.0194979681074145,0,0,1.693346116970278,9.123650364007975,ANKLE2;CDKN1A;MAX;PSMB10;TUBA1C;PSMB4;PSMB2;PPP2R1B;UBB;PSMB3;PPP2R5E;UBC;JAK2;E2F5;LYN;HSP90AA1;CDKN2A;RANGAP1;PSMB8;PSMB9;RBX1;EML4;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;CHMP4B;OPTN;KPNB1
1648,Reactome_2022,Costimulation By CD28 Family R-HSA-388841,8 of 68,0.0047630943065195,0.0202369983055597,0,0,3.318095238095238,17.741383264080273,LYN;CD274;PPP2R1B;PPP2R5E;HLA-DRA;MAP3K8;TNFRSF14;MAP3K14
1649,Reactome_2022,Negative Regulation Of MAPK Pathway R-HSA-5675221,6 of 41,0.0047786525410607,0.0202369983055597,0,0,4.260621761658031,22.76704424662333,DUSP5;PPP2R1B;UBB;YWHAB;PPP2R5E;UBC
1650,Reactome_2022,Circadian Clock R-HSA-400253,8 of 69,0.0052086765030727,0.0219798760236047,0,0,3.2635299127102404,17.157778390247746,HELZ2;UBB;NOCT;NAMPT;NRIP1;UBC;CREM;HIF1A
1651,Reactome_2022,Signaling By SCF-KIT R-HSA-1433557,6 of 42,0.0053954566506992,0.0226876092379226,0,0,4.142055267702936,21.630632902791483,LYN;STAT5A;SOCS1;STAT1;STAT3;JAK2
1652,Reactome_2022,Nicotinamide Salvaging R-HSA-197264,4 of 19,0.0055204491497439,0.0230502964498081,0,0,6.61739879414298,34.40581544009113,NNMT;NAMPT;PARP14;PARP9
1653,Reactome_2022,RHO GTPases Activate ROCKs R-HSA-5627117,4 of 19,0.0055204491497439,0.0230502964498081,0,0,6.61739879414298,34.40581544009113,LIMK2;MYH9;MYL12B;RHOB
1654,Reactome_2022,Activation Of BH3-only Proteins R-HSA-114452,5 of 30,0.0055823447273574,0.0232272385508928,0,0,4.966882276843467,25.768912348268135,YWHAB;TP53BP2;PMAIP1;YWHAZ;BBC3
1655,Reactome_2022,MAPK3 (ERK1) Activation R-HSA-110056,3 of 10,0.0057316275076885,0.0236827664380188,0,0,10.625806451612902,54.84781761194556,IL6ST;JAK2;JAK1
1656,Reactome_2022,STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,3 of 10,0.0057316275076885,0.0236827664380188,0,0,10.625806451612902,54.84781761194556,CD274;STAT3;HIF1A
1657,Reactome_2022,Hemostasis R-HSA-109582,35 of 576,0.0063630991813394,0.0262009966290449,0,0,1.6266049362752293,8.226131104931113,LGALS3BP;CD63;SDC4;TTF2;F11R;RAP1B;DOCK10;PPP2R1B;GNG5;PPP2R5E;STX4;ITGAV;QSOX1;TIMP1;JAK2;LYN;CD74;HSPA5;ITGA3;ACTN1;ITGA1;TNFRSF10B;ATP1B1;SERPINB8;YWHAZ;RHOB;EHD1;CEACAM1;IRF1;IRF2;SERPING1;TAGLN2;SCG3;CD47;PFN1
1658,Reactome_2022,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,5 of 31,0.0064467541515575,0.0263630152589468,0,0,4.775599562145487,24.088976670153038,UBB;STAT1;UBE2D3;UBC;SKIL
1659,Reactome_2022,Nicotinate Metabolism R-HSA-196807,5 of 31,0.0064467541515575,0.0263630152589468,0,0,4.775599562145487,24.088976670153038,NNMT;NAMPT;CD38;PARP14;PARP9
1660,Reactome_2022,Apoptotic Factor-Mediated Response R-HSA-111471,4 of 20,0.0066912306600728,0.0269917440185988,0,0,6.203488372093023,31.060602423566824,GSDMD;CASP7;CDKN2A;CASP3
1661,Reactome_2022,CD209 (DC-SIGN) Signaling R-HSA-5621575,4 of 20,0.0066912306600728,0.0269917440185988,0,0,6.203488372093023,31.060602423566824,LYN;NFKB1;RELA;RELB
1662,Reactome_2022,Chaperone Mediated Autophagy R-HSA-9613829,4 of 20,0.0066912306600728,0.0269917440185988,0,0,6.203488372093023,31.060602423566824,HSPA8;HSP90AA1;UBB;UBC
1663,Reactome_2022,TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,4 of 20,0.0066912306600728,0.0269917440185988,0,0,6.203488372093023,31.060602423566824,PRELID1;TP53BP2;PMAIP1;BBC3
1664,Reactome_2022,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,6 of 44,0.0068007036945605,0.0273406668801591,0,0,3.923643305154077,19.581841164999293,PPP1R15A;USP15;UBB;UBC;ITGAV;SRFBP1
1665,Reactome_2022,PERK Regulates Gene Expression R-HSA-381042,5 of 32,0.0074008062301613,0.0295535550801746,0,0,4.598485937425135,22.5609368967168,CEBPB;CXCL8;HSPA5;CCL2;ATF3
1666,Reactome_2022,Termination Of Translesion DNA Synthesis R-HSA-5656169,5 of 32,0.0074008062301613,0.0295535550801746,0,0,4.598485937425135,22.5609368967168,UBB;UBC;TRIM25;UBE2L6;ISG15
1667,Reactome_2022,M Phase R-HSA-68886,25 of 380,0.007635114801844,0.0300646774837994,0,0,1.7644913304528365,8.60189047917961,ANKLE2;PSMB10;TUBA1C;PSMB4;PPP2R1B;PSMB2;UBB;PSMB3;PPP2R5E;UBC;HSP90AA1;RANGAP1;PSMB8;PSMB9;EML4;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;CHMP4B;KPNB1
1668,Reactome_2022,Apoptotic Cleavage Of Cell Adhesion Proteins R-HSA-351906,3 of 11,0.0076551237626817,0.0300646774837994,0,0,9.297096774193548,45.298989147115385,TJP1;CASP3;TJP2
1669,Reactome_2022,Regulated Proteolysis Of p75NTR R-HSA-193692,3 of 11,0.0076551237626817,0.0300646774837994,0,0,9.297096774193548,45.298989147115385,PSENEN;NFKB1;RELA
1670,Reactome_2022,Regulation Of BACH1 Activity R-HSA-9708530,3 of 11,0.0076551237626817,0.0300646774837994,0,0,9.297096774193548,45.298989147115385,UBB;UBC;RBX1
1671,Reactome_2022,SUMOylation Of Immune Response Proteins R-HSA-4755510,3 of 11,0.0076551237626817,0.0300646774837994,0,0,9.297096774193548,45.298989147115385,NFKBIA;RELA;NFKB2
1672,Reactome_2022,Inflammasomes R-HSA-622312,4 of 21,0.0080152632342738,0.0311704681332873,0,0,5.83827329381365,28.177886892465256,TXNIP;NFKB1;RELA;NFKB2
1673,Reactome_2022,Interleukin-37 Signaling R-HSA-9008059,4 of 21,0.0080152632342738,0.0311704681332873,0,0,5.83827329381365,28.177886892465256,TBK1;STAT3;PTPN2;IL18BP
1674,Reactome_2022,Negative Regulation Of MET Activity R-HSA-6807004,4 of 21,0.0080152632342738,0.0311704681332873,0,0,5.83827329381365,28.177886892465256,UBB;UBC;EPS15;PTPN2
1675,Reactome_2022,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,5 of 33,0.0084489426115556,0.0325379990542109,0,0,4.4340232858990944,21.16675894829674,B4GALT1;B3GNT2;B4GALT6;GNS;B4GALT5
1676,Reactome_2022,NOD1/2 Signaling Pathway R-HSA-168638,5 of 33,0.0084489426115556,0.0325379990542109,0,0,4.4340232858990944,21.16675894829674,CYLD;RIPK2;CASP4;TNFAIP3;BIRC3
1677,Reactome_2022,Oncogene Induced Senescence R-HSA-2559585,5 of 33,0.0084489426115556,0.0325379990542109,0,0,4.4340232858990944,21.16675894829674,MOV10;UBB;CDKN2A;UBC;ETS2
1678,Reactome_2022,Cell Cycle R-HSA-1640170,38 of 654,0.0092725962730448,0.0355948050481397,0,0,1.551044226044226,7.259960092671274,ANKLE2;CDKN1A;MAX;RRAD;YWHAB;PSMB10;TUBA1C;PSMB4;PSMB2;PPP2R1B;UBB;PSMB3;PPP2R5E;UBC;RBBP8;JAK2;E2F5;LYN;HSP90AA1;CDKN2A;SMARCA5;RANGAP1;YWHAZ;PSMB8;PSMB9;RBX1;EML4;PSMA5;PSMA6;PSMA3;PSMA4;PSMA1;PSMA2;PSME1;PSME2;CHMP4B;OPTN;KPNB1
1679,Reactome_2022,Laminin Interactions R-HSA-3000157,4 of 22,0.0095001259233973,0.0362344546437271,0,0,5.513637668676428,25.673979364911524,LAMB3;ITGA3;ITGA1;ITGAV
1680,Reactome_2022,Response Of Mtb To Phagocytosis R-HSA-9637690,4 of 22,0.0095001259233973,0.0362344546437271,0,0,5.513637668676428,25.673979364911524,RNF213;UBB;UBC;KPNB1
1681,Reactome_2022,Clathrin-mediated Endocytosis R-HSA-8856828,12 of 142,0.0095510875276344,0.0363124413989934,0,0,2.3007029524000804,10.700800085674144,ITSN2;BTC;ACTR3;VAMP8;HSPA8;NECAP2;UBB;ARPC2;UBC;TRIP10;ARPC5;EPS15
1682,Reactome_2022,Josephin Domain DUBs R-HSA-5689877,3 of 12,0.0099149167239826,0.0374563520683789,0,0,8.263655913978495,38.12615255133503,VCP;UBB;UBC
1683,Reactome_2022,TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,3 of 12,0.0099149167239826,0.0374563520683789,0,0,8.263655913978495,38.12615255133503,IGFBP3;TP53BP2;TNFRSF10B
1684,Reactome_2022,Vesicle-mediated Transport R-HSA-5653656,37 of 637,0.01020562599244,0.038432578895581,0,0,1.5497390913180389,7.105268803101233,ITSN2;RALA;STX17;YWHAB;MIA3;UBE2Z;GNS;HSP90B1;UBB;FTH1;UBC;STX4;APOL1;EPS15;RAB8B;DENND2D;ACTR3;HSPA8;HSP90AA1;DENND4A;RAB27A;AP3B1;ARPC5;YWHAZ;VAMP8;RAB10;BTC;TJP1;NECAP2;ARPC2;RAB13;TRIP10;CHMP4B;MYH9;OPTN;RAB9B;CHMP5
1685,Reactome_2022,RAF-independent MAPK1/3 Activation R-HSA-112409,4 of 23,0.0111528307932012,0.0418670935139099,0,0,5.223174214606283,23.483714742663043,DUSP5;IL6ST;JAK2;JAK1
1686,Reactome_2022,mRNA Splicing - Major Pathway R-HSA-72163,14 of 181,0.0113675274782261,0.0425388606889595,0,0,2.09087061479136,9.360816148555896,HSPA8;DDX5;RBM8A;DDX23;HNRNPU;U2SURP;HNRNPM;LSM8;HNRNPK;LSM6;HNRNPF;HNRNPA2B1;SNRPG;SRSF7
1687,Reactome_2022,Cellular Senescence R-HSA-2559583,13 of 165,0.0124901608148027,0.0461319411956472,0,0,2.1320089439284486,9.344198816947868,KDM6B;JUN;CDKN1A;CEBPB;CXCL8;CDKN2A;STAT3;ETS2;NFKB1;RELA;MOV10;UBB;UBC
1688,Reactome_2022,Glycogen Synthesis R-HSA-3322077,3 of 13,0.0125215268959614,0.0461319411956472,0,0,7.436903225806452,32.57591155517704,UBB;UBC;GYG1
1689,Reactome_2022,NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,3 of 13,0.0125215268959614,0.0461319411956472,0,0,7.436903225806452,32.57591155517704,IFIH1;TRIM25;RIPK1
1690,Reactome_2022,Suppression Of Phagosomal Maturation R-HSA-9637687,3 of 13,0.0125215268959614,0.0461319411956472,0,0,7.436903225806452,32.57591155517704,UBB;UBC;KPNB1
1691,Reactome_2022,p75NTR Recruits Signaling Complexes R-HSA-209543,3 of 13,0.0125215268959614,0.0461319411956472,0,0,7.436903225806452,32.57591155517704,UBB;RIPK2;UBC
1692,Reactome_2022,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,11 of 130,0.012657747318683,0.0464898744112123,0,0,2.3022471048393283,10.059636067247038,LGALS3BP;CD63;HSPA5;ACTN1;SERPING1;SCG3;TAGLN2;QSOX1;STX4;TIMP1;PFN1
1693,Reactome_2022,FOXO-mediated Transcription R-HSA-9614085,7 of 65,0.0129114765724046,0.0472353723990961,0,0,2.999865825841943,13.048332509935674,CDKN1A;BTG1;BCL6;YWHAB;TXNIP;YWHAZ;BBC3
1694,Reactome_2022,Aggrephagy R-HSA-9646399,4 of 24,0.0129798040121886,0.0472353723990961,0,0,4.961757105943152,21.55566241044204,HSP90AA1;VCP;UBB;UBC
1695,Reactome_2022,Signaling By EGFR In Cancer R-HSA-1643713,4 of 24,0.0129798040121886,0.0472353723990961,0,0,4.961757105943152,21.55566241044204,BTC;HSP90AA1;UBB;UBC
1696,Reactome_2022,Signaling By NTRK1 (TRKA) R-HSA-187037,10 of 114,0.0134661006351587,0.0488556699873137,0,0,2.393579727564102,10.31053572150645,EGR1;NTRK2;RALA;PPP2R1B;VGF;RRAD;YWHAB;STAT3;ID4;TRIB1
1697,Reactome_2022,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,6 of 51,0.0138127313245852,0.0499609430889253,0,0,3.3120898100172718,14.182913578699052,UBB;STAT1;UBE2D3;UBC;E2F5;SKIL
2559,GO_Biological_Process_2023,Defense Response To Virus (GO:0051607),57 of 189,5.235667083176002e-35,1.6848376673660374e-31,0,0,11.43329970999874,902.4873295735872,IFITM3;RTP4;CD40;IFIT5;DDX60L;IFIT1;IFI44L;IFIT3;IFIT2;OASL;IFIH1;TBK1;TRIM5;DHX58;TRIM25;TRIM26;TRIM21;GBP5;RAB2B;GBP7;RSAD2;NT5C3A;PLSCR1;IFI27;OAS1;OAS2;TRAF3;IRF1;OAS3;IRF2;IRF7;TRIM56;IFI6;NLRC5;DDX60;SAMHD1;TANK;USP18;RELA;PMAIP1;GBP2;APOBEC3G;MLKL;STAT1;MX2;STAT2;MX1;EIF2AK2;ISG15;PML;BST2;ISG20;CXCL10;MOV10;ZNFX1;MAP3K14;SHFL
2560,GO_Biological_Process_2023,Defense Response To Symbiont (GO:0140546),50 of 148,1.6638575277645506e-33,2.6771467621731623e-30,0,0,13.402668759811617,1011.5820970629096,IFITM3;RTP4;CD40;IFIT5;DDX60L;IFIT1;IFI44L;IFIT3;IFIT2;OASL;IFIH1;TBK1;TRIM5;GBP5;RAB2B;GBP7;RSAD2;NT5C3A;PLSCR1;IFI27;OAS1;OAS2;TRAF3;IRF1;OAS3;IRF2;IRF7;TRIM56;IFI6;NLRC5;DDX60;SAMHD1;TANK;RELA;PMAIP1;GBP2;APOBEC3G;MLKL;STAT1;MX2;STAT2;MX1;EIF2AK2;ISG15;BST2;ISG20;MOV10;ZNFX1;MAP3K14;SHFL
2561,GO_Biological_Process_2023,Negative Regulation Of Viral Process (GO:0048525),28 of 61,1.1642603142984613e-23,1.248863230470816e-20,0,0,21.70876767676768,1146.3829524989342,IFITM3;IFIT5;IFIT1;OASL;IFIH1;ZFP36;CCL5;TRIM21;N4BP1;RSAD2;APOBEC3G;STAT1;MX1;EIF2AK2;LARP7;ISG15;SRPK1;BST2;ISG20;FAM111A;PLSCR1;ZNFX1;OAS1;TNIP1;OAS2;OAS3;TRIM14;SHFL
2562,GO_Biological_Process_2023,Response To Cytokine (GO:0034097),37 of 125,8.392701581151753e-23,6.751928422036585e-20,0,0,10.85691939639308,551.8799545828547,IFITM3;CD274;CD40;SP100;CALCOCO2;ADAR;RELA;CXCL16;RELB;NUB1;LAMP3;UBD;CASP3;DPYSL3;RIPK1;TIMP1;JAK2;TRIM21;MCL1;CD74;GCH1;STAT1;SPHK1;MX2;MX1;EIF2AK2;ISG15;NFKB1;PML;NFKB2;BST2;PLSCR1;REL;IL6ST;XAF1;SHFL;TRIM56
2563,GO_Biological_Process_2023,Regulation Of Viral Genome Replication (GO:0045069),26 of 67,8.636518331082564e-20,5.558463197884739e-17,0,0,16.174948105864036,710.0107072455737,IFITM3;CXCL8;STAU1;IFIT5;IFIT1;OASL;IFIH1;CCL5;N4BP1;GBP7;RSAD2;APOBEC3G;MX1;EIF2AK2;ISG15;SRPK1;BST2;ISG20;FAM111A;PLSCR1;ZNFX1;OAS1;TNIP1;OAS2;OAS3;SHFL
2564,GO_Biological_Process_2023,Negative Regulation Of Viral Genome Replication (GO:0045071),23 of 53,5.566945990436013e-19,2.985738699537182e-16,0,0,19.488565121412805,819.1486342036181,IFITM3;RSAD2;APOBEC3G;MX1;IFIT5;EIF2AK2;ISG15;IFIT1;OASL;SRPK1;IFIH1;BST2;ISG20;FAM111A;PLSCR1;ZNFX1;OAS1;TNIP1;OAS2;OAS3;CCL5;SHFL;N4BP1
2565,GO_Biological_Process_2023,Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),44 of 232,1.6026806612247289e-18,7.367751954030254e-16,0,0,6.069163429764044,248.68308563895016,CD40;TRAF3IP2;TRADD;IFIT5;TNFAIP3;LITAF;TANK;CX3CL1;RELA;TBK1;TRIM5;UBD;ZC3H12A;DHX36;MIER1;TIFA;TNFSF10;TRIM25;RIPK1;PIM2;TRIM21;TRIM22;APOL2;CD74;GBP7;RIPK2;STAT1;DAB2IP;TNFRSF10B;CFLAR;TNFRSF1A;BST2;TRAF4;TNIP1;TRAF3;TNIP2;REL;PELI1;RBCK1;TRIM38;ALPK1;MAP3K14;OPTN;BIRC3
2566,GO_Biological_Process_2023,Cellular Response To Tumor Necrosis Factor (GO:0071356),29 of 119,1.179768772153374e-15,4.745619885986948e-13,0,0,8.230648271769766,282.91584211813426,CD40;CXCL8;TRADD;ILK;CIB1;TANK;CX3CL1;RELA;ZFP36L1;ZFP36;CCL5;ZC3H12A;CCL2;RIPK1;JAK2;GBP2;GBP1;GBP3;EIF5A;CCL20;STAT1;DAB2IP;TNFRSF1A;NFKBIA;TRAF4;TRAF3;NFE2L2;BIRC3;LIMS1
2567,GO_Biological_Process_2023,Response To Type II Interferon (GO:0034341),24 of 80,2.0980507179330922e-15,7.50169690034299e-13,0,0,10.893899204244033,368.1894747700047,IFITM3;GBP6;GBP5;CD74;CD40;SP100;GCH1;CALCOCO2;CCL20;STAT1;CX3CL1;CXCL16;BST2;NUB1;CCL5;UBD;IRF8;CCL2;CD47;GBP2;TRIM21;GBP1;SHFL;GBP4
2568,GO_Biological_Process_2023,Cytokine-Mediated Signaling Pathway (GO:0019221),42 of 257,2.5184760834850717e-15,8.10445603665496e-13,0,0,5.0448306370070775,169.58259937591745,CXCL9;CXCL8;TRAF3IP2;TRADD;EBI3;ILK;CXCL1;CXCL3;CXCL2;CX3CL1;RELA;OASL;SOCS1;CCL5;CCL2;STAT6;RIPK1;JAK2;JAK1;LYN;STAT5A;EIF5A;IL15RA;EGR1;IL15;CCL20;STAT1;STAT3;MX1;TNFRSF1A;NFKBIA;CXCL10;CEACAM1;CXCL11;OAS1;TRAF4;OAS2;TRAF3;TNIP2;IL6ST;LIMS1;BIRC3
2569,GO_Biological_Process_2023,Response To Tumor Necrosis Factor (GO:0034612),27 of 108,5.764275216082509e-15,1.671981542108634e-12,0,0,8.495783399911229,278.5520741732649,CD40;CXCL8;TRADD;CIB1;TANK;CX3CL1;RELA;CXCL16;ZFP36L1;NUB1;ZFP36;UBD;CASP3;CCL5;ZC3H12A;CCL2;RIPK1;JAK2;GBP2;GBP1;GBP3;GCH1;CCL20;SPHK1;DAB2IP;NFKBIA;NFE2L2
2570,GO_Biological_Process_2023,Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),34 of 175,6.2348596971111264e-15,1.671981542108634e-12,0,0,6.184263707770914,202.27873356695795,CD40;TRAF3IP2;TRADD;IFIT5;LITAF;CX3CL1;RELA;TBK1;TRIM5;UBD;DHX36;MIER1;TIFA;TNFSF10;TRIM25;RIPK1;PIM2;TRIM21;TRIM22;APOL2;CD74;RIPK2;TNFRSF10B;CFLAR;TNFRSF1A;BST2;TNIP2;REL;PELI1;RBCK1;TRIM38;ALPK1;MAP3K14;BIRC3
2571,GO_Biological_Process_2023,Cellular Response To Cytokine Stimulus (GO:0071345),45 of 308,1.7708094376385566e-14,4.383434438708366e-12,0,0,4.425559837949154,140.13426601705416,CD40;CXCL8;TRADD;EBI3;HNRNPU;MT1X;CIB1;IFIT1;HIF1A;TANK;CX3CL1;RELA;ZFP36L1;MT2A;ZFP36;SOCS1;CCL5;DPYSL3;ZC3H12A;CCL2;STAT6;RIPK1;JAK2;GBP2;GBP1;GBP4;JAK1;GBP3;GBP6;STAT5A;GBP5;EGR1;CCL20;STAT1;STAT3;DAB2IP;NFKB1;TNFRSF1A;NFKBIA;OAS1;IRF1;IRF8;CD47;IL6ST;NFE2L2
2572,GO_Biological_Process_2023,Regulation Of Apoptotic Process (GO:0042981),68 of 705,4.7182213249571135e-12,1.084516873122285e-09,0,0,2.7943042872620336,72.87430798224705,ANKLE2;TNFAIP8;TRADD;PDCD5;CIB1;UBE2Z;ACTB;IFIT3;CX3CL1;IFIT2;PTMS;CASP3;CFL1;TNFSF10;CD38;PIM2;IER3;TGM2;HSP90AA1;TSC22D1;ANXA4;SPHK1;IGFBP3;ACTN1;YWHAZ;RHOB;CLIP3;SUPV3L1;RNF144B;TAX1BP1;IL6ST;PTMA;BIRC3;VCP;BCL2A1;IFI6;RELA;HSP90B1;SAV1;SOCS2;SOCS3;NUAK2;UBB;PDCD10;UBD;PMAIP1;RIPK1;MCL1;EGR1;CD74;JUN;PRELID1;GADD45B;HSPA5;STAT1;DAB2IP;TNFRSF10B;CFLAR;NFKB1;DNAJA1;TJP1;CXCL10;LSM8;HNRNPK;BCL6;TCIM;BCL3;FAS
2573,GO_Biological_Process_2023,Positive Regulation Of Intracellular Signal Transduction (GO:1902533),56 of 525,8.077431089225127e-12,1.732878216341764e-09,0,0,3.101335428122545,79.21414584282618,DDR1;CD40;TRAF3IP2;TRADD;IFIT5;ILK;IFI35;LITAF;CX3CL1;BBC3;TBK1;TRIM5;TNFSF10;TRIM25;ITGAV;PIM2;JAK2;TRIM21;TRIM22;TGM2;HSP90AA1;RIPK2;SPHK1;ARRDC3;TNFRSF1A;PELI1;RBCK1;ALPK1;BIRC3;TRIM56;TXN;RELA;CCL5;UBD;TIFA;DHX36;MIER1;PMAIP1;RIPK1;APOL2;LYN;NTRK2;CD74;RBPMS;DAB2IP;EIF2AK2;TNFRSF10B;CFLAR;BST2;TCIM;TNIP2;REL;TRIM38;PIK3AP1;MAP3K14;LIMS1
2574,GO_Biological_Process_2023,Negative Regulation Of Apoptotic Process (GO:0043066),53 of 482,9.418785146913172e-12,1.894353162672912e-09,0,0,3.202408166546097,81.30374729389622,ANKLE2;TNFAIP8;CIB1;UBE2Z;IFIT3;CX3CL1;PTMS;MDK;LAMP3;ZC3H12A;CFL1;CD38;PIM2;IER3;TSC22D1;ANXA4;SPHK1;YWHAZ;SUPV3L1;RNF144B;TMBIM1;TAX1BP1;IL6ST;PTMA;BIRC3;BCL2A1;IFI6;RELA;HSP90B1;SOCS2;SOCS3;NUAK2;PDCD10;CCL2;RIPK1;MCL1;SNX6;NTRK2;CD74;PRELID1;HSPA5;CFLAR;SOD2;NFKB1;DNAJA1;TJP1;LSM8;HNRNPK;TCIM;BCL3;FAS;LGMN;GRINA
2575,GO_Biological_Process_2023,Cellular Response To Lipopolysaccharide (GO:0071222),24 of 124,6.649110963303845e-11,1.2586375929359866e-08,0,0,6.08657824933687,142.63258781585827,LYN;CD274;CXCL9;CXCL8;DAB2IP;TNFAIP3;CXCL1;CXCL3;CXCL2;NFKB1;RELA;CXCL10;ZFP36;CXCL11;CASP7;TNIP1;TNIP2;CCL5;ZC3H12A;CCL2;GBP2;CD68;CHMP5;GBP3
2576,GO_Biological_Process_2023,Regulation Of Innate Immune Response (GO:0045088),19 of 78,1.0069822374147524e-10,1.7149982474833494e-08,0,0,8.130613429802818,187.15772020294656,GBP5;AKIRIN2;ERAP1;TNFAIP3;TRAFD1;IFI35;PARP9;SAMHD1;YWHAZ;HLA-E;PLSCR1;IRF1;CCL5;DHX58;TRIM21;N4BP1;BIRC3;TRIM56;NFE2L2
2577,GO_Biological_Process_2023,Response To Lipopolysaccharide (GO:0032496),27 of 159,1.0125844220691001e-10,1.7149982474833494e-08,0,0,5.199431061614817,119.65630099934056,CD274;CXCL9;CXCL8;TNFAIP3;CXCL1;CXCL3;CXCL2;RELA;ZFP36;CASP7;NOCT;ZC3H12A;CCL2;JAK2;GBP2;GBP3;GCH1;DAB2IP;NFKB1;CXCL10;CXCL11;TNIP1;TNIP2;PELI1;TRIB1;CD68;CHMP5
2578,GO_Biological_Process_2023,Negative Regulation Of Programmed Cell Death (GO:0043069),44 of 381,1.17371805742891e-10,1.8885123544031163e-08,0,0,3.35926066672596,76.81176060619336,ANKLE2;TNFAIP8;BCL2A1;IFI6;CIB1;UBE2Z;IFIT3;CX3CL1;RELA;PTMS;HSP90B1;SOCS2;SOCS3;NUAK2;PDCD10;CFL1;CD38;RIPK1;PIM2;IER3;MCL1;CD74;PRELID1;TSC22D1;HSPA5;ANXA4;SPHK1;CFLAR;YWHAZ;NFKB1;TJP1;SUPV3L1;DNAJA1;RNF144B;LSM8;HNRNPK;TCIM;XPNPEP1;BCL3;TAX1BP1;FAS;IL6ST;PTMA;BIRC3
2579,GO_Biological_Process_2023,Positive Regulation Of Type I Interferon Production (GO:0032481),17 of 64,2.232813298484256e-10,3.4215205688201605e-08,0,0,9.113847960410434,202.53329352057656,RAB2B;HSP90AA1;RIPK2;STAT1;ISG15;TANK;IFIH1;TBK1;OAS1;OAS2;TRAF3;IRF1;OAS3;DHX58;DHX36;IRF7;TRIM56
2580,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class I (GO:0002474),10 of 18,2.4705995306203016e-10,3.6138133134255154e-08,0,0,31.27278645833333,691.797508252358,PDIA3;ERAP2;ERAP1;TAP2;TAP1;HLA-A;TAPBPL;IFI30;B2M;TAPBP
2581,GO_Biological_Process_2023,Cellular Response To Type II Interferon (GO:0071346),17 of 66,3.78601986885649e-10,5.297135625208778e-08,0,0,8.740942369063262,189.6306856583043,GBP6;GBP5;SP100;CCL20;STAT1;IFNGR2;CX3CL1;IRF1;CCL5;IRF8;CCL2;CD47;JAK2;GBP2;GBP1;GBP4;JAK1
2582,GO_Biological_Process_2023,Negative Regulation Of Innate Immune Response (GO:0045824),15 of 52,7.232804759826014e-10,9.514294033288359e-08,0,0,10.193581523856754,214.546594055836,USP15;STAT2;NLRC5;TNFAIP3;TRAFD1;ISG15;SAMHD1;YWHAZ;USP18;OAS1;OAS3;DHX58;SERPING1;TRIM21;PTPN2
2583,GO_Biological_Process_2023,Cellular Response To Molecule Of Bacterial Origin (GO:0071219),22 of 117,7.391465221634832e-10,9.514294033288359e-08,0,0,5.859008632692843,123.18873215248344,CD274;CXCL9;CXCL8;DAB2IP;TNFAIP3;CXCL1;CXCL3;CXCL2;NFKB1;RELA;CXCL10;ZFP36;CXCL11;CASP7;TNIP1;TNIP2;ZC3H12A;CCL2;GBP2;CD68;CHMP5;GBP3
2584,GO_Biological_Process_2023,I-kappaB kinase/NF-kappaB Signaling (GO:0007249),14 of 45,8.795954513023887e-10,1.0886685239581106e-07,0,0,11.344114169903731,236.54246624077197,RIPK2;DAB2IP;TANK;RELA;NFKB1;RELB;NFKB2;NFKBIA;TBK1;TIFA;BCL3;REL;MAP3K14;BIRC3
2585,GO_Biological_Process_2023,Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),13 of 38,9.301988242441898e-10,1.108659191265853e-07,0,0,13.048941176470588,271.36085816403977,EIF5A;STAT1;TRADD;ILK;RELA;TNFRSF1A;NFKBIA;TRAF4;TRAF3;RIPK1;JAK2;BIRC3;LIMS1
2586,GO_Biological_Process_2023,Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),76 of 938,1.0352139237866363e-09,1.1897565738376412e-07,0,0,2.305907549527039,47.706132076714745,CSRNP1;CD40;CHD8;AKR1B1;HNRNPU;LITAF;ETS2;CX3CL1;PTMS;TBK1;ZC3H12A;NAMPT;JUNB;IER5;IER2;KLF10;ACTR3;EIF5A;KDM6B;RIPK2;RFX3;LMO7;TNFRSF1A;CREB3;PLSCR1;ELF3;IRF1;RFX5;IRF2;IRF7;IRF8;NCOA7;PTMA;ATF3;IRF9;CEBPB;KMT2A;MAX;NLRC5;ASCL2;HIF1A;RELA;FSTL3;RELB;HELZ2;TBX21;DHX36;NRIP1;STAT6;HES1;RIPK1;BCL9L;STAT5A;EGR1;AKIRIN2;JUN;STAT1;PCGF5;STAT2;STAT3;DAB2IP;SMARCA5;LARP7;INHBA;INO80;NFKB1;NFKB2;FOSL2;NFKBIA;CXCL10;KLF6;TNIP1;TNIP2;BCL3;REL;NFE2L2
2587,GO_Biological_Process_2023,Cellular Response To Interleukin-1 (GO:0071347),18 of 81,1.5627347526005207e-09,1.7340967013339573e-07,0,0,7.2026315789473685,146.04652530336978,EGR1;CD40;CXCL8;CCL20;DAB2IP;HIF1A;TANK;CX3CL1;RELA;NFKB1;TNIP2;CCL5;ZC3H12A;CCL2;CD47;GBP2;GBP1;GBP3
2588,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen (GO:0002483),10 of 21,1.7905217018817071e-09,1.920632945551778e-07,0,0,22.740293560606062,458.00676778164,ERAP2;ERAP1;HLA-B;TAP2;HLA-C;TAP1;HLA-DRA;HLA-A;HLA-F;HLA-E
2589,GO_Biological_Process_2023,Regulation Of Cell Population Proliferation (GO:0042127),65 of 766,2.9886919074604202e-09,3.0972136559731204e-07,0,0,2.408630827929646,47.2776416847492,BTG2;CDKN1A;CXCL9;BTG1;CXCL8;CSF1;PDCD5;AKR1B1;CIB1;CXCL1;IFI35;ACTB;IFIT3;CX3CL1;FTH1;NAMPT;ITGAV;TIMP1;PIM2;JAK2;IER5;JUNB;KLF10;TSC22D1;IL15;IGFBP3;ITGA1;NCCRP1;PLAAT4;BTC;IRF1;CD47;IL6ST;COX17;RELA;SAV1;ZFP36L1;SDCBP;PAK1;SERTAD1;PDCD10;STAT6;STX4;HES1;S100A11;LYN;STAT5A;NTRK2;JUN;CDKN2A;STAT1;STAT2;STAT3;DAB2IP;EIF2AK2;INHBA;SOD2;PML;TJP1;CXCL10;CXCL11;BCL6;PTPN2;LGMN;LIMS1
2590,GO_Biological_Process_2023,Interferon-Mediated Signaling Pathway (GO:0140888),14 of 49,3.079889278779983e-09,3.0972136559731204e-07,0,0,10.045549738219895,196.876422613299,IFITM3;SP100;IL10RB;STAT1;IFNGR2;STAT2;TANK;TBK1;IFI27;OAS2;TRAF3;IRF1;JAK2;JAK1
2591,GO_Biological_Process_2023,Regulation Of Interferon-Beta Production (GO:0032648),14 of 50,4.125728245270472e-09,4.0232101494789037e-07,0,0,9.765997673065735,188.5425785109982,HSP90AA1;RIPK2;ISG15;RELB;IFIH1;TBK1;OAS1;OAS2;TRAF3;IRF1;OAS3;IRF7;REL;TRIM56
2592,GO_Biological_Process_2023,Regulation Of Response To Biotic Stimulus (GO:0002831),11 of 31,1.1942785598500184e-08,1.1303495310580467e-06,0,0,13.769361147327247,251.19636186803916,HERC5;TRIM5;TRAF3;IRF1;DHX58;ERAP1;SAMHD1;CX3CL1;N4BP1;BIRC3;NFE2L2
2593,GO_Biological_Process_2023,Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),8 of 15,2.5540886341248028e-08,2.3483020641753184e-06,0,0,28.51948051948052,498.60565819807647,OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18;PTPN2
2594,GO_Biological_Process_2023,Extrinsic Apoptotic Signaling Pathway (GO:0097191),15 of 67,3.2395193683221135e-08,2.8957703686834886e-06,0,0,7.247454380481903,124.98420446022496,BCL2A1;CD70;TRADD;DAB2IP;G0S2;TNFRSF10B;CIB1;INHBA;TNFRSF1A;IFI27;FAS;ITGAV;RIPK1;JAK2;MCL1
2595,GO_Biological_Process_2023,Regulation Of Type I Interferon Production (GO:0032479),14 of 59,4.226276555078662e-08,3.675718366011658e-06,0,0,7.80913321698662,132.5940793809724,RAB2B;GBP7;TANK;RBX1;CYLD;TBK1;TRAF3;IRF1;DHX58;IRF7;IRF8;XAF1;TRIM21;TRIM56
2596,GO_Biological_Process_2023,Inflammatory Response (GO:0006954),29 of 236,4.544466004747559e-08,3.848445158757275e-06,0,0,3.556658475390698,60.13160863985506,CD40;CXCL9;CEBPB;CXCL8;TRAF3IP2;ADM;CXCL1;F11R;CXCL3;CXCL2;CX3CL1;RELA;RELB;TBK1;CCL5;CCL2;RAC1;APOL2;RIPK2;CCL20;IL10RB;STAT3;NFKB1;NFKB2;TNFRSF1A;CXCL10;CXCL11;ELF3;REL
2597,GO_Biological_Process_2023,Positive Regulation Of Defense Response (GO:0031349),20 of 124,6.56315324415339e-08,5.298872788265678e-06,0,0,4.850314593058656,80.2203695787877,GSDMD;GBP5;AKIRIN2;IL15;TRADD;IFI35;CX3CL1;TNFRSF1A;NFKBIA;PLSCR1;TNIP1;MDK;CCL5;NINJ1;CASP4;NFKBIZ;RIPK1;CD47;OPTN;TRIM56
2598,GO_Biological_Process_2023,Regulation Of Inflammatory Response (GO:0050727),29 of 240,6.586541688335212e-08,5.298872788265678e-06,0,0,3.4884996741310688,57.684617712156346,TRADD;TNFAIP3;IFI35;USP18;CX3CL1;RELA;MDK;CCL5;CASP4;NFKBIZ;RIPK1;JAK2;SNX6;GSDMD;IL15;SPHK1;STAT3;TNFRSF1A;NFKBIA;CYLD;PSMA6;BCL6;TNIP1;NINJ1;OTULIN;CD47;PIK3AP1;PTPN2;BIRC3
2599,GO_Biological_Process_2023,Positive Regulation Of Interferon-Beta Production (GO:0032728),11 of 36,7.091607251053007e-08,5.566046861924042e-06,0,0,11.012620599739243,181.2872134949087,IFIH1;HSP90AA1;TBK1;OAS1;RIPK2;OAS2;IRF1;OAS3;IRF7;ISG15;TRIM56
2600,GO_Biological_Process_2023,Cellular Response To Lipid (GO:0071396),28 of 228,7.840726778858911e-08,6.007490184373328e-06,0,0,3.5507733333333333,58.09544248110463,CD274;CXCL9;CXCL8;AKR1B1;TNFAIP3;CXCL1;CXCL3;CXCL2;RELA;ZFP36;CASP7;ZC3H12A;NRIP1;CCL2;GBP2;GBP3;LYN;HSPA8;DAB2IP;SSTR2;NFKB1;CXCL10;CXCL11;TNIP1;TNIP2;LCOR;CD68;CHMP5
2601,GO_Biological_Process_2023,Interleukin-27-Mediated Signaling Pathway (GO:0070106),5 of 5,8.796654330419279e-08,6.4335530989293735e-06,0,0,96110.0,1561432.7853317305,OAS1;OAS2;STAT1;MX1;OASL
2602,GO_Biological_Process_2023,Regulation Of Protein Deubiquitination (GO:0090085),5 of 5,8.796654330419279e-08,6.4335530989293735e-06,0,0,96110.0,1561432.7853317305,OTUD4;TNIP1;ZC3H12A;TANK;TRIM21
2603,GO_Biological_Process_2023,Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),9 of 23,9.742254729808845e-08,6.7630587064620425e-06,0,0,16.057217165149545,259.2310564057139,IFIH1;CYLD;TBK1;OAS3;DHX58;TIFA;IRF7;TNFAIP3;TRIM25
2604,GO_Biological_Process_2023,Positive Regulation Of Inflammatory Response (GO:0050729),18 of 104,9.81421110681727e-08,6.7630587064620425e-06,0,0,5.270012239902081,85.04139330197202,GSDMD;IL15;TRADD;C2CD4A;C2CD4B;IFI35;CX3CL1;TNFRSF1A;NFKBIA;VAMP8;TNIP1;MDK;NINJ1;CASP4;NFKBIZ;RIPK1;CD47;IL6ST
2605,GO_Biological_Process_2023,Regulation Of Response To External Stimulus (GO:0032101),20 of 127,9.87768052217887e-08,6.7630587064620425e-06,0,0,4.713584691638103,76.03202076725358,ERAP1;SAMHD1;USP18;CX3CL1;RELA;HERC5;CYLD;PSMA6;BCL6;TRIM5;TRAF3;IRF1;DHX58;CASP4;NMT1;JAK2;PIK3AP1;N4BP1;NFE2L2;BIRC3
2606,GO_Biological_Process_2023,Positive Regulation Of Programmed Cell Death (GO:0043068),29 of 245,1.034139845443475e-07,6.933045880493962e-06,0,0,3.406851110122138,54.79758402211001,TNFAIP8;BCL2A1;TRADD;PDCD5;UBE2Z;IFIT2;SAV1;UBD;CASP3;TNFSF10;PMAIP1;RIPK1;GBP2;GBP1;TGM2;MCL1;GBP3;GBP5;JUN;GADD45B;IGFBP3;DAB2IP;TNFRSF10B;CFLAR;RHOB;CLIP3;DNAJA1;BCL6;FAS
2607,GO_Biological_Process_2023,Regulation Of Transcription By RNA Polymerase II (GO:0006357),125 of 2028,1.1495663440958275e-07,7.549601010817087e-06,0,0,1.742131188041128,27.837010554438677,UBE2D3;ZBTB20;HNRNPU;ARID4B;BACH1;ACTB;ETS2;ZFP36;TBK1;ZC3H12A;NAMPT;BBX;JUNB;IER5;IER2;SP110;ARID5A;RFX3;ARID5B;LMO7;IFI27;SUB1;RFX5;ATF3;DDX5;KMT2A;MAX;CREM;HIF1A;HELZ2;SDCBP;DHX36;MIER1;CAMTA1;RIPK1;HIVEP2;BCL9L;STAT5A;EGR1;AKIRIN2;JUN;PTCH1;ZBTB10;SMARCA5;LARP7;INHBA;INO80;NFKB1;HOPX;NFKB2;FOSL2;NFKBIA;CXCL10;HNRNPK;BCL6;BCL3;ID4;REL;SP140L;MXD1;SIM1;NFE2L2;CSRNP1;CD40;CHD8;AKR1B1;LITAF;CX3CL1;PTMS;KLF10;ACTR3;EIF5A;KDM6B;BATF2;BATF3;RIPK2;ANXA4;BAZ1A;PARP9;YWHAZ;TNFRSF1A;ETV6;TOX4;ETV7;CREB3;PLSCR1;ZEB1;ELF3;IRF1;IRF2;IRF7;LCOR;IRF8;NCOA7;PTMA;KDM7A;IRF9;CEBPB;SP100;CEBPD;NLRC5;ASCL2;RELA;FSTL3;MLLT6;RELB;CREG1;TBX21;NRIP1;RBBP8;STAT6;HES1;E2F5;FNIP2;HES4;STAT1;PCGF5;STAT2;STAT3;DAB2IP;SOD2;KLF6;TNIP1;TNIP2;HDGF
2608,GO_Biological_Process_2023,Antiviral Innate Immune Response (GO:0140374),12 of 46,1.269533038400974e-07,8.170714635148668e-06,0,0,8.841038242973429,140.39079382264623,IFIH1;CXCL10;TBK1;OAS1;DHX58;MX1;TRIM25;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2
2609,GO_Biological_Process_2023,Cellular Response To Type I Interferon (GO:0071357),11 of 38,1.322748350440279e-07,8.346282728856505e-06,0,0,10.195808585639094,161.48513152116783,IFITM3;SP100;TBK1;IFI27;STAT1;OAS2;TRAF3;STAT2;IFIT1;TANK;JAK1
2610,GO_Biological_Process_2023,Response To Interleukin-1 (GO:0070555),16 of 85,1.508606859070179e-07,9.33595552401507e-06,0,0,5.828445357373806,91.54686104889804,CD40;CXCL8;CCL20;DAB2IP;HIF1A;TANK;CX3CL1;RELA;NFKB1;CCL5;ZC3H12A;CCL2;CD47;GBP2;GBP1;GBP3
2611,GO_Biological_Process_2023,Regulation Of Defense Response (GO:0031347),17 of 97,1.8383083469425198e-07,1.116165332162458e-05,0,0,5.345170827858081,82.89959001457777,ERAP1;SAMHD1;USP18;RELA;HERC5;CYLD;PSMA6;BCL6;TRAF3;IRF1;DHX58;CASP4;JAK2;PIK3AP1;N4BP1;NFE2L2;BIRC3
2612,GO_Biological_Process_2023,Chemokine-Mediated Signaling Pathway (GO:0070098),13 of 57,2.1227940801399641e-07,1.2650280277574825e-05,0,0,7.406833036244801,113.80867433959348,LYN;CXCL9;CXCL8;CCL20;CIB1;CXCL1;CXCL3;CXCL2;CX3CL1;CXCL10;CXCL11;CCL5;CCL2
2613,GO_Biological_Process_2023,Regulation Of Immune Response (GO:0050776),15 of 77,2.3013462122120127e-07,1.3464967474360464e-05,0,0,6.075339280429544,92.85913920790055,LYN;RSAD2;IL15;SPPL2A;ERAP1;SAMHD1;PLSCR1;BCL6;IRF1;DHX58;IRF7;HLA-DRA;N4BP1;BIRC3;NFE2L2
2614,GO_Biological_Process_2023,Positive Regulation Of Apoptotic Process (GO:0043065),30 of 270,2.5360526981317894e-07,1.4328470067552958e-05,0,0,3.172125668449198,48.17661682720173,TNFAIP8;BTG1;BCL2A1;TRADD;PDCD5;UBE2Z;CTSS;IFIT2;SAV1;CTSL;UBD;CASP3;ZC3H12A;TNFSF10;TP53BP2;PMAIP1;RIPK1;TGM2;MCL1;JUN;GADD45B;IGFBP3;DAB2IP;TNFRSF10B;CFLAR;RHOB;CLIP3;DNAJA1;BCL6;FAS
2615,GO_Biological_Process_2023,Response To Type I Interferon (GO:0034340),6 of 9,2.582508588931235e-07,1.4328470067552958e-05,0,0,49.79015544041451,755.2835178595585,SP100;MX1;ISG15;IFIT1;SHFL;TRIM56
2616,GO_Biological_Process_2023,Type II Interferon-Mediated Signaling Pathway (GO:0060333),6 of 9,2.582508588931235e-07,1.4328470067552958e-05,0,0,49.79015544041451,755.2835178595585,SP100;STAT1;IFNGR2;IRF1;JAK2;JAK1
2617,GO_Biological_Process_2023,Apoptotic Process (GO:0006915),27 of 228,2.808887280425488e-07,1.532033774306647e-05,0,0,3.4022099886718205,51.32338294570076,PPP1R15A;CSRNP1;TRADD;IFI6;CIB1;IFIT2;BBC3;CASP7;CASP3;CASP4;PMAIP1;C19ORF12;RIPK1;JAK2;PHLDA2;IER3;RIPK2;MX1;TNFRSF10B;CFLAR;RHOB;NFKBIA;PLSCR1;IFI27;RRAGC;IRF1;FAS
2618,GO_Biological_Process_2023,Positive Regulation Of Cytokine Production (GO:0001819),33 of 320,3.692923573939089e-07,1.9806380101559975e-05,0,0,2.9224095596660664,43.285787073620384,CD274;CD40;CEBPB;EBI3;HIF1A;TANK;RELA;IFIH1;TBK1;MDK;DHX58;RIPK1;TNFRSF14;JAK2;GBP5;EGR1;CD74;RAB2B;AKIRIN2;BTN3A1;IL15;RIPK2;SPHK1;STAT3;EIF2AK2;ISG15;HLA-A;BTN3A2;HLA-E;TRAF3;IRF1;IRF7;IL6ST
2619,GO_Biological_Process_2023,Protein Catabolic Process (GO:0030163),17 of 102,3.892037806497117e-07,2.0532094526733974e-05,0,0,5.029434954007884,74.23024914132259,HSPA8;VCP;HSP90AA1;DAB2IP;NCCRP1;UCHL3;CTSS;PSMA6;CASP7;CEACAM1;CTSL;CASP3;PMAIP1;FBXO6;RIPK1;TRIM21;LGMN
2620,GO_Biological_Process_2023,Response To Endoplasmic Reticulum Stress (GO:0034976),18 of 114,4.113179706823853e-07,2.1348729510579287e-05,0,0,4.718585526315789,69.38160627709534,PDIA3;PPP1R15A;PPP1R15B;VCP;JUN;CEBPB;CXCL8;HSPA5;DAB2IP;TNFRSF10B;SELENOK;PDIA6;HSP90B1;BBC3;ERP44;TMX1;CASP4;ATF3
2621,GO_Biological_Process_2023,Negative Regulation Of NF-kappaB Transcription Factor Activity (GO:0032088),15 of 81,4.597013376264231e-07,2.3481252452092533e-05,0,0,5.705945430716073,83.26508611920276,CDKN2A;ANXA4;NLRC5;DAB2IP;TNFAIP3;COMMD1;NFKBIA;CYLD;TRAF3;ZC3H12A;BCL3;OTULIN;TAX1BP1;RBCK1;TRIM21
2622,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I (GO:0019885),5 of 6,5.108083189972986e-07,2.5684080789582923e-05,0,0,124.32729624838292,1801.163286499088,ERAP2;ERAP1;TAP2;TAP1;HLA-A
2623,GO_Biological_Process_2023,Regulation Of Cytokine Production (GO:0001817),22 of 167,5.738218943206975e-07,2.8408597783446224e-05,0,0,3.828626163108922,55.02098282066161,LYN;GBP7;BTN2A2;BTN3A1;IL15;HLA-B;ZBTB20;EIF2AK2;ISG15;BTN3A3;BTN3A2;LITAF;IFIH1;TBK1;BCL6;TRAF3;IRF7;IRF8;CD47;TRIM21;N4BP1;TRIM56
2624,GO_Biological_Process_2023,Cellular Response To Oxygen-Containing Compound (GO:1901701),38 of 406,5.834167328881953e-07,2.844598555203352e-05,0,0,2.630919506462985,37.765176508960025,CD274;VCP;CXCL9;CXCL8;TNFAIP3;CXCL1;CXCL3;CXCL2;ACTB;RELA;HSP90B1;ZFP36L1;RAP1B;ZFP36;CASP7;ZC3H12A;DHX36;NRIP1;CCL2;GBP2;TGM2;GBP3;LYN;EGR1;JUN;TPM1;DAB2IP;SSTR2;NFKB1;CXCL10;CXCL11;RRAGC;TNIP1;TNIP2;LCOR;CD68;LGMN;CHMP5
2625,GO_Biological_Process_2023,Intrinsic Apoptotic Signaling Pathway (GO:0097193),17 of 105,5.961956590217091e-07,2.8635188518385967e-05,0,0,4.857215386453231,69.61699609082643,PPP1R15A;DDX5;CDKN1A;CEBPB;BCL2A1;IFI6;DAB2IP;TNFRSF10B;SELENOK;PML;BBC3;CASP3;CASP4;TP53BP2;PMAIP1;FNIP2;MCL1
2626,GO_Biological_Process_2023,Defense Response To Protozoan (GO:0042832),7 of 15,6.424121632757588e-07,3.0111650666530956e-05,0,0,21.805771725032425,310.9074726020291,GBP6;BATF2;CD40;GBP7;GBP2;GBP1;GBP4
2627,GO_Biological_Process_2023,Positive Regulation Of Response To External Stimulus (GO:0032103),21 of 155,6.456506824085257e-07,3.0111650666530956e-05,0,0,3.9516551982491768,56.32297006654473,GSDMD;GBP5;AKIRIN2;IL15;TRADD;IFI35;CX3CL1;TNFRSF1A;NFKBIA;PLSCR1;TNIP1;MDK;CCL5;NINJ1;CASP4;NFKBIZ;RIPK1;STX4;CD47;OPTN;TRIM56
2628,GO_Biological_Process_2023,Cellular Response To Virus (GO:0098586),13 of 64,8.85915603837413e-07,4.072680590212564e-05,0,0,6.387876457772651,89.02556104148857,EIF5A;HSP90AA1;IL10RB;IFNGR2;IFI6;HIF1A;IFIH1;CXCL10;OAS1;CCL5;ZC3H12A;JAK2;JAK1
2629,GO_Biological_Process_2023,Positive Regulation Of DNA-templated Transcription (GO:0045893),83 of 1243,9.43328320845778e-07,4.275535966875653e-05,0,0,1.8595212106177128,25.79872104159826,CSRNP1;CD40;CHD8;AKR1B1;ILK;HNRNPU;LITAF;ACTB;ETS2;CX3CL1;PTMS;TBK1;ZC3H12A;NAMPT;CD38;PIM2;JUNB;IER5;IER2;KLF10;ACTR3;EIF5A;KDM6B;DTX3L;RIPK2;RFX3;LMO7;PARP9;TNFRSF1A;CREB3;PLSCR1;ELF3;IRF1;RFX5;IRF2;IRF7;IRF8;NCOA7;PTMA;ATF3;IRF9;CEBPB;SP100;KMT2A;MAX;NLRC5;ASCL2;HIF1A;RELA;FSTL3;RELB;HELZ2;TBX21;DHX36;NRIP1;STAT6;HES1;RIPK1;BCL9L;STAT5A;EGR1;AKIRIN2;CD74;JUN;STAT1;PCGF5;STAT2;STAT3;DAB2IP;SMARCA5;INHBA;INO80;NFKB1;NFKB2;FOSL2;NFKBIA;CXCL10;KLF6;TNIP1;TNIP2;BCL3;REL;NFE2L2
2630,GO_Biological_Process_2023,Integrated Stress Response Signaling (GO:0140467),9 of 29,9.67617028420191e-07,4.3247105520224646e-05,0,0,11.236540962288686,155.608444887847,BATF2;CREB3;CEBPB;BATF3;JUN;CEBPD;EIF2AK2;JUNB;NFE2L2
2631,GO_Biological_Process_2023,Type I Interferon-Mediated Signaling Pathway (GO:0060337),10 of 37,1.0041921176530482e-06,4.426698951517135e-05,0,0,9.25684799382716,127.84935650892392,IFITM3;SP100;TBK1;IFI27;STAT1;OAS2;TRAF3;STAT2;TANK;JAK1
2632,GO_Biological_Process_2023,Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),13 of 65,1.0683718073191784e-06,4.64597361615286e-05,0,0,6.264705882352941,86.1357888362649,LYN;CD40;IL15;PARP9;PARP14;TNFRSF1A;SOCS3;SOCS1;CCL5;HES1;JAK2;IL6ST;PTPN2
2633,GO_Biological_Process_2023,Negative Regulation Of DNA-binding Transcription Factor Activity (GO:0043433),20 of 149,1.3780107242625155e-06,5.912584680902367e-05,0,0,3.90521772923442,52.70040402702752,SP100;CDKN2A;PTCH1;ANXA4;NLRC5;DAB2IP;TNFAIP3;COMMD1;NFKBIA;CYLD;TRAF3;ZC3H12A;BCL3;OTULIN;TAX1BP1;HES1;RBCK1;TRIB1;NFKBIE;TRIM21
2634,GO_Biological_Process_2023,Defense Response To Bacterium (GO:0042742),24 of 204,1.4362225956472304e-06,6.081268832622089e-05,0,0,3.367285587975243,45.30175675196394,GBP6;GSDMD;CHGA;AKIRIN2;CEBPB;GBP7;ISG15;HLA-A;MR1;HLA-E;RNF213;ZNFX1;OAS1;OAS2;OAS3;CASP4;LCN2;TNFRSF14;RBCK1;GBP2;GBP1;OPTN;GBP4;GBP3
2635,GO_Biological_Process_2023,Antigen Processing And Presentation Of Exogenous Peptide Antigen (GO:0002478),9 of 31,1.8161820143483152e-06,7.59022561321153e-05,0,0,10.213973282893958,135.0162050267284,CTSL;HLA-DRA;HLA-A;IFI30;HLA-F;HLA-DOB;CTSS;HLA-E;LGMN
2636,GO_Biological_Process_2023,Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),20 of 152,1.8915195967687344e-06,7.803730849233061e-05,0,0,3.815863116654673,50.285940337453496,CD40;RIPK2;TRADD;SPHK1;STAT3;EIF2AK2;AKR1B1;CIB1;CFLAR;CX3CL1;RELA;PSMA6;TRIM5;TRIM25;TRIM14;RIPK1;RBCK1;TRIM38;TRIM21;TRIM22
2637,GO_Biological_Process_2023,Regulation Of Endopeptidase Activity (GO:0052548),13 of 69,2.178660905395104e-06,8.874595941217018e-05,0,0,5.816013071895425,75.8221999920116,PSENEN;SERPINB1;PRELID1;SERPINB7;SERPINB8;PSMB8;PSMB9;PSMA3;PSME1;PSME2;SERPING1;TIMP1;BIRC3
2638,GO_Biological_Process_2023,Cellular Response To Chemokine (GO:1990869),12 of 59,2.2954996239748505e-06,9.233647237438836e-05,0,0,6.391311593800345,82.98836910530193,CXCL10;CXCL9;CXCL11;CXCL8;CCL20;CCL5;ZC3H12A;CCL2;CXCL1;CXCL3;CXCL2;CX3CL1
2639,GO_Biological_Process_2023,NIK/NF-kappaB Signaling (GO:0038061),9 of 32,2.440041591999504e-06,9.6938936334005e-05,0,0,9.76937863967886,126.25452062296507,NFKBIA;REL;TNFRSF10B;MAP3K14;RELA;NFKB1;RELB;NFKB2;BIRC3
2640,GO_Biological_Process_2023,Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),12 of 60,2.7688202869787226e-06,0.0001086593132133845,0,0,6.257832898172324,80.08204590711243,LGALS3;CYLD;SP100;TNFSF10;AKR1B1;G0S2;ITGAV;RIPK1;STX4;CFLAR;RELA;PML
2641,GO_Biological_Process_2023,Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),34 of 367,2.8602303414524808e-06,0.00011041161698544838,0,0,2.592213180922858,33.08858613707496,VCP;UBA6;UBE2D3;RNF19B;TNFAIP3;UBE2L6;HERC5;NUB1;PSMB4;RNF114;RNF213;PSMB2;PSMB3;RNF19A;UBD;TBX21;TRIM25;HERC6;UBE2B;DTX3L;PML;RBX1;PSMA5;PSMA6;RNF144B;PSMA3;PSMA4;IFI27;PSMA1;PSMA2;PELI1;RBCK1;NFE2L2;CHMP5
2642,GO_Biological_Process_2023,Negative Regulation Of Cellular Process (GO:0048523),44 of 537,2.882093171776776e-06,0.00011041161698544838,0,0,2.277321188740459,29.051772130623792,BTG2;CDKN1A;BTG1;CXCL8;CCDC125;PDCD5;AKR1B1;MIA3;CIB1;CXCL1;IFI35;ACTB;IFIT3;SAV1;RND1;MDK;FTH1;TP53BP2;PIM2;PLXNC1;JAK2;S100A11;LYN;KLF10;APOBEC3G;CDKN2A;IGFBP3;ITGA1;DAB2IP;EIF2AK2;INHBA;SOD2;PLAAT4;HOPX;PML;RHOB;VAMP8;BST2;BCL6;IRF1;TXNIP;MYH9;PTPN2;CHMP5
2643,GO_Biological_Process_2023,Positive Regulation Of Peptidase Activity (GO:0010952),8 of 25,3.03539608262342e-06,0.00011491652463390785,0,0,11.73720397249809,149.12315579727664,PSENEN;VCP;PRELID1;CTSL;PSME1;PSME2;TANK;CTSS
2644,GO_Biological_Process_2023,Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),9 of 33,3.239822494166828e-06,0.00012122963704917268,0,0,9.36183355006502,118.33350132243623,OAS1;STAT2;OAS3;NLRC5;ISG15;SAMHD1;USP18;PTPN2;TRIM56
2645,GO_Biological_Process_2023,Regulation Of Viral Entry Into Host Cell (GO:0046596),10 of 44,5.589257281693138e-06,0.00020673827508607492,0,0,7.348345588235294,88.87577191222726,IFITM3;CD74;TRIM5;TRIM25;TRIM26;TRIM38;TRIM21;TRIM22;NECTIN2;LY6E
2646,GO_Biological_Process_2023,Positive Regulation Of Cell Adhesion (GO:0045785),14 of 88,7.192187575270966e-06,0.0002630052229229769,0,0,4.74161596151125,56.15265900209367,TPM1;CIB1;FSTL3;MDK;CCL5;ITGAV;STX4;RAC1;CD47;RSU1;JAK2;PLPP3;TGM2;LIMS1
2647,GO_Biological_Process_2023,Positive Regulation Of Defense Response To Virus By Host (GO:0002230),8 of 28,7.863617547639423e-06,0.0002843272052618389,0,0,9.975064935064935,117.23956969984246,HSP90AA1;TRAF3IP2;APOBEC3G;DTX3L;STAT1;ZC3H12A;PARP9;TRIM22
2648,GO_Biological_Process_2023,Protein Polyubiquitination (GO:0000209),24 of 226,8.63245257560996e-06,0.0003086581376479205,0,0,2.997084854374032,34.94595515896194,TRAF3IP2;UBE2B;DTX3L;MYCBP2;UBE2D3;RNF19B;TNFAIP3;UBE2L6;RBX1;RNF144B;RNF114;RNF213;IFI27;TRAF4;TRIM5;TRAF3;RNF19A;PELI1;TRIM25;RBCK1;TRIM38;TRIM21;TRIM22;TRIM56
2649,GO_Biological_Process_2023,Regulation Of Defense Response To Virus By Host (GO:0050691),9 of 37,9.088223576591128e-06,0.0003213835546095632,0,0,8.022756827048115,93.13242209433652,HSP90AA1;TRAF3IP2;APOBEC3G;DTX3L;STAT1;ZC3H12A;TNFAIP3;PARP9;TRIM22
2650,GO_Biological_Process_2023,Modulation By Symbiont Of Entry Into Host (GO:0052372),7 of 21,9.458966948021066e-06,0.000330858213464476,0,0,12.456549935149155,144.1041881531723,CXCL8;TRIM5;TRIM25;TRIM38;TRIM21;NECTIN2;TRIM22
2651,GO_Biological_Process_2023,Response To Interferon-Beta (GO:0035456),8 of 29,1.049068872348927e-05,0.00036300039045363946,0,0,9.4995670995671,108.91275037026166,IFITM3;BST2;PLSCR1;OAS1;STAT1;IRF1;XAF1;SHFL
2652,GO_Biological_Process_2023,Regulation Of Ribonuclease Activity (GO:0060700),4 of 5,1.1011742211688636e-05,0.00037697645145972367,0,0,99.33333333333331,1134.0438058182897,OAS1;OAS2;OAS3;OASL
2653,GO_Biological_Process_2023,Protein Localization To Cell-Cell Junction (GO:0150105),6 of 15,1.2584115973356911e-05,0.0004262703705501321,0,0,16.59153713298791,187.2035607620964,TJP1;LSR;F11R;ACTG1;JAK1;TJP2
2654,GO_Biological_Process_2023,Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),11 of 59,1.4601371569718956e-05,0.0004840590859142227,0,0,5.728867883528901,63.7874784366645,OTUD4;CYLD;OAS1;OAS3;STAT2;NLRC5;ISG15;SAMHD1;PARP14;USP18;PTPN2
2655,GO_Biological_Process_2023,Negative Regulation Of Cell Population Proliferation (GO:0008285),33 of 379,1.4674027760695585e-05,0.0004840590859142227,0,0,2.416526360709159,26.89456446859105,BTG2;CDKN1A;BTG1;CXCL8;PDCD5;AKR1B1;TNFAIP3;CIB1;CXCL1;IFI35;IFIT3;SAV1;PAK1;FTH1;HES1;PIM2;JAK2;B2M;S100A11;LYN;KLF10;CDKN2A;IGFBP3;ITGA1;DAB2IP;EIF2AK2;INHBA;SOD2;PLAAT4;PML;IRF1;TRIB1;PTPN2
2656,GO_Biological_Process_2023,Neutrophil Chemotaxis (GO:0030593),12 of 70,1.4741389191918529e-05,0.0004840590859142227,0,0,5.176195192221122,57.58440248223318,LGALS3;CXCL10;CXCL9;CXCL11;CXCL8;CCL20;CCL5;CCL2;CXCL1;CXCL3;CXCL2;CX3CL1
2657,GO_Biological_Process_2023,Protein Transport (GO:0015031),29 of 313,1.5143103531673366e-05,0.0004922273451002515,0,0,2.581855619699505,28.65334418568044,RAB3B;MACF1;STX12;STX17;UNC93B1;MIA3;STX11;HSP90B1;ARL5B;RAB24;RAB29;ARFIP1;STX4;SNX6;RAB8B;GSDMD;CD74;ARRDC3;CMTM6;AP3B1;EHD1;VMP1;RAB10;RAB13;TXNIP;UNC119;MYH9;VAMP5;OPTN
2658,GO_Biological_Process_2023,Protein Ubiquitination (GO:0016567),36 of 434,1.7566035278010233e-05,0.0005644027064594054,0,0,2.294708041555486,25.12600514025555,VCP;UBA6;UBE2D3;MYCBP2;RNF19B;UBE2L6;HERC5;NUB1;RNF114;RNF213;UBB;TRIM5;RNF19A;UBD;TRIM69;TRIM25;TRIM26;TRIM21;TRIM22;HERC6;ATG3;DTX3L;UBE2B;LMO7;ISG15;UCHL3;RBX1;BSPRY;RNF144B;OTULIN;RNF181;TRIM14;RBCK1;TRIM38;NFE2L2;TRIM56
2659,GO_Biological_Process_2023,Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),8 of 31,1.799546105852164e-05,0.0005644027064594054,0,0,8.672614342179559,94.75170263960304,CYLD;PPP2R1B;TNFSF10;PMAIP1;G0S2;RIPK1;INHBA;PML
2660,GO_Biological_Process_2023,Regulation Of Extrinsic Apoptotic Signaling Pathway Via Death Domain Receptors (GO:1902041),8 of 31,1.799546105852164e-05,0.0005644027064594054,0,0,8.672614342179559,94.75170263960304,LGALS3;SP100;TMBIM1;TNFAIP3;PMAIP1;STX4;CFLAR;ICAM1
2661,GO_Biological_Process_2023,Regulation Of NIK/NF-kappaB Signaling (GO:1901222),13 of 83,1.8065095949446475e-05,0.0005644027064594054,0,0,4.649411764705882,50.77868487270316,TRADD;SPHK1;ILK;EIF2AK2;IFI35;RELA;NFKBIA;CYLD;TCIM;ZC3H12A;BCL3;TRIM56;LIMS1
2662,GO_Biological_Process_2023,Adaptive Immune Response Based On Somatic Recombination Of Immune Receptors Built From Immunoglobulin Superfamily Domains (GO:0002460),7 of 23,1.8629710155525508e-05,0.0005715460489539617,0,0,10.898346303501944,118.6911969524354,CD70;CR1L;EBI3;STAT3;BTN3A3;BTN3A2;IL18BP
2663,GO_Biological_Process_2023,Cellular Response To Interleukin-15 (GO:0071350),5 of 10,1.882656345218146e-05,0.0005715460489539617,0,0,24.860284605433375,270.4859061283556,STAT5A;IL15RA;IL15;STAT3;JAK1
2664,GO_Biological_Process_2023,Interleukin-15-Mediated Signaling Pathway (GO:0035723),5 of 10,1.882656345218146e-05,0.0005715460489539617,0,0,24.860284605433375,270.4859061283556,STAT5A;IL15RA;IL15;STAT3;JAK1
2665,GO_Biological_Process_2023,Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),6 of 16,1.947243486612603e-05,0.0005856289289644258,0,0,14.93160621761658,161.95582644441842,SOCS3;GBP7;SOCS1;BCL3;PARP14;PTPN2
2666,GO_Biological_Process_2023,Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),29 of 319,2.161868404336818e-05,0.0006441567152922112,0,0,2.5276368491321763,27.151755261722816,VCP;UBE2D3;UBR2;HSP90B1;PSMB4;PSMB2;PSMB3;TBX21;TRIM25;FBXO6;ASCC3;UBXN4;AKIRIN2;HSPA5;UBE2B;ERLIN1;NCCRP1;PML;RBX1;PSMA5;PSMA6;PSMA3;PSMA4;IFI27;PSMA1;PSMA2;PELI1;RBCK1;NFE2L2
2667,GO_Biological_Process_2023,Granulocyte Chemotaxis (GO:0071621),12 of 73,2.289682528015992e-05,0.0006759815023078405,0,0,4.920857766553953,52.57696528934717,LGALS3;CXCL10;CXCL9;CXCL11;CXCL8;CCL20;CCL5;CCL2;CXCL1;CXCL3;CXCL2;CX3CL1
2668,GO_Biological_Process_2023,Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),11 of 62,2.384755610761273e-05,0.0006976494141299796,0,0,5.391032032108802,57.38122208682504,CYLD;CTSL;TNFSF10;DAB2IP;PMAIP1;G0S2;FAS;RIPK1;CTSS;PML;BBC3
2669,GO_Biological_Process_2023,Regulation Of Viral Life Cycle (GO:1903900),7 of 24,2.5420997117662625e-05,0.000736979898420165,0,0,10.256733043411918,108.5155696014953,TRIM5;LAMP3;TRIM25;TRIM38;TRIM21;NECTIN2;TRIM22
2670,GO_Biological_Process_2023,Cellular Response To Organic Cyclic Compound (GO:0071407),18 of 152,2.651716518167925e-05,0.0007618949781664629,0,0,3.3737627651217594,35.55176160276379,EGR1;HSPA8;TIPARP;AKR1B1;SSTR2;ACTB;HSP90B1;ZFP36L1;RAP1B;CASP7;CASP3;CCL5;ZC3H12A;NRIP1;CTNNA1;LCOR;CCL2;TGM2
2671,GO_Biological_Process_2023,Growth Hormone Receptor Signaling Pathway (GO:0060396),6 of 17,2.9104787105311827e-05,0.000828842521282243,0,0,13.573480923221856,141.76968597231172,LYN;STAT5A;SOCS2;STAT3;STAT6;JAK2
2672,GO_Biological_Process_2023,Positive Regulation Of T Cell Mediated Cytotoxicity (GO:0001916),8 of 33,2.9561751822331564e-05,0.0008344712049496752,0,0,7.977974025974026,83.2025240766597,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;MR1;NECTIN2;HLA-E
2673,GO_Biological_Process_2023,Cellular Response To Interleukin-9 (GO:0071355),4 of 6,3.2013914509205925e-05,0.0008805194606036296,0,0,49.6640826873385,513.9904736089461,STAT5A;STAT1;STAT3;JAK1
2674,GO_Biological_Process_2023,Interleukin-9-Mediated Signaling Pathway (GO:0038113),4 of 6,3.2013914509205925e-05,0.0008805194606036296,0,0,49.6640826873385,513.9904736089461,STAT5A;STAT1;STAT3;JAK1
2675,GO_Biological_Process_2023,Regulation Of Nuclease Activity (GO:0032069),4 of 6,3.2013914509205925e-05,0.0008805194606036296,0,0,49.6640826873385,513.9904736089461,OAS1;OAS2;OAS3;OASL
2676,GO_Biological_Process_2023,Protein K63-linked Ubiquitination (GO:0070534),10 of 54,3.793089708730469e-05,0.00103442056633,0,0,5.675307765151516,57.77318329990229,RNF213;TRAF3IP2;TRAF4;UBE2B;TRIM5;TRAF3;PELI1;TRIM21;TRIM22;TRIM56
2677,GO_Biological_Process_2023,Neutrophil Migration (GO:1990266),12 of 77,3.970177144960338e-05,0.0010736159707968,0,0,4.617071701144808,46.7899344300866,LGALS3;CXCL10;CXCL9;CXCL11;CXCL8;CCL20;CCL5;CCL2;CXCL1;CXCL3;CXCL2;CX3CL1
2678,GO_Biological_Process_2023,Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),9 of 44,4.058093713692989e-05,0.001088245464222,0,0,6.415864759427828,64.87858544643689,CD74;CSF1;CASP4;NLRC5;RIPK1;PARP14;PARP9;HIF1A;TRIM56
2679,GO_Biological_Process_2023,Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),10 of 55,4.47617325083917e-05,0.001190440125719,0,0,5.548900462962963,55.56756023951375,LYN;CD40;IL15;CCL5;HES1;JAK2;PARP9;IL6ST;PARP14;TNFRSF1A
2680,GO_Biological_Process_2023,Regulation Of Apoptotic Signaling Pathway (GO:2001233),9 of 45,4.8991816488850217e-05,0.00129225955296,0,0,6.237321196358908,61.89828538858768,CYLD;SGMS1;CTSL;TMBIM1;DAB2IP;FAS;CTSS;CX3CL1;GRINA
2681,GO_Biological_Process_2023,Receptor Signaling Pathway Via JAK-STAT (GO:0007259),8 of 36,5.810581937088872e-05,0.0015144441037377,0,0,7.1220779220779225,69.46336901594488,STAT5A;IL15;STAT1;STAT2;STAT3;STAT6;JAK2;JAK1
2682,GO_Biological_Process_2023,Positive Regulation Of Immune Response (GO:0050778),12 of 80,5.851036833669277e-05,0.0015144441037377,0,0,4.412686223314391,43.00739278658915,GBP5;AKIRIN2;CD74;PLSCR1;RSAD2;IL15;CCL5;HLA-DRA;STX4;IFI35;IL6ST;TRIM56
2683,GO_Biological_Process_2023,Homotypic Cell-Cell Adhesion (GO:0034109),9 of 46,5.882707053052359e-05,0.0015144441037377,0,0,6.068428636699118,59.11200763877864,CSRP1;ACTN1;ILK;MYH9;PLPP3;CLIC1;MYL12A;ACTG1;TJP2
2684,GO_Biological_Process_2023,Negative Regulation Of Cytokine Production (GO:0001818),19 of 178,6.801310978164811e-05,0.0017370332323598,0,0,3.0012760915139918,28.799675373203616,CD274;GBP7;BTN2A2;ANXA4;TNFAIP3;INHBA;CX3CL1;RBX1;CYLD;ZFP36;CEACAM1;TBX21;DHX58;ZC3H12A;BCL3;RAC1;XAF1;GBP1;N4BP1
2685,GO_Biological_Process_2023,Positive Regulation Of T Cell Activation (GO:0050870),14 of 107,6.880491453762872e-05,0.001743419015607,0,0,3.769154985081349,36.124468573320925,CD274;IL15;CD70;HLA-A;ACTB;MDK;CCL5;HLA-DRA;CCL2;CD47;IL6ST;JAK2;B2M;HLA-DOB
2686,GO_Biological_Process_2023,Growth Hormone Receptor Signaling Pathway Via JAK-STAT (GO:0060397),4 of 7,7.23925172102242e-05,0.0018199931279882,0,0,33.107665805340226,315.6288733817682,LYN;STAT5A;STAT3;STAT6
2687,GO_Biological_Process_2023,Regulation Of Phosphorylation (GO:0042325),12 of 82,7.494869901711698e-05,0.0018696504917603,0,0,4.286161879895562,40.71299452974522,LYN;SDCBP;ANKLE2;CDKN1A;SOCS1;CDKN2A;CCL5;STAT2;NLRC5;ILK;INHBA;FNIP2
2688,GO_Biological_Process_2023,Negative Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001237),11 of 70,7.653759143455246e-05,0.0018945997633568,0,0,4.658100015468587,44.14820748916871,LGALS3;TMBIM1;IFI6;AKR1B1;TNFAIP3;ITGAV;RIPK1;CFLAR;RELA;ICAM1;MCL1
2689,GO_Biological_Process_2023,Positive Regulation Of Protein Phosphorylation (GO:0001934),31 of 377,7.787371384401488e-05,0.0019129588637407,0,0,2.2639923857278825,21.41832359256414,CD40;CDKN1A;CSF1;ILK;CIB1;TXN;CX3CL1;SDCBP;PAK1;TBK1;PDCD10;RIPK1;TNFRSF14;RAC1;NBN;JAK2;FNIP2;LYN;CD74;NTRK2;HSP90AA1;RBPMS;IL15;RIPK2;SPHK1;LIMK2;INHBA;RAP2C;CLIP3;TRAF4;FAS
2690,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway (GO:0002484),5 of 13,8.720288097690689e-05,0.0020633740513506,0,0,15.535252263906855,145.21224696873472,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2691,GO_Biological_Process_2023,"Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class I Via ER Pathway, TAP-independent (GO:0002486)",5 of 13,8.720288097690689e-05,0.0020633740513506,0,0,15.535252263906855,145.21224696873472,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2692,GO_Biological_Process_2023,Antigen Processing And Presentation Of Endogenous Peptide Antigen Via MHC Class Ib (GO:0002476),5 of 13,8.720288097690689e-05,0.0020633740513506,0,0,15.535252263906855,145.21224696873472,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2693,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class Ib (GO:0002428),5 of 13,8.720288097690689e-05,0.0020633740513506,0,0,15.535252263906855,145.21224696873472,HLA-B;HLA-C;HLA-A;HLA-F;HLA-E
2694,GO_Biological_Process_2023,Negative Regulation Of Viral Transcription (GO:0032897),5 of 13,8.720288097690689e-05,0.0020633740513506,0,0,15.535252263906855,145.21224696873472,IFITM3;ZFP36;LARP7;TRIM14;TRIM21
2695,GO_Biological_Process_2023,Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),23 of 246,9.804068942253787e-05,0.0023028827632242,0,0,2.595414723962819,23.956010030327725,CD40;RIPK2;SPHK1;TRADD;STAT3;EIF2AK2;AKR1B1;ARID5B;CIB1;CFLAR;CX3CL1;RELA;PSMA6;TRIM5;TRIM25;TRIM14;TRIM26;RIPK1;RBCK1;TRIM38;PLPP3;TRIM21;TRIM22
2696,GO_Biological_Process_2023,Positive Regulation Of ATP-dependent Activity (GO:0032781),8 of 39,0.00010655872596068164,0.0024848259430541,0,0,6.431839128613322,58.83083816397034,VMP1;PLSCR1;FXYD2;TPM1;DNAJB11;HNRNPU;ATP1B1;PFN1
2697,GO_Biological_Process_2023,Positive Regulation Of Interferon-Alpha Production (GO:0032727),6 of 21,0.00011167434133375056,0.0025853815137554,0,0,9.951813471502591,90.56074216073428,IFIH1;TBK1;RIPK2;STAT1;DHX36;IRF7
2698,GO_Biological_Process_2023,Intrinsic Apoptotic Signaling Pathway In Response To Endoplasmic Reticulum Stress (GO:0070059),7 of 30,0.00012196828377111848,0.0028035281226818,0,0,7.578695088253538,68.29730179437493,PPP1R15A;CEBPB;CASP4;DAB2IP;TNFRSF10B;SELENOK;BBC3
2699,GO_Biological_Process_2023,Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001959),8 of 40,0.00012870060110363384,0.0029372945698687,0,0,6.23051948051948,55.81312916230565,CD74;CYLD;TBK1;SPHK1;SPPL2A;OTULIN;TNFAIP3;PTPN2
2700,GO_Biological_Process_2023,Negative Regulation Of Receptor Signaling Pathway Via STAT (GO:1904893),5 of 14,0.00013131182757736103,0.0029757849376334,0,0,13.808394422883426,123.41854147409448,SOCS3;GBP7;SOCS1;BCL3;PTPN2
2701,GO_Biological_Process_2023,Negative Regulation Of Phosphorylation (GO:0042326),11 of 75,0.00014526200723605096,0.0032463886828831,0,0,4.293065514993481,37.93769760213619,LYN;PPP1R15B;CDKN1A;CDKN2A;IGFBP3;ZC3H12A;DAB2IP;HNRNPU;CIB1;INHBA;PLPP3
2702,GO_Biological_Process_2023,Proteasomal Protein Catabolic Process (GO:0010498),21 of 220,0.00014527034503890012,0.0032463886828831,0,0,2.651852392743108,23.43419180831065,VCP;UBE2B;UBE2D3;PML;RBX1;PSMA5;PSMA6;PSMA3;PSMB4;PSMA4;IFI27;PSMA1;PSMB2;PSMA2;PSMB3;TBX21;PELI1;PMAIP1;RBCK1;TRIM21;NFE2L2
2703,GO_Biological_Process_2023,Positive Regulation Of Mononuclear Cell Migration (GO:0071677),7 of 31,0.00015229387488325234,0.003356723899824,0,0,7.262537829658452,63.83551798603827,LGALS3;CREB3;CXCL10;CCL5;MOSPD2;CD47;LGMN
2704,GO_Biological_Process_2023,Receptor Signaling Pathway Via STAT (GO:0097696),7 of 31,0.00015229387488325234,0.003356723899824,0,0,7.262537829658452,63.83551798603827,STAT5A;STAT1;STAT2;STAT3;STAT6;JAK2;JAK1
2705,GO_Biological_Process_2023,Positive Regulation Of Cell Population Proliferation (GO:0008284),36 of 483,0.00015852366041098036,0.0034702662530784,0,0,2.037844389370285,17.83033692023775,CDKN1A;CSF1;COX17;HNRNPU;AKR1B1;CIB1;ACTB;CX3CL1;RELA;SDCBP;PAK1;SERTAD1;MDK;PDCD10;CCL5;NAMPT;STX4;ITGAV;HES1;TIMP1;JAK2;LYN;NTRK2;CD74;TSC22D1;STAT1;IL15;SPHK1;NCCRP1;BTC;BST2;TJP1;S100A6;CD47;IL6ST;LGMN
2706,GO_Biological_Process_2023,Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),9 of 53,0.0001855782070710625,0.0040079910762059,0,0,5.101134885920321,43.829125211451576,TCIM;TRADD;SPHK1;ILK;EIF2AK2;IFI35;RELA;TRIM56;LIMS1
2707,GO_Biological_Process_2023,Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046425),9 of 53,0.0001855782070710625,0.0040079910762059,0,0,5.101134885920321,43.829125211451576,SOCS3;GBP7;SOCS1;IL10RB;CCL5;BCL3;HES1;JAK2;PTPN2
2708,GO_Biological_Process_2023,3'-UTR-mediated mRNA Destabilization (GO:0061158),5 of 15,0.00019067611508682863,0.0040906382556627,0,0,12.426908150064683,106.43565188016956,MOV10;ZFP36;DHX36;ZC3H12A;ZFP36L1
2709,GO_Biological_Process_2023,Cellular Response To Interleukin-6 (GO:0071354),6 of 23,0.0001943696782502692,0.0041422624146315,0,0,8.780097531240475,75.0325066611879,STAT3;IL6ST;JAK2;NFKB1;RELA;JAK1
2710,GO_Biological_Process_2023,Regulation Of Cell Migration (GO:0030334),33 of 434,0.0002043019852508563,0.0043252880824819,0,0,2.079007180036486,17.66306067443556,MACF1;CSF1;TRADD;MIA3;ARID4B;CIB1;CX3CL1;CXCL16;ACTG1;AMOT;DOCK10;SDCBP;PAK1;MDK;PDCD10;CCL5;DPYSL3;STX4;PLXNC1;RAC1;TMSB10;CD74;HSPA5;SPHK1;STAT3;TPM1;SOD2;RHOB;BST2;RAP2C;TJP1;CEACAM1;NUMB
2711,GO_Biological_Process_2023,Proteolysis Involved In Protein Catabolic Process (GO:0051603),11 of 78,0.00020756529381198824,0.004365654349588,0,0,4.100196540115589,34.769931528030185,PSMA6;VCP;UBB;CTSL;HM13;TNFAIP3;PMAIP1;ISG15;TRIM21;CTSS;LGMN
2712,GO_Biological_Process_2023,Regulation Of DNA-templated Transcription (GO:0006355),105 of 1922,0.00021260096085983583,0.0044425317665386,0,0,1.4944911071840083,12.637556645617323,ARID4B;BACH1;ACTB;ETS2;GPBP1;BBX;PIM2;JUNB;TRIM22;SP110;ARID5A;RFX3;ARID5B;SUB1;RFX5;ATF3;DDX5;CRABP2;KMT2A;MAX;CREM;HIF1A;DHX36;MIER1;CAMTA1;HIVEP2;SNX6;STAT5A;EGR1;HSPA8;JUN;DENND4A;ZBTB10;SMARCA5;INHBA;INO80;NFKB1;HOPX;NFKB2;FOSL2;HNRNPK;BCL6;BCL3;ID4;REL;SP140L;MXD1;SIM1;NFE2L2;CSRNP1;BTG1;CHD8;AKR1B1;ILK;CD38;KLF10;BATF2;TSFM;BATF3;DTX3L;ANXA4;BAZ1A;PARP9;ETV6;TOX4;ETV7;CREB3;ZEB1;ELF3;IRF1;IRF2;IRF7;LCOR;IRF8;NCOA7;KDM7A;IRF9;CEBPB;SP100;CEBPD;RELA;FSTL3;MLLT6;RELB;CREG1;TBX21;RBBP8;STAT6;HES1;E2F5;HES4;CD74;STAT1;PCGF5;CDKN2A;STAT2;STAT3;DAB2IP;SOD2;PML;KLF6;TNIP1;TCIM;TNIP2;LIMS1
2713,GO_Biological_Process_2023,Protein Modification By Small Protein Conjugation (GO:0032446),29 of 364,0.00022471232452841847,0.0046653178085964,0,0,2.1829025765697545,18.33788682319428,VCP;UBA6;MYCBP2;UBE2D3;UBE2L6;HERC5;IFIH1;NUB1;RNF213;UBB;UBD;TRIM69;TRIM26;TRIM21;HERC6;ATG3;UBE2B;LMO7;ISG15;UCHL3;RANGAP1;PML;RBX1;BSPRY;NSMCE4A;OTULIN;TRIM14;RNF181;NFE2L2
2714,GO_Biological_Process_2023,Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),4 of 9,0.0002447963084547036,0.004985788105109,0,0,19.8625322997416,165.15862625870022,SOCS3;SOCS1;PARP14;PTPN2
2715,GO_Biological_Process_2023,Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),4 of 9,0.0002447963084547036,0.004985788105109,0,0,19.8625322997416,165.15862625870022,USP15;DHX58;DDX60;OASL
2716,GO_Biological_Process_2023,Positive Regulation Of T Cell Apoptotic Process (GO:0070234),4 of 9,0.0002447963084547036,0.004985788105109,0,0,19.8625322997416,165.15862625870022,CD274;PRELID1;CCL5;IDO1
2717,GO_Biological_Process_2023,Regulation Of Protein Localization To Plasma Membrane (GO:1903076),11 of 80,0.00026059267439800334,0.0052741334981935,0,0,3.980934565311869,32.85286952551568,CLIP3;VAMP8;LGALS3;ITGA3;TMBIM1;NUMB;AKR1B1;CIB1;STX4;GBP1;ACTB
2718,GO_Biological_Process_2023,Negative Regulation Of Natural Killer Cell Mediated Cytotoxicity (GO:0045953),5 of 16,0.0002684964936078683,0.0053665945119883,0,0,11.29660119957662,92.8882543237027,CEACAM1;HLA-B;HLA-A;HLA-F;HLA-E
2719,GO_Biological_Process_2023,Positive Regulation Of Homotypic Cell-Cell Adhesion (GO:0034112),5 of 16,0.0002684964936078683,0.0053665945119883,0,0,11.29660119957662,92.8882543237027,CCL5;F11R;IL6ST;JAK2;JAK1
2720,GO_Biological_Process_2023,Apoptotic Mitochondrial Changes (GO:0008637),7 of 34,0.0002814863921338861,0.0055571976066677,0,0,6.454580391026565,52.76894726605327,ATG3;BCL2A1;IFI6;SOD2;BBC3;IFIT2;MCL1
2721,GO_Biological_Process_2023,Regulation Of T Cell Receptor Signaling Pathway (GO:0050856),7 of 34,0.0002814863921338861,0.0055571976066677,0,0,6.454580391026565,52.76894726605327,LGALS3;CEACAM1;RAB29;GBP1;RELA;NECTIN2;PTPN2
2722,GO_Biological_Process_2023,Positive Regulation Of Innate Immune Response (GO:0045089),8 of 45,0.0003038804727876049,0.0059627278136006,0,0,5.387153387153387,43.62988789771881,AKIRIN2;GBP5;PLSCR1;CCL5;NLRC5;IFI35;HLA-E;TRIM56
2723,GO_Biological_Process_2023,Regulation Of Monocyte Chemotaxis (GO:0090025),6 of 25,0.0003190739004338798,0.006222907949068,0,0,7.855058631033542,63.2339118048398,LYN;CREB3;CXCL10;CCL5;MOSPD2;LGMN
2724,GO_Biological_Process_2023,Platelet Aggregation (GO:0070527),7 of 35,0.00034016429672335265,0.0065942693184081,0,0,6.223735408560311,49.70326026982568,CSRP1;ACTN1;ILK;MYH9;CLIC1;MYL12A;ACTG1
2725,GO_Biological_Process_2023,Positive Regulation Of Cell-Cell Adhesion (GO:0022409),8 of 46,0.0003554709072222962,0.0068089605919127,0,0,5.245112781954887,41.65703791466058,TJP1;MDK;CCL5;CD47;PLPP3;CX3CL1;FSTL3;JAK1
2726,GO_Biological_Process_2023,Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042058),8 of 46,0.0003554709072222962,0.0068089605919127,0,0,5.245112781954887,41.65703791466058,RALA;CEACAM1;MVP;ITGA1;RHBDF2;IFI6;DAB2IP;PTPN2
2727,GO_Biological_Process_2023,Protein K48-linked Ubiquitination (GO:0070936),10 of 70,0.00035922803337088137,0.0068402119017011,0,0,4.158420138888889,32.98273047919099,DTX3L;IFI27;UBE2B;UBE2D3;MYCBP2;PELI1;TNFAIP3;TRIM25;TRIM21;RBX1
2728,GO_Biological_Process_2023,Regulation Of Viral Transcription (GO:0046782),5 of 17,0.00036824366219419805,0.0069298719587188,0,0,10.354678740836569,81.87201884107021,IFITM3;ZFP36;LARP7;TRIM14;TRIM21
2729,GO_Biological_Process_2023,Response To Interferon-Alpha (GO:0035455),5 of 17,0.00036824366219419805,0.0069298719587188,0,0,10.354678740836569,81.87201884107021,IFITM3;BST2;MX2;LAMP3;EIF2AK2
2730,GO_Biological_Process_2023,Negative Regulation Of DNA-templated Transcription (GO:0045892),62 of 1025,0.00038107122131794593,0.0071295766872159,0,0,1.641834467475359,12.925381688769484,CHD8;UBE2D3;ZBTB20;AKR1B1;HNRNPU;ARID4B;BACH1;ETS2;ZFP36;CD38;KLF10;BATF3;ARID5A;RFX3;ARID5B;PARP9;YWHAZ;ETV6;ETV7;ZEB1;IFI27;ELF3;IRF1;IRF2;IRF7;LCOR;IRF8;ATF3;DDX5;CEBPB;SP100;MAX;CREM;ASCL2;HIF1A;RELA;SDCBP;TBX21;MIER1;NRIP1;HES1;FNIP2;SNX6;HSPA8;JUN;STAT1;CDKN2A;PTCH1;STAT3;DAB2IP;ZBTB10;SMARCA5;LARP7;NFKB1;PML;HNRNPK;BCL6;BCL3;ID4;HDGF;MXD1;LIMS1
2731,GO_Biological_Process_2023,T-helper Cell Lineage Commitment (GO:0002295),4 of 10,0.00039544391322882686,0.007271648644402,0,0,16.551248923341948,129.6873373071267,SOCS3;TBX21;STAT3;JAK1
2732,GO_Biological_Process_2023,Establishment Of Endothelial Intestinal Barrier (GO:0090557),4 of 10,0.00039544391322882686,0.007271648644402,0,0,16.551248923341948,129.6873373071267,RAP2C;TJP1;F11R;TJP2
2733,GO_Biological_Process_2023,Regulation Of Programmed Necrotic Cell Death (GO:0062098),4 of 10,0.00039544391322882686,0.007271648644402,0,0,16.551248923341948,129.6873373071267,CYLD;PELI1;CFLAR;BIRC3
2734,GO_Biological_Process_2023,Antigen Processing And Presentation Of Exogenous Peptide Antigen Via MHC Class II (GO:0019886),6 of 26,0.0004012547621190699,0.0072951289519726,0,0,7.461917098445596,58.35901201684396,CTSL;HLA-DRA;IFI30;HLA-DOB;CTSS;LGMN
2735,GO_Biological_Process_2023,Regulation Of Interferon-Alpha Production (GO:0032647),6 of 26,0.0004012547621190699,0.0072951289519726,0,0,7.461917098445596,58.35901201684396,IFIH1;TBK1;RIPK2;STAT1;DHX36;IRF7
2736,GO_Biological_Process_2023,Positive Regulation Of Cell-Substrate Adhesion (GO:0010811),10 of 71,0.0004037851145550544,0.0072985619196579,0,0,4.090035860655738,31.962107596829917,CSF1;MDK;ILK;CIB1;RAC1;RSU1;JAK2;UTRN;CX3CL1;LIMS1
2737,GO_Biological_Process_2023,Regulation Of T Cell Mediated Cytotoxicity (GO:0001914),7 of 36,0.00040824771458621473,0.0072985619196579,0,0,6.0088107697124205,46.890574588674426,CEACAM1;HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;HLA-E
2738,GO_Biological_Process_2023,Regulation Of Erythrocyte Differentiation (GO:0045646),7 of 36,0.00040824771458621473,0.0072985619196579,0,0,6.0088107697124205,46.890574588674426,LYN;ZFP36;STAT1;STAT3;INHBA;HIF1A;ZFP36L1
2739,GO_Biological_Process_2023,Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),49 of 763,0.00042209934964938486,0.007504506669457,0,0,1.7423276580865543,13.53835606335474,CHD8;UBE2D3;HNRNPU;ZBTB20;AKR1B1;ARID4B;BACH1;ETS2;ZFP36;KLF10;BATF3;ARID5A;ARID5B;PARP9;YWHAZ;ETV6;ETV7;ZEB1;IFI27;IRF2;IRF7;LCOR;IRF8;ATF3;CEBPB;SP100;DDX5;MAX;CREM;ASCL2;RELA;SDCBP;TBX21;MIER1;NRIP1;HES1;FNIP2;JUN;STAT1;PTCH1;STAT3;DAB2IP;ZBTB10;LARP7;NFKB1;BCL6;ID4;HDGF;MXD1
2740,GO_Biological_Process_2023,Regulation Of Angiogenesis (GO:0045765),19 of 205,0.0004285771712234784,0.0075778095439404,0,0,2.561973167863771,19.86820372943753,CD40;SP100;BTG1;CXCL8;STAT1;SPHK1;DAB2IP;TNFAIP3;HIF1A;PML;RHOB;AMOT;CXCL10;CEACAM1;RRAS;PDCD10;ZC3H12A;NINJ1;GLUL
2741,GO_Biological_Process_2023,Defense Response To Gram-positive Bacterium (GO:0050830),11 of 85,0.0004451458251927058,0.007827755549017,0,0,3.710983473695338,28.63806259961012,GBP6;CHGA;GSDMD;GBP7;CASP4;TNFRSF14;HLA-A;GBP2;MR1;GBP4;HLA-E
2742,GO_Biological_Process_2023,Cellular Response To Mechanical Stimulus (GO:0071260),8 of 48,0.0004800604866740658,0.0083504575465791,0,0,4.982337662337662,38.07302374841531,CD40;IRF1;TNFRSF10B;FAS;F11R;MAP3K14;NFKB1;TNFRSF1A
2743,GO_Biological_Process_2023,Regulation Of Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0010803),8 of 48,0.0004800604866740658,0.0083504575465791,0,0,4.982337662337662,38.07302374841531,CYLD;TBK1;SPHK1;SPPL2A;CASP4;OTULIN;TNFAIP3;PTPN2
2744,GO_Biological_Process_2023,Negative Regulation Of ERBB Signaling Pathway (GO:1901185),5 of 18,0.0004936367692261575,0.0083606480177356,0,0,9.557667429594984,72.76931378364591,MVP;ITGA1;DAB2IP;PTPN2;LGMN
2745,GO_Biological_Process_2023,Peptide Antigen Assembly With MHC Protein Complex (GO:0002501),5 of 18,0.0004936367692261575,0.0083606480177356,0,0,9.557667429594984,72.76931378364591,PDIA3;HLA-DRA;TAPBPL;HLA-DOB;TAPBP
2746,GO_Biological_Process_2023,Positive Regulation Of Monocyte Chemotaxis (GO:0090026),5 of 18,0.0004936367692261575,0.0083606480177356,0,0,9.557667429594984,72.76931378364591,CREB3;CXCL10;CCL5;MOSPD2;LGMN
2747,GO_Biological_Process_2023,Positive Regulation Of Neutrophil Chemotaxis (GO:0090023),5 of 18,0.0004936367692261575,0.0083606480177356,0,0,9.557667429594984,72.76931378364591,CD74;CXCL8;MDK;MOSPD2;RAC1
2748,GO_Biological_Process_2023,Regulation Of RIG-I Signaling Pathway (GO:0039535),5 of 18,0.0004936367692261575,0.0083606480177356,0,0,9.557667429594984,72.76931378364591,USP15;DHX58;DDX60;OASL;BIRC3
2749,GO_Biological_Process_2023,Modification-Dependent Protein Catabolic Process (GO:0019941),18 of 192,0.0005241516951759172,0.0088081623243618,0,0,2.5927404718693285,19.584859983190565,UBE2B;DTX3L;UBA6;UBE2D3;RNF19B;UBE2L6;ISG15;RBX1;HERC5;RNF144B;NUB1;RNF114;RNF213;UBB;RNF19A;UBD;TRIM25;HERC6
2750,GO_Biological_Process_2023,Positive Regulation Of Protein Modification Process (GO:0031401),20 of 225,0.0005255336128892091,0.0088081623243618,0,0,2.447647853787245,18.482424912032663,LYN;EGR1;CD74;NTRK2;ANKLE2;CD40;CDKN1A;HSP90AA1;NNMT;LIMK2;SMARCA5;ILK;CIB1;TXN;CLIP3;PAK1;FAS;CAMTA1;RIPK1;RAC1
2751,GO_Biological_Process_2023,DNA Damage Response (GO:0006974),29 of 384,0.0005414530228456081,0.0089856687930776,0,0,2.057740837548657,15.476792017824184,PPP1R15A;BTG2;CDKN1A;VCP;BCL2A1;CIB1;SAMHD1;BACH1;TANK;PAK1;ZC3H12A;RBBP8;FBXO6;FNIP2;IER3;MCL1;LYN;UVRAG;UBE2B;DTX3L;SMARCA5;INO80;PML;RBX1;FAM111A;NSMCE4A;BCL6;BCL3;IRF7
2752,GO_Biological_Process_2023,Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),14 of 130,0.0005440685775501105,0.0089856687930776,0,0,3.0181892038274056,22.68602374509331,LYN;CD74;CD40;IL15;RIPK2;PARP14;PARP9;TNFRSF1A;CCL5;UNC119;TNFRSF14;HES1;IL6ST;JAK2
2753,GO_Biological_Process_2023,Interleukin-4-Mediated Signaling Pathway (GO:0035771),3 of 5,0.0005528783160439336,0.0089856687930776,0,0,37.2,279.01386161187804,STAT5A;STAT6;JAK1
2754,GO_Biological_Process_2023,Interleukin-5-Mediated Signaling Pathway (GO:0038043),3 of 5,0.0005528783160439336,0.0089856687930776,0,0,37.2,279.01386161187804,LYN;STAT5A;JAK2
2755,GO_Biological_Process_2023,Protein Modification By Small Protein Conjugation Or Removal (GO:0070647),3 of 5,0.0005528783160439336,0.0089856687930776,0,0,37.2,279.01386161187804,DESI1;UBA6;UBD
2756,GO_Biological_Process_2023,Toll-Like Receptor 9 Signaling Pathway (GO:0034162),3 of 5,0.0005528783160439336,0.0089856687930776,0,0,37.2,279.01386161187804,TNIP2;UNC93B1;PIK3AP1
2757,GO_Biological_Process_2023,Positive Regulation Of Cellular Process (GO:0048522),40 of 594,0.0005651156107753298,0.0091048091054062,0,0,1.826382162738595,13.65856289081902,CSF1;COX17;AKR1B1;CIB1;ACTB;CX3CL1;RELA;CXCL16;ZFP36L1;SDCBP;ZFP36;PAK1;SERTAD1;MDK;PDCD10;CCL5;NAMPT;DHX36;STX4;ITGAV;HES1;TIMP1;IER5;TRIM21;TGM2;LYN;NTRK2;TSC22D1;IL15;SLC30A2;SPHK1;TPM1;INO80;NCCRP1;BTC;TJP1;SUPV3L1;CD47;IL6ST;LGMN
2758,GO_Biological_Process_2023,Positive Regulation Of Lymphocyte Proliferation (GO:0050671),10 of 74,0.0005658675640401647,0.0091048091054062,0,0,3.897705078125,29.14372744621682,CD274;CD74;CD40;IL15;CD70;CCL5;CD38;JAK2;IL6ST;HLA-E
2759,GO_Biological_Process_2023,Negative Regulation Of Type I Interferon Production (GO:0032480),7 of 38,0.000576919358319157,0.009236450224234,0,0,5.620559809213003,41.91705625530462,CYLD;GBP7;DHX58;REL;XAF1;RELB;RBX1
2760,GO_Biological_Process_2023,Central Nervous System Neuron Axonogenesis (GO:0021955),4 of 11,0.0006023225273113039,0.0094090965674163,0,0,14.186046511627907,105.18552727550588,HSP90AA1;MYCBP2;B4GALT6;B4GALT5
2761,GO_Biological_Process_2023,Nucleotide-Binding Oligomerization Domain Containing Signaling Pathway (GO:0070423),4 of 11,0.0006023225273113039,0.0094090965674163,0,0,14.186046511627907,105.18552727550588,RIPK2;OTULIN;TNFAIP3;RELA
2762,GO_Biological_Process_2023,Regulation Of T Cell Apoptotic Process (GO:0070232),4 of 11,0.0006023225273113039,0.0094090965674163,0,0,14.186046511627907,105.18552727550588,CD274;LGALS3;PRELID1;IDO1
2763,GO_Biological_Process_2023,Regulation Of T-helper 17 Cell Differentiation (GO:2000319),4 of 11,0.0006023225273113039,0.0094090965674163,0,0,14.186046511627907,105.18552727550588,TBX21;NFKBIZ;ZC3H12A;JUNB
2764,GO_Biological_Process_2023,Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),4 of 11,0.0006023225273113039,0.0094090965674163,0,0,14.186046511627907,105.18552727550588,NLRC5;PARP14;PARP9;PTPN2
2765,GO_Biological_Process_2023,Antigen Processing And Presentation Of Peptide Antigen Via MHC Class II (GO:0002495),6 of 28,0.0006144762177470234,0.0095066560995669,0,0,6.782854451248234,50.15744737335342,CTSL;HLA-DRA;IFI30;HLA-DOB;CTSS;LGMN
2766,GO_Biological_Process_2023,Establishment Of Endothelial Barrier (GO:0061028),6 of 28,0.0006144762177470234,0.0095066560995669,0,0,6.782854451248234,50.15744737335342,RAP1B;RAP2C;TJP1;F11R;ICAM1;TJP2
2767,GO_Biological_Process_2023,Regulation Of T Cell Activation (GO:0050863),9 of 62,0.000622218488573347,0.0095803784508566,0,0,4.232917044924799,31.248321731226568,LGALS3;PRELID1;CCL5;TBX21;CCL2;HLA-DRA;CD47;B2M;HLA-DOB
2768,GO_Biological_Process_2023,Release Of Cytochrome C From Mitochondria (GO:0001836),5 of 19,0.0006486199911380399,0.0099393291975343,0,0,8.874514877102198,65.14482781645678,BCL2A1;IFI6;SOD2;BBC3;MCL1
2769,GO_Biological_Process_2023,Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),7 of 39,0.0006798112001878507,0.010367926266372,0,0,5.4446335927367056,39.711499235732965,USP15;RSAD2;DHX58;NINJ1;IFI35;DDX60;OASL
2770,GO_Biological_Process_2023,Regulation Of Protein Phosphorylation (GO:0001932),22 of 265,0.0007188940660790232,0.0109122693615202,0,0,2.2728351514359746,16.450318409090613,LYN;CD74;PPP1R15B;NTRK2;CD40;CDKN1A;HSP90AA1;STAT2;IGFBP3;LIMK2;DAB2IP;ILK;CIB1;CLIP3;PAK1;SOCS1;ZC3H12A;FAS;RIPK1;RAC1;PLPP3;FNIP2
2771,GO_Biological_Process_2023,Positive Regulation Of Angiogenesis (GO:0045766),13 of 119,0.0007407867379522684,0.0111917921254948,0,0,3.064594894561598,22.08898026880911,CD40;BTG1;CXCL8;SPHK1;HIF1A;RHOB;TJP1;PKM;RRAS;MDK;ZC3H12A;NINJ1;JAK1
2772,GO_Biological_Process_2023,Positive Regulation Of Endopeptidase Activity (GO:0010950),6 of 29,0.0007495401460720185,0.0112711223834568,0,0,6.487609822031989,46.68516905876286,LYN;PSENEN;PRELID1;STAT3;PSME1;PSME2
2773,GO_Biological_Process_2023,Regulation Of T Cell Proliferation (GO:0042129),10 of 77,0.0007783789156807723,0.0116503411658638,0,0,3.722597947761194,26.647462146787188,LGALS3;CD274;CEBPB;SDC4;IL15;CD70;CCL5;JAK2;IL6ST;IDO1
2774,GO_Biological_Process_2023,T Cell Mediated Immunity (GO:0002456),5 of 20,0.0008373376871765884,0.0123038935038094,0,0,8.282449331608452,58.683498436566325,CD70;CR1L;BTN3A3;BTN3A2;HLA-A
2775,GO_Biological_Process_2023,Negative Regulation Of Viral Life Cycle (GO:1903901),5 of 20,0.0008373376871765884,0.0123038935038094,0,0,8.282449331608452,58.683498436566325,IFITM3;BST2;TRIM5;TRIM26;LY6E
2776,GO_Biological_Process_2023,Regulation Of Necroptotic Process (GO:0060544),5 of 20,0.0008373376871765884,0.0123038935038094,0,0,8.282449331608452,58.683498436566325,CYLD;PELI1;RIPK1;CFLAR;BIRC3
2777,GO_Biological_Process_2023,Response To Fibroblast Growth Factor (GO:0071774),5 of 20,0.0008373376871765884,0.0123038935038094,0,0,8.282449331608452,58.683498436566325,ZFP36;CXCL8;CCL5;IER2;ZFP36L1
2778,GO_Biological_Process_2023,Negative Regulation Of Protein Modification Process (GO:0031400),10 of 78,0.0008623223850239,0.0126134247045768,0,0,3.66766237745098,25.878590606295827,PPP1R15A;LYN;PPP1R15B;CDKN1A;YWHAB;IGFBP3;ZC3H12A;DAB2IP;CIB1;PLPP3
2779,GO_Biological_Process_2023,Positive Regulation Of Cell Migration (GO:0030335),22 of 272,0.0010133279241601,0.0147551550223869,0,0,2.2083809523809523,15.225716463716964,CSF1;HSPA5;SPHK1;TRADD;STAT3;DAB2IP;MIA3;CIB1;SOD2;HIF1A;CXCL16;TJP1;SDCBP;PAK1;PDCD10;GLIPR2;MDK;CCL5;NUMB;STX4;PFN1;S100A11
2780,GO_Biological_Process_2023,"Regulation Of mRNA Splicing, Via Spliceosome (GO:0048024)",11 of 94,0.0010508026511285,0.0151462092592764,0,0,3.307032563107711,22.68029395591776,DDX5;RBMXL1;HNRNPK;RBM8A;WTAP;NCL;HNRNPU;LARP7;SRSF7;QKI;SRPK1
2781,GO_Biological_Process_2023,Positive Regulation Of Granulocyte Chemotaxis (GO:0071624),5 of 21,0.001064108573042,0.0151462092592764,0,0,7.764391979301423,53.15206033516914,CD74;CXCL8;MDK;MOSPD2;RAC1
2782,GO_Biological_Process_2023,Regulation Of Lipid Storage (GO:0010883),5 of 21,0.001064108573042,0.0151462092592764,0,0,7.764391979301423,53.15206033516914,NFKBIA;ZC3H12A;ITGAV;NFKB1;PTPN2
2783,GO_Biological_Process_2023,DNA Strand Resection Involved In Replication Fork Processing (GO:0110025),3 of 6,0.001073746572689,0.0151462092592764,0,0,24.798709677419357,169.5388902381483,RBBP8;NBN;SAMHD1
2784,GO_Biological_Process_2023,Autophagosome Membrane Docking (GO:0016240),3 of 6,0.001073746572689,0.0151462092592764,0,0,24.798709677419357,169.5388902381483,VAMP8;VMP1;STX17
2785,GO_Biological_Process_2023,Nucleotide-Binding Oligomerization Domain Containing 2 Signaling Pathway (GO:0070431),3 of 6,0.001073746572689,0.0151462092592764,0,0,24.798709677419357,169.5388902381483,RIPK2;OTULIN;RELA
2786,GO_Biological_Process_2023,Toll-Like Receptor 3 Signaling Pathway (GO:0034138),3 of 6,0.001073746572689,0.0151462092592764,0,0,24.798709677419357,169.5388902381483,OAS1;TNIP2;UNC93B1
2787,GO_Biological_Process_2023,Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),7 of 42,0.0010778377627017,0.0151462092592764,0,0,4.977172503242542,34.0080158998052,TNIP1;STAT1;ZC3H12A;DAB2IP;TNFAIP3;RIPK1;TANK
2788,GO_Biological_Process_2023,Cellular Response To Arsenic-Containing Substance (GO:0071243),4 of 13,0.0012262413521617,0.0168634387660538,0,0,11.032443296009188,73.95931101278,VCP;GSTO1;DHX36;ZC3H12A
2789,GO_Biological_Process_2023,Endolysosomal Toll-Like Receptor Signaling Pathway (GO:0140894),4 of 13,0.0012262413521617,0.0168634387660538,0,0,11.032443296009188,73.95931101278,OAS1;UNC93B1;TNIP2;PIK3AP1
2790,GO_Biological_Process_2023,Interleukin-6-Mediated Signaling Pathway (GO:0070102),4 of 13,0.0012262413521617,0.0168634387660538,0,0,11.032443296009188,73.95931101278,STAT3;IL6ST;JAK2;JAK1
2791,GO_Biological_Process_2023,Regulation Of ERBB Signaling Pathway (GO:1901184),4 of 13,0.0012262413521617,0.0168634387660538,0,0,11.032443296009188,73.95931101278,CEACAM1;RHBDF2;IFI6;LGMN
2792,GO_Biological_Process_2023,Suppression Of Viral Release By Host (GO:0044790),4 of 13,0.0012262413521617,0.0168634387660538,0,0,11.032443296009188,73.95931101278,TRIM5;TRIM26;TRIM21;PML
2793,GO_Biological_Process_2023,Positive Regulation Of Cell-Matrix Adhesion (GO:0001954),7 of 43,0.0012448476942982,0.0170464675755395,0,0,4.83866551376279,32.364585683493964,CSF1;RRAS;CIB1;RAC1;UTRN;CX3CL1;LIMS1
2794,GO_Biological_Process_2023,Negative Regulation Of Apoptotic Signaling Pathway (GO:2001234),10 of 82,0.0012757928278475,0.017396192033955,0,0,3.463179976851852,23.079280600688445,LGALS3;PRELID1;TMBIM1;AKR1B1;ITGAV;RIPK1;CFLAR;CX3CL1;RELA;GRINA
2795,GO_Biological_Process_2023,Dendritic Cell Differentiation (GO:0097028),5 of 22,0.0013333992975207,0.0179534683657813,0,0,7.307282550795221,48.37438392179183,LYN;BATF2;BATF3;UBD;IRF8
2796,GO_Biological_Process_2023,Membrane Protein Ectodomain Proteolysis (GO:0006509),5 of 22,0.0013333992975207,0.0179534683657813,0,0,7.307282550795221,48.37438392179183,PSENEN;HM13;ERAP1;SPPL2A;MYH9
2797,GO_Biological_Process_2023,Regulation Of Mononuclear Cell Migration (GO:0071675),5 of 22,0.0013333992975207,0.0179534683657813,0,0,7.307282550795221,48.37438392179183,LYN;LGALS3;CSF1;MDK;CCL5
2798,GO_Biological_Process_2023,Regulation Of Tumor Necrosis Factor Production (GO:0032680),13 of 127,0.0013593883533884,0.0182137886999433,0,0,2.8483430799220275,18.801116332382616,STAT3;TNFAIP3;CX3CL1;HLA-E;IFIH1;ZFP36;OAS1;OAS2;OAS3;ZC3H12A;RIPK1;CD47;JAK2
2799,GO_Biological_Process_2023,Cellular Response To Peptide (GO:1901653),8 of 56,0.0013753731056824,0.0182137886999433,0,0,4.15021645021645,27.345901672623263,RIPK2;CACNA2D1;CASP4;ICAM1;CHMP5;ZFP36L1;SNX6;LGMN
2800,GO_Biological_Process_2023,Pattern Recognition Receptor Signaling Pathway (GO:0002221),8 of 56,0.0013753731056824,0.0182137886999433,0,0,4.15021645021645,27.345901672623263,IFIH1;TBK1;TRAF3;DHX58;TIFA;TRIM25;ALPK1;CTSS
2801,GO_Biological_Process_2023,Positive Regulation Of Cellular Metabolic Process (GO:0031325),8 of 56,0.0013753731056824,0.0182137886999433,0,0,4.15021645021645,27.345901672623263,CDKN1A;PRELID1;CXCL8;IL10RB;CCL5;ZC3H12A;RIPK1;B2M
2802,GO_Biological_Process_2023,Lymphocyte Chemotaxis (GO:0048247),7 of 44,0.001431442069061,0.0188786089272064,0,0,4.707645388579241,30.830712851001525,CXCL10;CXCL11;CCL20;CCL5;CCL2;CX3CL1;CXCL16
2803,GO_Biological_Process_2023,Regulation Of Cell Adhesion (GO:0030155),14 of 144,0.0014895060801529,0.0195642063915601,0,0,2.6911800241643173,17.51772693717216,LYN;CXCL8;TPM1;C2CD4A;C2CD4B;MIA3;RND1;MDK;CCL5;ITGAV;STX4;PLXNC1;RSU1;TGM2
2804,GO_Biological_Process_2023,Regulation Of Interleukin-1 Beta Production (GO:0032651),10 of 84,0.0015361593945701,0.0200949631371005,0,0,3.369228603603604,21.82744601762434,GSDMD;GBP5;EGR1;SERPINB1;RIPK2;ZC3H12A;STAT3;TNFAIP3;JAK2;CX3CL1
2805,GO_Biological_Process_2023,Negative Regulation Of Epidermal Growth Factor Receptor Signaling Pathway (GO:0042059),5 of 23,0.0016497977639528,0.0211677664181324,0,0,6.900963058789708,44.215178121035066,MVP;ITGA1;DAB2IP;PTPN2;SNX6
2806,GO_Biological_Process_2023,Positive Regulation Of Neutrophil Migration (GO:1902624),5 of 23,0.0016497977639528,0.0211677664181324,0,0,6.900963058789708,44.215178121035066,CD74;CXCL8;MDK;MOSPD2;RAC1
2807,GO_Biological_Process_2023,"Regulation Of Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:1900151)",5 of 23,0.0016497977639528,0.0211677664181324,0,0,6.900963058789708,44.215178121035066,ZFP36;CSDE1;DHX36;HNRNPU;ZFP36L1
2808,GO_Biological_Process_2023,Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034143),5 of 23,0.0016497977639528,0.0211677664181324,0,0,6.900963058789708,44.215178121035066,LYN;NINJ1;DAB2IP;TNFAIP3;IFI35
2809,GO_Biological_Process_2023,Positive Regulation Of Cytoplasmic Translation (GO:2000767),4 of 14,0.0016642153212515,0.0211677664181324,0,0,9.928682170542636,63.52769534144176,PKM;CSDE1;DHX36;HNRNPU
2810,GO_Biological_Process_2023,Positive Regulation Of Transcription From RNA Polymerase II Promoter Involved In Cellular Response To Chemical Stimulus (GO:1901522),4 of 14,0.0016642153212515,0.0211677664181324,0,0,9.928682170542636,63.52769534144176,CREB3;HIF1A;RELA;NFE2L2
2811,GO_Biological_Process_2023,Regulation Of Macrophage Differentiation (GO:0045649),4 of 14,0.0016642153212515,0.0211677664181324,0,0,9.928682170542636,63.52769534144176,CSF1;RIPK1;INHBA;PTPN2
2812,GO_Biological_Process_2023,Integrin-Mediated Signaling Pathway (GO:0007229),10 of 85,0.0016816282944212,0.0213050387852271,0,0,3.3241319444444444,21.234530701620542,CEACAM1;ITGA3;ITGA1;ZYX;ILK;MYH9;ITGAV;ISG15;CD47;PLPP3
2813,GO_Biological_Process_2023,Regulation Of Phagocytosis (GO:0050764),8 of 58,0.0017337886856759,0.0218797332960992,0,0,3.983792207792208,25.326744924985224,IL15RA;PLSCR1;IL15;SPHK1;RAB27A;ITGAV;CD47;TGM2
2814,GO_Biological_Process_2023,Positive Regulation Of Phosphorylation (GO:0042327),19 of 231,0.0017914263409299,0.0223273737367161,0,0,2.2446988341163894,14.197143547793486,LYN;DDR1;CD74;NTRK2;CD40;CDKN1A;HSP90AA1;LIMK2;AKR1B1;ILK;CIB1;CLIP3;SDCBP;PAK1;CCL5;FAS;RIPK1;RAC1;NBN
2815,GO_Biological_Process_2023,T-helper 17 Cell Lineage Commitment (GO:0072540),3 of 7,0.0018247667162076,0.0223273737367161,0,0,18.598064516129032,117.28503241149184,SOCS3;STAT3;JAK1
2816,GO_Biological_Process_2023,Cellular Response To Interleukin-2 (GO:0071352),3 of 7,0.0018247667162076,0.0223273737367161,0,0,18.598064516129032,117.28503241149184,STAT5A;STAT3;JAK1
2817,GO_Biological_Process_2023,Interleukin-2-Mediated Signaling Pathway (GO:0038110),3 of 7,0.0018247667162076,0.0223273737367161,0,0,18.598064516129032,117.28503241149184,STAT5A;STAT3;JAK1
2818,GO_Biological_Process_2023,Negative Regulation Of Mitochondrial Membrane Potential (GO:0010917),3 of 7,0.0018247667162076,0.0223273737367161,0,0,18.598064516129032,117.28503241149184,HEBP2;PRELID1;PMAIP1
2819,GO_Biological_Process_2023,Regulation Of Alpha-Beta T Cell Proliferation (GO:0046640),3 of 7,0.0018247667162076,0.0223273737367161,0,0,18.598064516129032,117.28503241149184,IRF1;EBI3;TNFRSF14
2820,GO_Biological_Process_2023,Regulation Of Hydrogen Peroxide-Induced Cell Death (GO:1903205),3 of 7,0.0018247667162076,0.0223273737367161,0,0,18.598064516129032,117.28503241149184,RIPK1;TXN;NFE2L2
2821,GO_Biological_Process_2023,Regulation Of Lymphocyte Apoptotic Process (GO:0070228),3 of 7,0.0018247667162076,0.0223273737367161,0,0,18.598064516129032,117.28503241149184,LYN;CD274;LGALS3
2822,GO_Biological_Process_2023,Exocytosis (GO:0006887),10 of 86,0.0018380496777129,0.0224047116018195,0,0,3.280222039473684,20.66228338327044,RAB10;RAB11FIP1;STX17;CCL5;TNFAIP2;MYH9;RAB27A;MIA3;STX4;STX11
2823,GO_Biological_Process_2023,Regulation Of mRNA Catabolic Process (GO:0061013),7 of 46,0.0018695565136535,0.0227027655129705,0,0,4.465762080548073,28.054158696189564,MOV10;ZFP36;CARHSP1;RBM8A;DHX36;ZC3H12A;ZFP36L1
2824,GO_Biological_Process_2023,Regulation Of Type II Interferon Production (GO:0032649),10 of 87,0.0020060165367123,0.0242308974654471,0,0,3.2374526515151514,20.10977495963865,CD274;BTN3A1;ZC3H12A;EBI3;ISG15;BTN3A2;HLA-A;CD47;INHBA;JAK2
2825,GO_Biological_Process_2023,Protein Processing (GO:0016485),12 of 117,0.0020157017133054,0.0242308974654471,0,0,2.852219321148825,17.70312036891295,PSENEN;FAM111A;CTSL;C1R;PTCH1;HM13;C1RL;CASP4;ECE1;CPXM1;CTSS;LGMN
2826,GO_Biological_Process_2023,Mononuclear Cell Differentiation (GO:1903131),5 of 24,0.002017986488732,0.0242308974654471,0,0,6.5374140396268805,40.568936464959705,LYN;BATF3;IRF8;MYH9;RELB
2827,GO_Biological_Process_2023,Regulation Of mRNA Processing (GO:0050684),6 of 35,0.0021009090963807,0.0251328084466665,0,0,5.143737716633911,31.71312400446926,HNRNPK;RBM8A;LARP7;QKI;ZFP36L1;SRPK1
2828,GO_Biological_Process_2023,Cellular Response To Corticosteroid Stimulus (GO:0071384),4 of 15,0.0022000501875839,0.0260285349398714,0,0,9.025604886070004,55.23015929898816,ZFP36;HNRNPU;SSTR2;ZFP36L1
2829,GO_Biological_Process_2023,Cellular Response To Zinc Ion (GO:0071294),4 of 15,0.0022000501875839,0.0260285349398714,0,0,9.025604886070004,55.23015929898816,MT2A;MT1F;MT1X;MT1E
2830,GO_Biological_Process_2023,Regulation Of Monocyte Differentiation (GO:0045655),4 of 15,0.0022000501875839,0.0260285349398714,0,0,9.025604886070004,55.23015929898816,CD74;CSF1;IRF7;ZFP36L1
2831,GO_Biological_Process_2023,Negative Regulation Of Neuron Apoptotic Process (GO:0043524),9 of 74,0.0022425825677295,0.0264345446994642,0,0,3.449294788436531,21.04113677076886,NTRK2;MDK;CCL2;IL6ST;SOD2;HIF1A;CX3CL1;SNX6;LGMN
2832,GO_Biological_Process_2023,Regulation Of Neutrophil Chemotaxis (GO:0090022),5 of 25,0.0024427162526978,0.0284806554390642,0,0,6.210219922380336,37.35226597263437,CD74;CXCL8;MDK;MOSPD2;RAC1
2833,GO_Biological_Process_2023,Regulation Of Platelet Aggregation (GO:0090330),5 of 25,0.0024427162526978,0.0284806554390642,0,0,6.210219922380336,37.35226597263437,LYN;CEACAM1;F11R;JAK2;IL6ST
2834,GO_Biological_Process_2023,Response To Zinc Ion (GO:0010043),5 of 25,0.0024427162526978,0.0284806554390642,0,0,6.210219922380336,37.35226597263437,MT2A;SLC30A2;MT1F;MT1X;MT1E
2835,GO_Biological_Process_2023,Positive Regulation Of miRNA Metabolic Process (GO:2000630),7 of 49,0.0027134343267844,0.0315228579913077,0,0,4.14613056636403,24.50172512019681,EGR1;JUN;ZC3H12A;STAT3;HIF1A;RELA;NFKB1
2836,GO_Biological_Process_2023,Negative Regulation Of Smooth Muscle Cell Proliferation (GO:0048662),6 of 37,0.0028173760054232,0.0318873986930095,0,0,4.8113822497075045,28.252192737809708,CDKN1A;IGFBP3;TPM1;TNFAIP3;SOD2;TRIB1
2837,GO_Biological_Process_2023,T-helper 17 Cell Differentiation (GO:0072539),3 of 8,0.0028354401198111,0.0318873986930095,0,0,14.87767741935484,87.26588142673744,SOCS3;STAT3;JAK1
2838,GO_Biological_Process_2023,Negative Regulation Of Membrane Potential (GO:0045837),3 of 8,0.0028354401198111,0.0318873986930095,0,0,14.87767741935484,87.26588142673744,HEBP2;PRELID1;PMAIP1
2839,GO_Biological_Process_2023,Regulation Of Endothelial Cell Differentiation (GO:0045601),3 of 8,0.0028354401198111,0.0318873986930095,0,0,14.87767741935484,87.26588142673744,CEACAM1;BTG1;ZEB1
2840,GO_Biological_Process_2023,Regulation Of miRNA Metabolic Process (GO:2000628),3 of 8,0.0028354401198111,0.0318873986930095,0,0,14.87767741935484,87.26588142673744,DDX5;NFKB1;RELA
2841,GO_Biological_Process_2023,Tyrosine Phosphorylation Of STAT Protein (GO:0007260),3 of 8,0.0028354401198111,0.0318873986930095,0,0,14.87767741935484,87.26588142673744,IL15;JAK2;JAK1
2842,GO_Biological_Process_2023,Cell Surface Toll-Like Receptor Signaling Pathway (GO:0140895),4 of 16,0.0028439041096624,0.0318873986930095,0,0,8.273040482342807,48.501340858688856,OAS1;RIPK2;TNIP2;PIK3AP1
2843,GO_Biological_Process_2023,Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand (GO:0097192),4 of 16,0.0028439041096624,0.0318873986930095,0,0,8.273040482342807,48.501340858688856,BCL2A1;FAS;ITGAV;MCL1
2844,GO_Biological_Process_2023,Positive Regulation Of Lymphocyte Migration (GO:2000403),4 of 16,0.0028439041096624,0.0318873986930095,0,0,8.273040482342807,48.501340858688856,CXCL10;CCL20;CCL5;TNFRSF14
2845,GO_Biological_Process_2023,Protein Localization To Endoplasmic Reticulum (GO:0070972),4 of 16,0.0028439041096624,0.0318873986930095,0,0,8.273040482342807,48.501340858688856,PPP1R15A;HSPA5;BCAP29;MIA3
2846,GO_Biological_Process_2023,Acute Inflammatory Response (GO:0002526),5 of 26,0.0029287802640284,0.0327250517001508,0,0,5.914187149633463,34.498454529897806,CEBPB;PLSCR1;C2CD4A;C2CD4B;APOL2
2847,GO_Biological_Process_2023,Regulation Of Epithelial Cell Migration (GO:0010632),7 of 50,0.0030513165557725,0.033976251475696,0,0,4.049497783006063,23.45542866937818,MACF1;CEACAM1;GLIPR2;DAB2IP;PFN1;GLUL;HIF1A
2848,GO_Biological_Process_2023,Regulation Of Cell Cycle (GO:0051726),22 of 298,0.0031843638360177,0.035335458014845,0,0,1.9976037113718272,11.48522802679322,PPP1R15A;JUN;CDKN1A;GADD45B;CDKN2A;MX2;STAT3;DAB2IP;HNRNPU;INO80;ACTB;UHMK1;RHOB;CYLD;SDCBP;IRF1;TP53BP2;NBN;PIM2;JUNB;TRIM21;BIRC3
2849,GO_Biological_Process_2023,Negative Regulation Of Epithelial Cell Apoptotic Process (GO:1904036),6 of 38,0.0032374629504787,0.0358012225932665,0,0,4.660783678756476,26.72011108195923,CAST;MDK;TNIP2;TNFAIP3;ICAM1;NFE2L2
2850,GO_Biological_Process_2023,Regulation Of Secretion By Cell (GO:1903530),8 of 64,0.0032656331054789,0.0359890662103812,0,0,3.555844155844156,20.3547244913492,RAB3B;VAMP8;RALA;RHBDF2;RAB13;ARFIP1;STX4;RAB8B
2851,GO_Biological_Process_2023,Positive Regulation Of Cellular Component Biogenesis (GO:0044089),10 of 93,0.003291556494931,0.0361509515381841,0,0,3.0024786646586343,17.163353207538115,CHGA;LGALS3;SDCBP;VCP;SDC4;SYNPO2;DAB2IP;PFN1;FNIP2;CX3CL1
2852,GO_Biological_Process_2023,Positive Regulation Of Actin Filament Bundle Assembly (GO:0032233),7 of 51,0.0034204351915322,0.0373117303266123,0,0,3.95725739889164,22.469257993812423,PAK1;SYNPO2;TPM1;RAC1;CD47;PFN1;CX3CL1
2853,GO_Biological_Process_2023,Positive Regulation Of Leukocyte Mediated Cytotoxicity (GO:0001912),7 of 51,0.0034204351915322,0.0373117303266123,0,0,3.95725739889164,22.469257993812423,HLA-B;HLA-C;HLA-DRA;HLA-A;HLA-F;NECTIN2;HLA-E
2854,GO_Biological_Process_2023,Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),11 of 109,0.0034598564457812,0.037614250143662,0,0,2.7986589681504936,15.85867991044304,SDCBP;RNF144B;NUB1;VCP;DESI1;RNF19A;RNF19B;COMMD1;TRIB1;N4BP1;RBX1
2855,GO_Biological_Process_2023,Regulation Of Peptidase Activity (GO:0052547),5 of 27,0.0034809890139189,0.0377165745683205,0,0,5.645066447136305,31.953553293684138,CSTB;PSMA3;CTSL;CTSS;PSMB8
2856,GO_Biological_Process_2023,Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),9 of 79,0.0035180465414238,0.0378631229775981,0,0,3.202080624187256,18.091273303697484,UBB;TNIP1;RIPK2;SPHK1;ZC3H12A;MYCBP2;COMMD1;TANK;BIRC3
2857,GO_Biological_Process_2023,Vesicle Fusion (GO:0006906),9 of 79,0.0035180465414238,0.0378631229775981,0,0,3.202080624187256,18.091273303697484,VAMP8;STX12;UVRAG;SAMD9;STX17;RAB13;STX4;RAB8B;CHMP5
2858,GO_Biological_Process_2023,Carbohydrate Derivative Catabolic Process (GO:1901136),4 of 17,0.0036056487328587,0.0380425495814406,0,0,7.636255217650566,42.95587193061886,FBXO6;BPGM;NCCRP1;SAMHD1
2859,GO_Biological_Process_2023,Cellular Response To Glucocorticoid Stimulus (GO:0071385),4 of 17,0.0036056487328587,0.0380425495814406,0,0,7.636255217650566,42.95587193061886,ZFP36;HNRNPU;SSTR2;ZFP36L1
2860,GO_Biological_Process_2023,Central Nervous System Neuron Development (GO:0021954),4 of 17,0.0036056487328587,0.0380425495814406,0,0,7.636255217650566,42.95587193061886,NTRK2;HSP90AA1;B4GALT6;B4GALT5
2861,GO_Biological_Process_2023,Neuron Maturation (GO:0042551),4 of 17,0.0036056487328587,0.0380425495814406,0,0,7.636255217650566,42.95587193061886,B4GALT6;CX3CL1;RND1;B4GALT5
2862,GO_Biological_Process_2023,Positive Regulation Of Alpha-Beta T Cell Proliferation (GO:0046641),4 of 17,0.0036056487328587,0.0380425495814406,0,0,7.636255217650566,42.95587193061886,EBI3;HLA-A;JAK2;HLA-E
2863,GO_Biological_Process_2023,Positive Regulation Of Transcription From RNA Polymerase II Promoter In Response To Stress (GO:0036003),4 of 17,0.0036056487328587,0.0380425495814406,0,0,7.636255217650566,42.95587193061886,CEBPB;HSPA5;HIF1A;NFE2L2
2864,GO_Biological_Process_2023,Positive Regulation Of Cell Differentiation (GO:0045597),21 of 283,0.0036772340097426,0.0386710426253323,0,0,2.007522663789365,11.253357876695455,CEBPB;BTG1;CSF1;IGFBP3;AKR1B1;TENT5A;ACTB;NFKB1;ZFP36L1;SDCBP;CEACAM1;ZFP36;ZEB1;RRAS;GLIPR2;MDK;NOCT;ZC3H12A;DHX36;IL6ST;BCL9L
2865,GO_Biological_Process_2023,Regulation Of Mitochondrial Membrane Potential (GO:0051881),6 of 39,0.003702491947049,0.0388098341550617,0,0,4.519312293923693,25.30249603062845,SPART;HEBP2;VCP;PRELID1;UBB;PMAIP1
2866,GO_Biological_Process_2023,Regulation Of Gene Expression (GO:0010468),62 of 1127,0.0037346611736268,0.0390199339504257,0,0,1.4762950140320508,8.252634072675276,BTG1;CXCL8;CSF1;PDCD5;ZBTB20;AKR1B1;LITAF;BACH1;ACTG1;LAMP3;GPBP1;ZC3H12A;NFKBIZ;TRIM22;KDM6B;BTN3A1;SFMBT2;RFX3;BTN3A3;BAZ1A;BTN3A2;PARP9;ATP1B1;TAPBP;PTBP3;PLSCR1;TRAF3;IRF2;CEBPB;CRABP2;CREM;HIF1A;RELA;MLLT6;ZFP36L1;PDCD10;NOCT;DHX36;MIER1;RIPK1;LYN;NTRK2;EGR1;CD74;BTN2A2;DENND4A;TIPARP;STAT3;SMARCA5;RAB27A;TDRD7;INHBA;PARP14;NFKB1;PML;NFKB2;BCL6;HNRNPF;REL;LGMN;LIMS1;NFE2L2
2867,GO_Biological_Process_2023,Regulation Of Protein Localization To Nucleus (GO:1900180),7 of 52,0.0038226018287018,0.0398094908891993,0,0,3.869116587404525,21.53869100490631,DTX3L;LIMK2;CTNNA1;PARP9;GLUL;YWHAZ;JAK1
2868,GO_Biological_Process_2023,Negative Regulation Of Immune Response (GO:0050777),8 of 66,0.0039600221235523,0.0411075844954566,0,0,3.432870577698164,18.988943054531543,LYN;LGALS3;DHX58;RHBDF2;TNFAIP3;TRAFD1;TRIM21;YWHAZ
2869,GO_Biological_Process_2023,Negative Regulation Of Signal Transduction (GO:0009968),20 of 267,0.0040719230996073,0.0412820223124502,0,0,2.026962067234252,11.155669278769423,LYN;OTUD4;VCP;CXCL8;YWHAB;IGFBP3;PTCH1;DAB2IP;TNFAIP3;CX3CL1;FSTL3;SOCS1;TCIM;CCL5;TMBIM1;CD47;TRIB1;PTPN2;LGMN;GRINA
2870,GO_Biological_Process_2023,Pyroptosis (GO:0070269),5 of 28,0.0041041459854495,0.0412820223124502,0,0,5.399347544856291,29.6735053059974,GSDMD;IFI27;CASP3;CASP4;TRIM21
2871,GO_Biological_Process_2023,Actin Filament Organization (GO:0007015),13 of 144,0.0041295194285411,0.0412820223124502,0,0,2.4765055131467344,13.59501040007002,MARCKSL1;ACTN1;TPM1;SERPINB8;CD2AP;CNN3;RND1;MARCKS;MYO5B;DPYSL3;XIRP1;TAGLN2;RAC1
2872,GO_Biological_Process_2023,B Cell Homeostasis (GO:0001782),3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,DOCK10;LYN;TNFAIP3
2873,GO_Biological_Process_2023,Myeloid Dendritic Cell Differentiation (GO:0043011),3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,BATF2;BATF3;UBD
2874,GO_Biological_Process_2023,Negative Regulation Of Lipid Localization (GO:1905953),3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,NFKBIA;ITGAV;PTPN2
2875,GO_Biological_Process_2023,Negative Regulation Of Necroptotic Process (GO:0060546),3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,PELI1;RIPK1;BIRC3
2876,GO_Biological_Process_2023,Negative Regulation Of Toll-Like Receptor 4 Signaling Pathway (GO:0034144),3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,LYN;DAB2IP;TNFAIP3
2877,GO_Biological_Process_2023,Positive Regulation Of Monocyte Differentiation (GO:0045657),3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,CD74;CSF1;ZFP36L1
2878,GO_Biological_Process_2023,"Regulation Of CD8-positive, Alpha-Beta T Cell Activation (GO:2001185)",3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,IRF1;HLA-A;HLA-E
2879,GO_Biological_Process_2023,Regulation Of PERK-mediated Unfolded Protein Response (GO:1903897),3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,PPP1R15A;PPP1R15B;HSPA5
2880,GO_Biological_Process_2023,Regulation Of Mast Cell Activation (GO:0033003),3 of 9,0.0041307679256087,0.0412820223124502,0,0,12.397419354838709,68.05305427631832,LYN;PLSCR1;NECTIN2
2881,GO_Biological_Process_2023,Regulation Of Proteasomal Protein Catabolic Process (GO:0061136),7 of 53,0.0042596537887335,0.042438284495804,0,0,3.784807985112502,20.65962945347689,DESI1;UBB;LAMP3;PSME1;DAB2IP;PSME2;COMMD1
2882,GO_Biological_Process_2023,Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),25 of 364,0.0044849406772278,0.0439643179634189,0,0,1.8493381439825751,9.999426844051872,CXCL8;CSF1;PDCD5;AKR1B1;ECE1;HIF1A;RELA;ACTG1;PDCD10;LAMP3;ZC3H12A;DHX36;RAB29;RIPK1;EGR1;CD74;NTRK2;DTX3L;STAT3;RAB27A;INHBA;NFKBIA;PLSCR1;LIMS1;NFE2L2
2883,GO_Biological_Process_2023,Maintenance Of Protein Location In Nucleus (GO:0051457),4 of 18,0.0044947982007348,0.0439643179634189,0,0,7.090439276485788,38.32265086587793,SP100;HNRNPU;RANGAP1;PML
2884,GO_Biological_Process_2023,Negative Regulation Of T Cell Receptor Signaling Pathway (GO:0050860),4 of 18,0.0044947982007348,0.0439643179634189,0,0,7.090439276485788,38.32265086587793,LGALS3;CEACAM1;GBP1;PTPN2
2885,GO_Biological_Process_2023,Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),4 of 18,0.0044947982007348,0.0439643179634189,0,0,7.090439276485788,38.32265086587793,IFITM3;TRIM5;TRIM26;LY6E
2886,GO_Biological_Process_2023,Positive Regulation Of Macrophage Migration (GO:1905523),4 of 18,0.0044947982007348,0.0439643179634189,0,0,7.090439276485788,38.32265086587793,CSF1;MDK;CCL5;CX3CL1
2887,GO_Biological_Process_2023,Regulation Of Adaptive Immune Response (GO:0002819),4 of 18,0.0044947982007348,0.0439643179634189,0,0,7.090439276485788,38.32265086587793,AKIRIN2;IRF1;IRF7;IL6ST
2888,GO_Biological_Process_2023,Regulation Of Protein Ubiquitination (GO:0031396),11 of 113,0.0045614924944097,0.0444814631727592,0,0,2.6883452207480123,14.490464111853823,DNAJA1;HSP90AA1;UBB;RIPK2;SPHK1;MYCBP2;TNFAIP3;ISG15;COMMD1;N4BP1;BIRC3
2889,GO_Biological_Process_2023,Positive Regulation Of Cellular Catabolic Process (GO:0031331),13 of 146,0.0046415430532713,0.0451253339741,0,0,2.4390092879256966,13.10408572170561,DTX3L;ZBTB20;HIF1A;SUPV3L1;MOV10;TBK1;TRIM5;ZC3H12A;PIM2;TRIM38;TRIM21;TRIM22;OPTN
2890,GO_Biological_Process_2023,Negative Regulation Of Cell Migration (GO:0030336),14 of 163,0.0046616590879449,0.0451843944126713,0,0,2.3456727221617064,12.592471598331551,CD74;IGFBP3;TPM1;DAB2IP;ARID4B;MIA3;CX3CL1;RHOB;BST2;RAP2C;DPYSL3;RAC1;TIMP1;TRIB1
2891,GO_Biological_Process_2023,Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),7 of 54,0.0047334501478454,0.045605516693912,0,0,3.704086982918012,19.82835145166924,CREB3;CXCL10;CSF1;MDK;CCL5;MOSPD2;LGMN
2892,GO_Biological_Process_2023,Regulation Of Exocytosis (GO:0017157),7 of 54,0.0047334501478454,0.045605516693912,0,0,3.704086982918012,19.82835145166924,RAB3B;RAB2B;RALA;RAB13;RAB27A;STX4;RAB8B
2893,GO_Biological_Process_2023,Positive Regulation Of Response To Biotic Stimulus (GO:0002833),6 of 41,0.0047786525410607,0.0458638942228721,0,0,4.260621761658031,22.76704424662333,AKIRIN2;GBP5;PLSCR1;CCL5;IFI35;TRIM56
2894,GO_Biological_Process_2023,Maintenance Of Blood-Brain Barrier (GO:0035633),5 of 29,0.0048030243483865,0.0458638942228721,0,0,5.174105217766279,27.62200979126485,TJP1;LSR;F11R;ACTG1;TJP2
2895,GO_Biological_Process_2023,Positive Regulation Of Viral Genome Replication (GO:0045070),5 of 29,0.0048030243483865,0.0458638942228721,0,0,5.174105217766279,27.62200979126485,GBP7;STAU1;CCL5;IFIT1;SRPK1
2896,GO_Biological_Process_2023,Response To Molecule Of Bacterial Origin (GO:0002237),8 of 69,0.0052086765030727,0.0495902987777752,0,0,3.2635299127102404,17.157778390247746,CXCL8;GCH1;NOCT;PELI1;TNFAIP3;JAK2;TRIB1;CXCL2
